AI 銘柄分析 · 10年
Smith & Nephew plc
SN. · GBP · 分析基準日 2026-11-06
{ "method": "旧株主の実日数別現金受取＋2037以降毎年固定株数のSBC交付・有償発行・申込金を同時評価する動的終価", "price_GBP": 11.61, "market_cap_oku": 97.20288656, "expected_PV_oku": 80.20475177, "expected_IRR": 0.0697092425, "expected_value_to_market": 0.82512726, "valuation_date": "2026-11-06", "calculation_status": "Verified actuals and explicit nonverified projections are distinguished.", "terminal_revision": "corrected_paid_issue_cash_and_nonconstant_dilution_per_year" }
AIによるシナリオ分析です。基準日以降の出来事、株価や為替の変化は個別に確認が必要です。各数値は元の分析の単位と前提に従います。
分析の要約
{
"investment_thesis": "スポーツ医療の新製品回復と米国整形外科の再建が価値を左右。2026Q3の売上/利益見通し下方修正を起点に、SBCと資本配分を所有権台帳で別管理した。",
"principal_risks": "米国人工関節の売上構成下振れ、Bioactivesの米国償還による数量・価格減、股関節訴訟と製造品質、買収成果、FX、未確定の事業構成見直し。",
"cashflow_definition": "旧株主現金＝配当権利落ち日に確定した配当受取＋比例応募した買戻し代金。株式報酬交付・有償増資は旧株主の現金受領0。",
"terminal_definition": "2036-11-06時点の同一旧株主コホート価値。2037年以降の一定年株数を年次分母に反映。有償社員申込金は営業FCFEでなく調達資金として受け入れ、その年の発行前株主へ還元するという明示的な定常資本政策を適用。資本投入の受益を一度のみ計上し純負債を再控除しない。",
"status_and_limitation": "完全JSONは将来の定量モデルであり、日付と確率・為替・買戻し株価などは会社予想ではない。四半期末以降の正確な信託持分・株数・財務更新が必要。 2037以降の有償20万株/年・時価90%の想定は公表された制度確約ではない。将来の日付の再確認イベントはスケジュール上の目印で実際の監視や通知ではない。"
}
株数は2026年10月末の議決権株数から従業員信託20万株の未確認代理値を差し引く。予測はGBP/USD 1.3352固定。2037年以降の株式報酬と有償発行は仮定であり、毎年の希薄化と払込資金を反映する。予測の配当・買戻し・発行等の確認日を過ぎた場合、実績確認まで期待リターンを保留。2036年表示損益は暦年予測で、10年受取CFは終点まで。
事業
- 説明
関節置換・外傷/再建、スポーツ医療関節修復/関節鏡器具/耳鼻咽喉科、および高度創傷管理の医療機器・処置製品。病院の手術件数・保険償還・販売セット数に連動。
- portfolio_2025_reported_usdm
- orthopaedics
- 2437
- sports_medicine_ENT
- 1934
- advanced_wound
- 1793
- revenue_recognition
医療機器の大半は商品引渡しで売上認識。卸売向け創傷管理には流通在庫への曝露。
- competitive_moat_and_risks
整形外科はZimmer Biomet、Stryker、DePuy Synthes等との技術・営業力競争が激しい。スポーツ分野ではREGENETEN、CARTIHEAL、TESSA、CORI等、創傷ではPICO、LEAF、ALLEVYN等が差別化要素。ただし製品承認と償還は販売保証ではない。
- Orthopaedics_2026_Nov04_status
米国膝−7.3%、米国股関節−1.0%（2026Q3の基礎成長）、北米市場鈍化。LANDMARKセメントレス膝510(k)、CORI Hip 2027上市計画。DePuy Synthesとの協議は終了し事業売却/提携は未決定。
- Sports_2026_Nov04_status
スポーツ関節修復2026Q3+11.2% underlying、REGENETEN/CARTIHEAL/TENDON SEAM。TESSAの追加FDA用途は申請段階。
- Wound_2026_Nov04_status
2026Q3 Wound Bioactives−8.8% underlying。2026年米国皮膚代用物償還改定により数量・純価格がともに低下。PICO/LEAFデバイス+10.7%。
- research_and_development
2026H1 R&D 150m USDはIFRS費用として営業利益に既に反映。予測も年次RD費用として営業利益に含め、無形資産への二重加算をしない。
- manufacturing_litigation_legal_risks
金属対金属股関節訴訟、製造品質・供給制約、医療機器の回収、サイバー対策、薬機規制、訴訟賠償額超過。2025非IFRS調整にlegal and other 162m USDを含むため調整後利益を丸ごとIFRS基礎利益としない。
- fx
売上・利益の報告通貨はUSD。欧州・日本等の地域売上は為替で報告額と実質成長が乖離し得る。主計算はGBPUSD固定、FXの移動リスクは明記。
- M_and_A
2026年1月Integrity Orthopaedics買収、H1現金買収支出221m USD。2025年末Bioventus持分の評価戻入109m USDは一過性のため永続化しない。
- unverified_asp_volume_disclosure
処置件数×ネット単価を全製品全地域で会社が開示しているわけではない。実績数量・単価を捏造せず、2026=100指数・確定売上・仮定価格/数量成長率を完全台帳に分けた。
競争力・事業の質
- score_10_assumed
- 7
- strengths
内容を開く
- 1
スポーツ医療の二桁成長と新製品
- 2
創傷管理の安定的な治療需要
- 3
2025年実績FCF840m USD
- 4
中期の営業効率改善余地
- weaknesses
内容を開く
- 1
米国Hip/Kneeのシェア・営業回復が遅延
- 2
創傷Bioactives償還による数量・価格の同時圧迫
- 3
金属対金属股関節訴訟
- 4
買収ののれんと条件付対価
- 5
SBCと継続買戻しの資本配分リスク
- NCI_treatment
FY2025・H1 2026のIFRS利益は親会社帰属利益、H1損益包括利益すべて親会社帰属。未公表将来NCI=0を仮定。
業界と環境
- category
医療技術、再建整形、スポーツ軟部組織修復、高度創傷管理
- main_demand_drivers
内容を開く
- 1
高齢化による関節置換
- 2
スポーツ外傷と手術技術の普及
- 3
慢性創傷と陰圧閉鎖療法
- 4
医療償還と手術件数
- competitors
内容を開く
- 1
Stryker
- 2
Zimmer Biomet
- 3
Johnson & Johnson DePuy Synthes
- 4
Arthrex
- 5
Solventum
- 6
Mölnlycke
- 7
ConvaTec
- 8
Coloplast
- reimbursement_and_geography
米国皮膚代替製品償還とChina VBPを別々に扱う。米国整形外科数量/シェア問題と為替価格影響は同一要因に混ぜない。
- not_assumed_as_completed
DePuy Synthes事業との統合／整形外科資産売却は2026-11-06時点で確定していないためどのケースにも売却益や代金を仮計上しない。
財務・資本配分
- actual_reported_usdm
内容を開く
- FY2025_parent_equity
- 5289
- H1_2026_parent_equity
- 5180
- FY2025_dividends_paid
- 330
- FY2025_own_share_purchases
- 502
- FY2025_equity_settled_SBC_expense
- 43
- H1_2026_equity_settled_SBC_expense
- 34
- H1_2026_own_share_purchase_equity_reduction
- 250
- H1_2026_own_share_purchase_cash_paid
- 116
- H1_2026_own_share_purchase_contingent_commitment
- 113
- H1_2026_lease_inclusive_gross_borrowings
- 3785
- H1_2026_cash
- 754
- H1_2026_reported_net_debt
- 3019
- 2026_500m_USD_share_buyback_program
内容を開く
- announcement_date
2026-05-06
- completed_USDm_end_Q3_2026
- 250
- programme_USDm_total
- 500
- not_yet_reported_as_completed_USDm
- 250
- full_completion_deadline_described
2027-05頃、当初は発表から12か月内
- 注記
Remaining $250m is board programme not unconditional cash obligation; scenarios assume partial/full realization.
- cohort_rule
基準日時点の外部実効株式の全てを旧株主コホートと置く。配当はex日の旧株主株数に確定した権利を支払日まで維持し、自己株取得には旧株主がその時点の外部保有比率で比例応札、受取現金と売却株数を同時記帳。非売却モデルに途中切替しない。
- SBC_rule
売上原価・SG&A等に含まれるSBC費用控除後IFRS利益を採用。非現金SBCの資本繰入は利益計上の逆側であり株主の受取現金ではない。自己株/信託から従業員へ交付すると実効流通株が増え、旧コホート比率が減る。
- buyback_rule
会社支払額は会社現金・資本を減らす。旧コホート応札受取は保有比率で按分。応札した旧株数は減るので、終価に全当初株数を掛け戻さない。
- capital_ledger_identity
E_end=E_begin+IFRS_NI(after_SBC)+noncash_SBC_credit+issue_cash-issuer_cash_dividend-issuer_cash_buyback+OCI(assumed0); stock transfers within treasury/trust have no net total equity debit. Cash_end=Cash_begin+FCFE+issue_cash-company_payouts+borrowings-repayments. Debt_end=Debt_begin+borrowings-repayments.
- fcfe_identity
FCFE_before_equity_payouts=IFRS_parent_NI+depreciation_amortization+noncash_SBC-charge-CAPEX-working_capital_investment-cash_acquisitions-lease_principal_paid. Interest/tax is already in NI. Avoid extra subtract of debt at terminal.
- special_case_H1_buyback_commitment
At H1 2026 $250m is charged to total equity although only $116m has settled in cash; $113m future buyback obligation and $137m acquired consideration. Pre-basis cash proxy assumes $134m further settlement until Nov06, with zero duplicate equity debit.
- unknown_and_sensitive
内容を開く
- 1
Nov06 precise trust shares not published: proxy 0.2m
- 2
Oct31-Nov06 precise treasury/issued movements not confirmed
- 3
Post-H1 2026 actual cash/balance/net debt unreported
- 4
All future buybacks/share issue/grants/ex-dates are assumptions
- post_2036_employee_equity_financing_terminal_policy
内容を開く
- full_year_old_holder_CFs_to_2036_are_unchanged
- はい
- paid_issuer_subscriptions_classification
employee cash -> company cash (equity financing, NOT trading FCFE or net income); same-year passes to pre-issuance stockholders in terminal policy; company does not retain or reinvest it
- free_SBC_classification
no cash from new shares; IFRS SBC already expensed, FCFE noncash addback remains; extra effective economic shares dilute holders
- repurchase_sensitivity
repurchase all employee shares at fair price and credit the same employee subscription proceeds against gross cost. No additional SBC accounting debit.
- tranche_timing
annual aggregation at 2037-11-06 and each later anniversary, not actual forecast employee exercise dates
- share_price_and_h_discount
future paid issue exercise price =90% x fair year-end stock price solved from continuation cash flows; hypothetical, not actual ShareSave plan exercise terms
- source_key
company_fy2025_20f
評価の前提と確認
- 2025_revenue_usdm
- 6164
- 2026_H1_revenue_usdm
- 3097
- 2026_Q3_revenue_usdm
- 1551
- 2026_FY_reported_revenue_proxy_usdm
- 6411
- 計算式
Q4 estimated 1763 = FY reported growth target 6411 − H1 actual 3097 − Q3 actual 1551
- 2026_FY_revenue_growth_reported_proxy
- 0.04007138
- market_cap_oku_using_proxy
- 97.20288656
- 2025_reported_EPS_USD
- 0.721
- FY2025_2026_H1_SBC_already_in_IFRS_profit
- はい
- FY2025_reporting_vs_normalization
2025 IFRS親会社利益625mには金額・再現性の異なる一時要因があるため、調整後EPSAのみを終価へ延長しない。
- market_PER_not_terminal_anchor
- はい
- market_PBR_not_terminal_anchor
- はい
- future_repayment_at_terminal_net_debt_not_subtracted
- はい
- initial_stock_price_not_used_for_perpetuity
市場価格£11.61は旧株主投資額と2026-2036仮想買戻し価格曲線の起点のみ。2036終価は次期FCFE,k,g,希薄化で独立計算。
- GBPUSD_fixed_conversion_is_scenario_assumption
- はい
- strict_calendar_ten_year_endpoint_note
2026-11-06→2036-11-06は閏日3日を含み3653日、365.25除算の年数は10.001369。2026-11-06終値をt0、2036-11-06を指定終点として扱い、2036-11-07以降のキャッシュを期中CFに入れない。
- post2036_market_multiple_not_used_to_set_issuer_subscription_price
- はい
- post2036_issuer_subscription_price_reference
Fair ex-issuance price solved from fundamental FCFE, 90% assumed discount. Market PER/PBR not used.
資本コストの前提
- 資本コスト
- 9.50%
- applied_to
各旧株主コホートの時点別現金流入と同一集団の2036-11-06残存終価を現在価値に割り引く共通ハードル
- currency
GBP
- nominal
- はい
- component_based_reasoning
内容を開く
- risk_free_nominal_assumed
- 0.042
- long_run_equity_risk_premium_assumed
- 0.05
- business_specific_risk_assumed
- 0.003
- sum
- 0.095
- 注記
構成比率は分析上の仮定。英国債2026-11-06の実勢金利との厳密照合値ではない。各シナリオ終価のkは事業リスク別に別途設定。
事業別データ
事業別の内訳と、収録されている年度別データを確認できます。
10年のシナリオ
シナリオごとの確率、期間内の株主還元・追加負担、終価です。金額は億GBP。株主の範囲や受取時点は各分析の前提を確認してください。
| シナリオ | 確率 | 株主還元・追加負担 | 終価 |
|---|---|---|---|
| 最良 | 8.0% | 81.16 | 305.35 |
| 強気 | 22.0% | 66.39 | 206.18 |
| 中立 | 40.0% | 49.06 | 115.75 |
| 弱気 | 20.0% | 26.02 | 42.30 |
| 最悪 | 10.0% | 17.65 | 10.77 |
最良（確率 8.0%）
- annual_2027_to_2036_segment_base_vol_growth
- Orthopaedics
- 0.06
- Sports_Medicine_ENT
- 0.1
- Advanced_Wound_Management
- 0.07
- annual_2027_to_2036_segment_base_realised_net_price_growth
- Orthopaedics
- 0.011
- Sports_Medicine_ENT
- 0.011
- Advanced_Wound_Management
- 0.011
- region_volume_adjustments
- US
- -0.003
- Other_Established
- 0.002
- Emerging
- 0.006
- region_net_price_adjustments
- US
- 0.001
- Other_Established
- 0
- Emerging
- -0.003
- 2036_full_year_IFRS_operating_margin
- 0.215
- terminal_cost_of_equity
- 0.084
- terminal_perpetual_total_FCFE_growth
- 0.03
- future_discretionary_buybacks_fraction_of_FCFE_surplus
- 0.57
- 2026_announced_500m_buyback_remaining_completion_fraction_assumed
- 1
- annual_2027_plus_ESPP_new_shares_m_assumed
- 0.24
- annual_2027_plus_vested_awards_m_assumed
- 3.05
- buyback_execution_GBP_per_share_growth_from_11_61_assumed
- 0.097
- future_fixed_FX_USD_per_GBP
- 1.3352
確率の根拠
需要、価格、利益率と資本政策に関する分析上の確率仮定。
強気（確率 22.0%）
- annual_2027_to_2036_segment_base_vol_growth
- Orthopaedics
- 0.044
- Sports_Medicine_ENT
- 0.08
- Advanced_Wound_Management
- 0.053
- annual_2027_to_2036_segment_base_realised_net_price_growth
- Orthopaedics
- 0.006
- Sports_Medicine_ENT
- 0.009
- Advanced_Wound_Management
- 0.007
- region_volume_adjustments
- US
- -0.003
- Other_Established
- 0.002
- Emerging
- 0.006
- region_net_price_adjustments
- US
- 0.001
- Other_Established
- 0
- Emerging
- -0.003
- 2036_full_year_IFRS_operating_margin
- 0.195
- terminal_cost_of_equity
- 0.088
- terminal_perpetual_total_FCFE_growth
- 0.024
- future_discretionary_buybacks_fraction_of_FCFE_surplus
- 0.5
- 2026_announced_500m_buyback_remaining_completion_fraction_assumed
- 1
- annual_2027_plus_ESPP_new_shares_m_assumed
- 0.2
- annual_2027_plus_vested_awards_m_assumed
- 2.9
- buyback_execution_GBP_per_share_growth_from_11_61_assumed
- 0.072
- future_fixed_FX_USD_per_GBP
- 1.3352
確率の根拠
需要、価格、利益率と資本政策に関する分析上の確率仮定。
中立（確率 40.0%）
- annual_2027_to_2036_segment_base_vol_growth
- Orthopaedics
- 0.024
- Sports_Medicine_ENT
- 0.06
- Advanced_Wound_Management
- 0.035
- annual_2027_to_2036_segment_base_realised_net_price_growth
- Orthopaedics
- 0.002
- Sports_Medicine_ENT
- 0.006
- Advanced_Wound_Management
- 0.003
- region_volume_adjustments
- US
- -0.003
- Other_Established
- 0.002
- Emerging
- 0.006
- region_net_price_adjustments
- US
- 0.001
- Other_Established
- 0
- Emerging
- -0.003
- 2036_full_year_IFRS_operating_margin
- 0.165
- terminal_cost_of_equity
- 0.095
- terminal_perpetual_total_FCFE_growth
- 0.018
- future_discretionary_buybacks_fraction_of_FCFE_surplus
- 0.43
- 2026_announced_500m_buyback_remaining_completion_fraction_assumed
- 1
- annual_2027_plus_ESPP_new_shares_m_assumed
- 0.2
- annual_2027_plus_vested_awards_m_assumed
- 2.9
- buyback_execution_GBP_per_share_growth_from_11_61_assumed
- 0.042
- future_fixed_FX_USD_per_GBP
- 1.3352
確率の根拠
需要、価格、利益率と資本政策に関する分析上の確率仮定。
弱気（確率 20.0%）
- annual_2027_to_2036_segment_base_vol_growth
- Orthopaedics
- 0.004
- Sports_Medicine_ENT
- 0.025
- Advanced_Wound_Management
- 0.01
- annual_2027_to_2036_segment_base_realised_net_price_growth
- Orthopaedics
- -0.006
- Sports_Medicine_ENT
- 0
- Advanced_Wound_Management
- -0.004
- region_volume_adjustments
- US
- -0.003
- Other_Established
- 0.002
- Emerging
- 0.006
- region_net_price_adjustments
- US
- 0.001
- Other_Established
- 0
- Emerging
- -0.003
- 2036_full_year_IFRS_operating_margin
- 0.12
- terminal_cost_of_equity
- 0.108
- terminal_perpetual_total_FCFE_growth
- 0.008
- future_discretionary_buybacks_fraction_of_FCFE_surplus
- 0.12
- 2026_announced_500m_buyback_remaining_completion_fraction_assumed
- 0.8
- annual_2027_plus_ESPP_new_shares_m_assumed
- 0.28
- annual_2027_plus_vested_awards_m_assumed
- 3.15
- buyback_execution_GBP_per_share_growth_from_11_61_assumed
- -0.006
- future_fixed_FX_USD_per_GBP
- 1.3352
確率の根拠
需要、価格、利益率と資本政策に関する分析上の確率仮定。
最悪（確率 10.0%）
- annual_2027_to_2036_segment_base_vol_growth
- Orthopaedics
- -0.02
- Sports_Medicine_ENT
- 0
- Advanced_Wound_Management
- -0.012
- annual_2027_to_2036_segment_base_realised_net_price_growth
- Orthopaedics
- -0.013
- Sports_Medicine_ENT
- -0.005
- Advanced_Wound_Management
- -0.01
- region_volume_adjustments
- US
- -0.003
- Other_Established
- 0.002
- Emerging
- 0.006
- region_net_price_adjustments
- US
- 0.001
- Other_Established
- 0
- Emerging
- -0.003
- 2036_full_year_IFRS_operating_margin
- 0.08
- terminal_cost_of_equity
- 0.125
- terminal_perpetual_total_FCFE_growth
- 0
- future_discretionary_buybacks_fraction_of_FCFE_surplus
- 0
- 2026_announced_500m_buyback_remaining_completion_fraction_assumed
- 0.5
- annual_2027_plus_ESPP_new_shares_m_assumed
- 0.4
- annual_2027_plus_vested_awards_m_assumed
- 3.4
- buyback_execution_GBP_per_share_growth_from_11_61_assumed
- -0.03
- future_fixed_FX_USD_per_GBP
- 1.3352
確率の根拠
需要、価格、利益率と資本政策に関する分析上の確率仮定。
事業別の前提
- 1
内容を開く
- id
consolidated
- 数量
- 1
- 価格・単価
- 39.306379
- 営業利益
- 3.14451032
- 注記
2036年暦年の連結売上・SBC控除後のIFRS営業利益の予測。詳細内訳は年次台帳。
日付別キャッシュフロー
- 1
内容を開く
- year
- 0.106776180698
- 想定日
2026-12-15
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.45
- source_treasury_shares_m
- 0.45
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9994628047
- 2
内容を開く
- year
- 0.112251882272
- 想定日
2026-12-17
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.08
- discounted_issuer_subscription_gbp
- 10.413335
- issuer_cash_proceeds_oku
- 0.0083306678
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9993673637
- 3
内容を開く
- year
- 0.11498973306
- 想定日
2026-12-18
- 金額
- 0.5613582406
- 種類
proportional_old_holder_buyback_tender
- date_status
仮定
- 金額の単位
億GBP
- issuer_buyback_cash_oku
- 0.561713601
- assumed_execution_price_gbp
- 11.569407
- bought_total_shares_m
- 4.85516322
- tendered_old_cohort_shares_m
- 4.85209167
- old_holder_fraction_before
- 0.9993673637
- old_holder_fraction_after
- 0.9993673637
- program_classification
announced_remaining_assumed
- price_is_scenario_assumption_not_a_terminal_multiple
- はい
- 4
内容を開く
- year
- 0.323066392882
- 想定日
2027-03-04
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2026
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2027-03-25
- 5
内容を開く
- year
- 0.35318275154
- 想定日
2027-03-15
- 金額
- 0.374238827
- 種類
proportional_old_holder_buyback_tender
- date_status
仮定
- 金額の単位
億GBP
- issuer_buyback_cash_oku
- 0.374475734
- assumed_execution_price_gbp
- 11.485773
- bought_total_shares_m
- 3.26034423
- tendered_old_cohort_shares_m
- 3.25828162
- old_holder_fraction_before
- 0.9993673637
- old_holder_fraction_after
- 0.9993673637
- program_classification
announced_remaining_assumed
- price_is_scenario_assumption_not_a_terminal_multiple
- はい
- 6
内容を開く
- year
- 0.355920602327
- 想定日
2027-03-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.891
- source_employee_trust_shares_m
- 0.027
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9982627935
- 7
内容を開く
- year
- 0.380561259411
- 想定日
2027-03-25
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2026
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2027-03-26
- payment_date
2027-05-26
- board_declaration_date_assumed
2027-02-26
- usd_per_share
- 0.25
- gbp_per_share
- 0.18723787
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 830.5666575
- old_holder_entitlement_oku
- 1.5524337023
- issuer_dividend_liability_oku
- 1.5551352935
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2027-03-04
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2027-03-25
- 8
内容を開く
- year
- 0.550308008214
- 想定日
2027-05-26
- 金額
- 1.5524337023
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 1.5551352935
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2026
- dividend_kind
final
- 9
内容を開く
- year
- 0.607802874743
- 想定日
2027-06-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.924
- source_employee_trust_shares_m
- 0.028
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9971198892
- 10
内容を開く
- year
- 0.777549623546
- 想定日
2027-08-17
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 10.204438
- issuer_cash_proceeds_oku
- 0.0408177525
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9966404578
- 11
内容を開く
- year
- 0.859685147159
- 想定日
2027-09-16
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2027
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2027-10-07
- 12
内容を開く
- year
- 0.859685147159
- 想定日
2027-09-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.891
- source_employee_trust_shares_m
- 0.027
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9955419039
- 13
内容を開く
- year
- 0.917180013689
- 想定日
2027-10-07
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2027
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2027-10-08
- payment_date
2027-11-05
- board_declaration_date_assumed
2027-08-04
- usd_per_share
- 0.1624
- gbp_per_share
- 0.12162972
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 832.8366575
- old_holder_entitlement_oku
- 1.008460933
- issuer_dividend_liability_oku
- 1.0129768813
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2027-09-16
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2027-10-07
- 14
内容を開く
- year
- 0.996577686516
- 想定日
2027-11-05
- 金額
- 1.008460933
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 1.0129768813
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2027
- dividend_kind
interim
- 15
内容を開く
- year
- 1.108829568789
- 想定日
2027-12-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.594
- source_employee_trust_shares_m
- 0.018
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9948108791
- 16
内容を開く
- year
- 1.338809034908
- 想定日
2028-03-09
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2027
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2028-03-30
- 17
内容を開く
- year
- 1.357973990418
- 想定日
2028-03-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.891
- source_employee_trust_shares_m
- 0.027
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9937163527
- 18
内容を開く
- year
- 1.396303901437
- 想定日
2028-03-30
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2027
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2028-03-31
- payment_date
2028-05-24
- board_declaration_date_assumed
2028-02-25
- usd_per_share
- 0.1879876
- gbp_per_share
- 0.14079357
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 834.3666575
- old_holder_entitlement_oku
- 1.1673529895
- issuer_dividend_liability_oku
- 1.1747346075
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2028-03-09
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2028-03-30
- 19
内容を開く
- year
- 1.54688569473
- 想定日
2028-05-24
- 金額
- 1.1673529895
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 1.1747346075
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2027
- dividend_kind
final
- 20
内容を開く
- year
- 1.609856262834
- 想定日
2028-06-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.924
- source_employee_trust_shares_m
- 0.028
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9925838292
- 21
内容を開く
- year
- 1.779603011636
- 想定日
2028-08-17
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 9.897686
- issuer_cash_proceeds_oku
- 0.0395907436
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9921087488
- 22
内容を開く
- year
- 1.856262833676
- 想定日
2028-09-14
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2028
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2028-10-05
- 23
内容を開く
- year
- 1.859000684463
- 想定日
2028-09-15
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.891
- source_employee_trust_shares_m
- 0.027
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.991020157
- 24
内容を開く
- year
- 1.913757700205
- 想定日
2028-10-05
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2028
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2028-10-06
- payment_date
2028-11-03
- board_declaration_date_assumed
2028-08-04
- usd_per_share
- 0.140155
- gbp_per_share
- 0.10496932
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 836.6366575
- old_holder_entitlement_oku
- 0.870325569
- issuer_dividend_liability_oku
- 0.8782117728
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2028-09-14
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2028-10-05
- 25
内容を開く
- year
- 1.993155373032
- 想定日
2028-11-03
- 金額
- 0.870325569
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.8782117728
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2028
- dividend_kind
interim
- 26
内容を開く
- year
- 2.108145106092
- 想定日
2028-12-15
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.594
- source_employee_trust_shares_m
- 0.018
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9902957553
- 27
内容を開く
- year
- 2.335386721424
- 想定日
2029-03-08
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2028
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2029-03-29
- 28
内容を開く
- year
- 2.357289527721
- 想定日
2029-03-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9892111363
- 29
内容を開く
- year
- 2.392881587953
- 想定日
2029-03-29
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2028
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2029-03-30
- payment_date
2029-05-23
- board_declaration_date_assumed
2029-02-26
- usd_per_share
- 0.1804615
- gbp_per_share
- 0.13515692
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 838.1666575
- old_holder_entitlement_oku
- 1.120618182
- issuer_dividend_liability_oku
- 1.1328402409
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2029-03-08
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2029-03-29
- 30
内容を開く
- year
- 2.543463381246
- 想定日
2029-05-23
- 金額
- 1.120618182
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 1.1328402409
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2028
- dividend_kind
final
- 31
内容を開く
- year
- 2.60643394935
- 想定日
2029-06-15
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.952
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9880888528
- 32
内容を開く
- year
- 2.778918548939
- 想定日
2029-08-17
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 9.600955
- issuer_cash_proceeds_oku
- 0.0384038219
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9876180645
- 33
内容を開く
- year
- 2.852840520192
- 想定日
2029-09-13
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2029
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2029-10-04
- 34
内容を開く
- year
- 2.855578370979
- 想定日
2029-09-14
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9865392999
- 35
内容を開く
- year
- 2.910335386721
- 想定日
2029-10-04
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2029
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2029-10-05
- payment_date
2029-11-05
- board_declaration_date_assumed
2029-08-03
- usd_per_share
- 0.1282466
- gbp_per_share
- 0.09605049
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 840.4366575
- old_holder_entitlement_oku
- 0.7963775004
- issuer_dividend_liability_oku
- 0.8072435639
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2029-09-13
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2029-10-04
- 36
内容を開く
- year
- 2.99794661191
- 想定日
2029-11-05
- 金額
- 0.7963775004
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.8072435639
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2029
- dividend_kind
interim
- 37
内容を開く
- year
- 3.104722792608
- 想定日
2029-12-14
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.612
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9858214317
- 38
内容を開く
- year
- 3.33196440794
- 想定日
2030-03-07
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2029
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2030-03-28
- 39
内容を開く
- year
- 3.353867214237
- 想定日
2030-03-15
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9847465862
- 40
内容を開く
- year
- 3.38945927447
- 想定日
2030-03-28
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2029
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2030-03-29
- payment_date
2030-05-22
- board_declaration_date_assumed
2030-02-26
- usd_per_share
- 0.1715416
- gbp_per_share
- 0.12847632
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 841.9666575
- old_holder_entitlement_oku
- 1.0652277023
- issuer_dividend_liability_oku
- 1.0817277432
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2030-03-07
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2030-03-28
- 41
内容を開く
- year
- 3.540041067762
- 想定日
2030-05-22
- 金額
- 1.0652277023
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 1.0817277432
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2029
- dividend_kind
final
- 42
内容を開く
- year
- 3.603011635866
- 想定日
2030-06-14
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.952
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9836344044
- 43
内容を開く
- year
- 3.775496235455
- 想定日
2030-08-16
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 9.313898
- issuer_cash_proceeds_oku
- 0.0372555906
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9831678504
- 44
内容を開く
- year
- 3.849418206708
- 想定日
2030-09-12
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2030
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2030-10-03
- 45
内容を開く
- year
- 3.860369609856
- 想定日
2030-09-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9820987804
- 46
内容を開く
- year
- 3.906913073238
- 想定日
2030-10-03
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2030
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2030-10-04
- payment_date
2030-11-05
- board_declaration_date_assumed
2030-08-02
- usd_per_share
- 0.1199153
- gbp_per_share
- 0.08981072
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 844.2366575
- old_holder_entitlement_oku
- 0.7446420811
- issuer_dividend_liability_oku
- 0.7582150553
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2030-09-12
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2030-10-03
- 47
内容を開く
- year
- 3.997262149213
- 想定日
2030-11-05
- 金額
- 0.7446420811
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.7582150553
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2030
- dividend_kind
interim
- 48
内容を開く
- year
- 4.109514031485
- 想定日
2030-12-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.612
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9813873577
- 49
内容を開く
- year
- 4.328542094456
- 想定日
2031-03-06
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2030
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2031-03-27
- 50
内容を開く
- year
- 4.350444900753
- 想定日
2031-03-14
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9803221542
- 51
内容を開く
- year
- 4.386036960986
- 想定日
2031-03-27
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2030
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2031-03-28
- payment_date
2031-05-28
- board_declaration_date_assumed
2031-02-26
- usd_per_share
- 0.1596889
- gbp_per_share
- 0.1195992
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 845.7666575
- old_holder_entitlement_oku
- 0.9916254567
- issuer_dividend_liability_oku
- 1.0115301917
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2031-03-06
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2031-03-27
- 52
内容を開く
- year
- 4.555783709788
- 想定日
2031-05-28
- 金額
- 0.9916254567
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 1.0115301917
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2030
- dividend_kind
final
- 53
内容を開く
- year
- 4.607802874743
- 想定日
2031-06-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.952
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9792199384
- 54
内容を開く
- year
- 4.772073921971
- 想定日
2031-08-15
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 9.035423
- issuer_cash_proceeds_oku
- 0.0361416902
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9787575617
- 55
内容を開く
- year
- 4.845995893224
- 想定日
2031-09-11
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2031
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2031-10-02
- 56
内容を開く
- year
- 4.859685147159
- 想定日
2031-09-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9776980562
- 57
内容を開く
- year
- 4.903490759754
- 想定日
2031-10-02
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2031
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2031-10-03
- payment_date
2031-11-05
- board_declaration_date_assumed
2031-08-04
- usd_per_share
- 0.1118417
- gbp_per_share
- 0.08376397
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 848.0366575
- old_holder_entitlement_oku
- 0.6945070151
- issuer_dividend_liability_oku
- 0.7103491826
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2031-09-11
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2031-10-02
- 58
内容を開く
- year
- 4.996577686516
- 想定日
2031-11-05
- 金額
- 0.6945070151
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.7103491826
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2031
- dividend_kind
interim
- 59
内容を開く
- year
- 5.108829568789
- 想定日
2031-12-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.612
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9769929927
- 60
内容を開く
- year
- 5.325119780972
- 想定日
2032-03-04
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2031
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2032-03-25
- 61
内容を開く
- year
- 5.357973990418
- 想定日
2032-03-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9759373021
- 62
内容を開く
- year
- 5.382614647502
- 想定日
2032-03-25
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2031
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2032-03-26
- payment_date
2032-05-26
- board_declaration_date_assumed
2032-02-26
- usd_per_share
- 0.1481762
- gbp_per_share
- 0.11097681
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 849.5666575
- old_holder_entitlement_oku
- 0.9201351483
- issuer_dividend_liability_oku
- 0.942821989
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2032-03-04
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2032-03-25
- 63
内容を開く
- year
- 5.552361396304
- 想定日
2032-05-26
- 金額
- 0.9201351483
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.942821989
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2031
- dividend_kind
final
- 64
内容を開く
- year
- 5.609856262834
- 想定日
2032-06-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.952
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9748449189
- 65
内容を開く
- year
- 5.779603011636
- 想定日
2032-08-17
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 8.76235
- issuer_cash_proceeds_oku
- 0.0350494007
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9743866636
- 66
内容を開く
- year
- 5.86173853525
- 想定日
2032-09-16
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2032
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2032-10-07
- 67
内容を開く
- year
- 5.86173853525
- 想定日
2032-09-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.973336595
- 68
内容を開く
- year
- 5.91923340178
- 想定日
2032-10-07
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2032
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2032-10-08
- payment_date
2032-11-05
- board_declaration_date_assumed
2032-08-04
- usd_per_share
- 0.1040072
- gbp_per_share
- 0.07789631
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 851.8366575
- old_holder_entitlement_oku
- 0.6458568654
- issuer_dividend_liability_oku
- 0.6635493505
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2032-09-16
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2032-10-07
- 69
内容を開く
- year
- 5.998631074606
- 想定日
2032-11-05
- 金額
- 0.6458568654
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.6635493505
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2032
- dividend_kind
interim
- 70
内容を開く
- year
- 6.110882956879
- 想定日
2032-12-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.612
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9726378057
- 71
内容を開く
- year
- 6.340862422998
- 想定日
2033-03-10
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2032
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2033-03-31
- 72
内容を開く
- year
- 6.357289527721
- 想定日
2033-03-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.971591501
- 73
内容を開く
- year
- 6.398357289528
- 想定日
2033-03-31
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2032
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2033-04-01
- payment_date
2033-05-25
- board_declaration_date_assumed
2033-02-25
- usd_per_share
- 0.1370357
- gbp_per_share
- 0.10263306
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 853.3666575
- old_holder_entitlement_oku
- 0.8509551521
- issuer_dividend_liability_oku
- 0.8758363481
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2033-03-10
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2033-03-31
- 74
内容を開く
- year
- 6.54893908282
- 想定日
2033-05-25
- 金額
- 0.8509551521
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.8758363481
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2032
- dividend_kind
final
- 75
内容を開く
- year
- 6.609171800137
- 想定日
2033-06-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.952
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9705088194
- 76
内容を開く
- year
- 6.778918548939
- 想定日
2033-08-17
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 8.499657
- issuer_cash_proceeds_oku
- 0.0339986274
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9700546307
- 77
内容を開く
- year
- 6.858316221766
- 想定日
2033-09-15
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2033
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2033-10-06
- 78
内容を開く
- year
- 6.861054072553
- 想定日
2033-09-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9690138734
- 79
内容を開く
- year
- 6.915811088296
- 想定日
2033-10-06
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2033
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2033-10-07
- payment_date
2033-11-04
- board_declaration_date_assumed
2033-08-04
- usd_per_share
- 0.0964171
- gbp_per_share
- 0.07221175
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 855.6366575
- old_holder_entitlement_oku
- 0.598724807
- issuer_dividend_liability_oku
- 0.6178702116
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2033-09-15
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2033-10-06
- 80
内容を開く
- year
- 6.995208761123
- 想定日
2033-11-04
- 金額
- 0.598724807
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.6178702116
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2033
- dividend_kind
interim
- 81
内容を開く
- year
- 7.110198494182
- 想定日
2033-12-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.612
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9683212749
- 82
内容を開く
- year
- 7.337440109514
- 想定日
2034-03-09
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2033
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2034-03-30
- 83
内容を開く
- year
- 7.356605065024
- 想定日
2034-03-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9672842316
- 84
内容を開く
- year
- 7.394934976044
- 想定日
2034-03-30
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2033
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2034-03-31
- payment_date
2034-05-24
- board_declaration_date_assumed
2034-02-24
- usd_per_share
- 0.1262371
- gbp_per_share
- 0.09454546
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 857.1666575
- old_holder_entitlement_oku
- 0.7838989053
- issuer_dividend_liability_oku
- 0.8104121619
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2034-03-09
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2034-03-30
- 85
内容を開く
- year
- 7.545516769336
- 想定日
2034-05-24
- 金額
- 0.7838989053
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.8104121619
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2033
- dividend_kind
final
- 86
内容を開く
- year
- 7.60848733744
- 想定日
2034-06-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.952
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9662111229
- 87
内容を開く
- year
- 7.778234086242
- 想定日
2034-08-17
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 8.244839
- issuer_cash_proceeds_oku
- 0.0329793562
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.965760947
- 88
内容を開く
- year
- 7.854893908282
- 想定日
2034-09-14
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2034
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2034-10-05
- 89
内容を開く
- year
- 7.857631759069
- 想定日
2034-09-15
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9647293776
- 90
内容を開く
- year
- 7.912388774812
- 想定日
2034-10-05
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2034
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2034-10-06
- payment_date
2034-11-03
- board_declaration_date_assumed
2034-08-04
- usd_per_share
- 0.0890617
- gbp_per_share
- 0.06670288
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 859.4366575
- old_holder_entitlement_oku
- 0.5530494849
- issuer_dividend_liability_oku
- 0.5732690408
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2034-09-14
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2034-10-05
- 91
内容を開く
- year
- 7.991786447639
- 想定日
2034-11-03
- 金額
- 0.5530494849
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.5732690408
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2034
- dividend_kind
interim
- 92
内容を開く
- year
- 8.106776180698
- 想定日
2034-12-15
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.612
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9640428881
- 93
内容を開く
- year
- 8.33401779603
- 想定日
2035-03-08
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2034
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2035-03-29
- 94
内容を開く
- year
- 8.355920602327
- 想定日
2035-03-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9630149837
- 95
内容を開く
- year
- 8.39151266256
- 想定日
2035-03-29
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2034
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2035-03-30
- payment_date
2035-05-23
- board_declaration_date_assumed
2035-02-26
- usd_per_share
- 0.115766
- gbp_per_share
- 0.08670312
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 860.9666575
- old_holder_entitlement_oku
- 0.7188761742
- issuer_dividend_liability_oku
- 0.7464849316
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2035-03-08
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2035-03-29
- 96
内容を開く
- year
- 8.542094455852
- 想定日
2035-05-23
- 金額
- 0.7188761742
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.7464849316
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2034
- dividend_kind
final
- 97
内容を開く
- year
- 8.605065023956
- 想定日
2035-06-15
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.952
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9619513216
- 98
内容を開く
- year
- 8.777549623546
- 想定日
2035-08-17
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 7.997661
- issuer_cash_proceeds_oku
- 0.0319906424
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9615051054
- 99
内容を開く
- year
- 8.851471594798
- 想定日
2035-09-13
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2035
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2035-10-04
- 100
内容を開く
- year
- 8.854209445585
- 想定日
2035-09-14
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9604826028
- 101
内容を開く
- year
- 8.908966461328
- 想定日
2035-10-04
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2035
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2035-10-05
- payment_date
2035-11-05
- board_declaration_date_assumed
2035-08-03
- usd_per_share
- 0.0819311
- gbp_per_share
- 0.0613624
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 863.2366575
- old_holder_entitlement_oku
- 0.5087702637
- issuer_dividend_liability_oku
- 0.5297027371
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2035-09-13
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2035-10-04
- 102
内容を開く
- year
- 8.996577686516
- 想定日
2035-11-05
- 金額
- 0.5087702637
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.5297027371
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2035
- dividend_kind
interim
- 103
内容を開く
- year
- 9.103353867214
- 想定日
2035-12-14
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.612
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9598021418
- 104
内容を開く
- year
- 9.330595482546
- 想定日
2036-03-06
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2035
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2036-03-27
- 105
内容を開く
- year
- 9.352498288843
- 想定日
2036-03-14
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9587832561
- 106
内容を開く
- year
- 9.388090349076
- 想定日
2036-03-27
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2035
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2036-03-28
- payment_date
2036-05-28
- board_declaration_date_assumed
2036-02-26
- usd_per_share
- 0.1056089
- gbp_per_share
- 0.07909591
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 864.7666575
- old_holder_entitlement_oku
- 0.6558030084
- issuer_dividend_liability_oku
- 0.6839950575
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2036-03-06
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2036-03-27
- 107
内容を開く
- year
- 9.557837097878
- 想定日
2036-05-28
- 金額
- 0.6558030084
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.6839950575
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2035
- dividend_kind
final
- 108
内容を開く
- year
- 9.609856262834
- 想定日
2036-06-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.952
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9577289163
- 109
内容を開く
- year
- 9.774127310062
- 想定日
2036-08-15
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 7.75854
- issuer_cash_proceeds_oku
- 0.031034158
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9572866079
- 110
内容を開く
- year
- 9.848049281314
- 想定日
2036-09-11
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
- 未確認
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2036
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- ex_date_assumed
2036-10-02
- 111
内容を開く
- year
- 9.86173853525
- 想定日
2036-09-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9562730532
- 112
内容を開く
- year
- 9.905544147844
- 想定日
2036-10-02
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2036
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
- 未確認
- record_date
2036-10-03
- payment_date
2036-11-05
- board_declaration_date_assumed
2036-08-04
- usd_per_share
- 0.075016
- gbp_per_share
- 0.05618332
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 867.0366575
- old_holder_entitlement_oku
- 0.4658293088
- issuer_dividend_liability_oku
- 0.4871300172
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2036-09-11
- needs_issuer_confirmation_before_date
- はい
- ex_date_assumed
2036-10-02
- 113
内容を開く
- year
- 9.998631074606
- 想定日
2036-11-05
- 金額
- 0.4658293088
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.4871300172
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2036
- dividend_kind
interim
その他の数値・前提
- label
最悪
- scenario_status
analyst_assumption_not_company_guidance
- drivers
内容を開く
- annual_2027_to_2036_segment_base_vol_growth
- Orthopaedics
- -0.02
- Sports_Medicine_ENT
- 0
- Advanced_Wound_Management
- -0.012
- annual_2027_to_2036_segment_base_realised_net_price_growth
- Orthopaedics
- -0.013
- Sports_Medicine_ENT
- -0.005
- Advanced_Wound_Management
- -0.01
- region_volume_adjustments
- US
- -0.003
- Other_Established
- 0.002
- Emerging
- 0.006
- region_net_price_adjustments
- US
- 0.001
- Other_Established
- 0
- Emerging
- -0.003
- 2036_full_year_IFRS_operating_margin
- 0.08
- terminal_cost_of_equity
- 0.125
- terminal_perpetual_total_FCFE_growth
- 0
- future_discretionary_buybacks_fraction_of_FCFE_surplus
- 0
- 2026_announced_500m_buyback_remaining_completion_fraction_assumed
- 0.5
- annual_2027_plus_ESPP_new_shares_m_assumed
- 0.4
- annual_2027_plus_vested_awards_m_assumed
- 3.4
- buyback_execution_GBP_per_share_growth_from_11_61_assumed
- -0.03
- future_fixed_FX_USD_per_GBP
- 1.3352
- annual_ledger
内容を開く
- 1
内容を開く
- fiscal_year
- 2026
- period_start_inclusive
2026-11-07
- 期間末
2026-12-31
- days_booked
- 55
- days_full_calendar_year
- 365
- accrual_fraction_of_calendar_year
- 0.150684931507
- is_partial_period
- はい
- period_status
発行会社実績からの部分期間推計
- financials_oku_gbp
内容を開く
- year
- 2026
- revenue
- 7.42863351
- revenue_usd_m
- 991.87114583
- cogs
- 2.16916098
- sga_including_sbc
- 3.9636888
- rd
- 0.36028873
- operating_profit
- 0.93549499
- 営業利益率
- 12.59%
- finance_cost_net
- 0.06370211
- associates_profit
- 0.00858174
- pretax_profit
- 0.88037462
- tax_expense
- 0.20248616
- parent_profit_after_sbc
- 0.67788846
- sbc_expense_within_sga
- 0.07674188
- sbc_equity_credit
- 0.07674188
- depreciation_amortization
- 0.6771342
- capital_expenditure
- 0.49656508
- net_working_capital_investment
- -0.68684232
- cash_acquisitions
- 0
- lease_principal_paid
- 0.06997053
- fcfe_before_equity_distributions
- 1.55207124
- segment_revenue_usd_m
- Orthopaedics
- 386.5090625
- Sports_Medicine_ENT
- 327.435625
- Advanced_Wound_Management
- 277.92645833333
- geography_revenue_usd_m
- 未確認
- volume_price_region_matrix
- 未確認
- dividend_policy_normalization_usd_m
- 未確認
- dividend_policy_adjusted_profit_proxy_usd_m
- 未確認
- capital
内容を開く
- begin_parent_equity_oku
- 39.43229479
- period_parent_profit_after_sbc_oku
- 0.67788846
- noncash_sbc_equity_credit_oku
- 0.07674188
- new_issue_cash_proceeds_oku
- 0.00833067
- issuer_paid_dividends_oku
- 0
- issuer_gross_buybacks_oku
- 0.5617136
- ending_parent_equity_oku
- 39.63354219
- begin_gross_financing_debt_oku
- 28.34781306
- begin_cash_oku
- 6.05901738
- operating_fcfe_before_distributions_oku
- 1.55207124
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 2.55770568
- ending_gross_financing_debt_oku
- 25.79010738
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 21.29010738
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 877.750024
- begin_treasury_m
- 40.315859
- begin_employee_trust_m
- 0.2
- begin_old_cohort_m
- 837.234165
- new_issuance_m
- 0.08
- treasury_or_trust_shares_delivered_to_employees_m
- 0.45
- issuer_buyback_shares_m
- 4.8551632
- old_cohort_proportionally_tendered_shares_m
- 4.8520917
- ending_issued_m
- 877.830024
- ending_treasury_m
- 44.7210222
- ending_employee_trust_m
- 0.2
- ending_economic_shares_m
- 832.9090018
- ending_old_cohort_shares_m
- 832.3820733
- ending_old_cohort_economic_fraction
- 0.99936736373
- old_holder_cash_oku
- dividends_received_oku
- 0
- proportional_tender_proceeds_oku
- 0.5613582406
- total_received_oku
- 0.5613582406
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- complete_calendar_year_projection_reference_not_fully_booked
内容を開く
- fy_2026_reported_guidance_sales_usd_m_proxy
- 6411
- fy_2026_full_year_IFRS_operating_profit_usd_m_estimate
- 850
- fy_2026_full_year_parent_profit_usd_m_estimate
- 585
- fy_2026_full_year_capex_usd_m_estimate
- 440
- fy_2026_full_year_sbc_usd_m_estimate
- 68
- fy_2026_full_year_fcf_usd_m_company_guidance
- 750
- h1_actual_sales_usd_m
- 3097
- q3_actual_sales_usd_m
- 1551
- q4_full_estimated_sales_usd_m
- 1763
- q4_post_basis_day_fraction
- 0.57291666666667
- full_year_is_forecast
- はい
- 2
内容を開く
- fiscal_year
- 2027
- period_start_inclusive
2027-01-01
- 期間末
2027-12-31
- days_booked
- 365
- days_full_calendar_year
- 365
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2027
- segment_revenue_usd_m
- Orthopaedics
- 2408.34194
- Sports_Medicine_ENT
- 2095.37738
- Advanced_Wound_Management
- 1776.0336
- geography_revenue_usd_m
- US
- 3269.40954
- Other_Established
- 1919.95037
- Emerging
- 1090.39302
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 97.7
- net_realised_price_index_2026_100
- 98.8
- revenue_usd_m
- 1321.94548
- 売上高
- 9.90073009
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 98.2
- net_realised_price_index_2026_100
- 98.7
- revenue_usd_m
- 724.0178
- 売上高
- 5.42254193
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 98.6
- net_realised_price_index_2026_100
- 98.4
- revenue_usd_m
- 362.37866
- 売上高
- 2.71404032
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 99.7
- net_realised_price_index_2026_100
- 99.6
- revenue_usd_m
- 1150.2058
- 売上高
- 8.61448322
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 100.2
- net_realised_price_index_2026_100
- 99.5
- revenue_usd_m
- 608.90167
- 売上高
- 4.56037802
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 100.6
- net_realised_price_index_2026_100
- 99.2
- revenue_usd_m
- 336.26991
- 売上高
- 2.5184984
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 98.5
- net_realised_price_index_2026_100
- 99.1
- revenue_usd_m
- 797.25826
- 売上高
- 5.97107745
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 99
- net_realised_price_index_2026_100
- 99
- revenue_usd_m
- 587.03089
- 売上高
- 4.39657651
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 99.4
- net_realised_price_index_2026_100
- 98.7
- revenue_usd_m
- 391.74445
- 売上高
- 2.93397577
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 47.03230171
- revenue_usd_m
- 6279.75292377
- cogs
- 13.84160639
- sga_including_sbc
- 24.91413155
- rd
- 2.28812148
- operating_profit
- 5.98844229
- 営業利益率
- 12.73%
- finance_cost_net
- 1.09655869
- associates_profit
- 0.06740563
- pretax_profit
- 4.95928923
- tax_expense
- 1.14063652
- parent_profit_after_sbc
- 3.81865271
- sbc_expense_within_sga
- 0.51737145
- sbc_equity_credit
- 0.51737145
- depreciation_amortization
- 4.32697176
- capital_expenditure
- 4.32697176
- net_working_capital_investment
- 4.25244976
- cash_acquisitions
- 0.37625841
- lease_principal_paid
- 0.44680687
- fcfe_before_equity_distributions
- -0.73949089
- dividend_policy_adjusted_profit_proxy_usd_m
- 768.0025408
- dividend_policy_normalization_usd_m
- 258.13603114
- capital
内容を開く
- begin_parent_equity_oku
- 39.63354219
- period_parent_profit_after_sbc_oku
- 3.81865271
- noncash_sbc_equity_credit_oku
- 0.51737145
- new_issue_cash_proceeds_oku
- 0.04081775
- issuer_paid_dividends_oku
- 2.56811217
- issuer_gross_buybacks_oku
- 0.37447573
- ending_parent_equity_oku
- 41.06779618
- begin_gross_financing_debt_oku
- 25.79010738
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- -0.73949089
- additional_new_debt_borrowings_oku
- 3.64126105
- debt_principal_repayment_oku
- 0
- ending_gross_financing_debt_oku
- 29.43136842
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 24.93136842
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 877.830024
- begin_treasury_m
- 44.7210222
- begin_employee_trust_m
- 0.2
- begin_old_cohort_m
- 832.3820733
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 3.2603442
- old_cohort_proportionally_tendered_shares_m
- 3.2582816
- ending_issued_m
- 878.230024
- ending_treasury_m
- 44.6813665
- ending_employee_trust_m
- 0.1
- ending_economic_shares_m
- 833.4486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.99481087911
- old_holder_cash_oku
- dividends_received_oku
- 2.5608946353
- proportional_tender_proceeds_oku
- 0.374238827
- total_received_oku
- 2.9351334623
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 3
内容を開く
- fiscal_year
- 2028
- period_start_inclusive
2028-01-01
- 期間末
2028-12-31
- days_booked
- 366
- days_full_calendar_year
- 366
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2028
- segment_revenue_usd_m
- Orthopaedics
- 2329.37339
- Sports_Medicine_ENT
- 2084.81827
- Advanced_Wound_Management
- 1737.91253
- geography_revenue_usd_m
- US
- 3196.4421
- Other_Established
- 1884.16053
- Emerging
- 1071.50156
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 95.4529
- net_realised_price_index_2026_100
- 97.6144
- revenue_usd_m
- 1276.04225
- 売上高
- 9.55693714
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 96.4324
- net_realised_price_index_2026_100
- 97.4169
- revenue_usd_m
- 701.74267
- 売上高
- 5.255712
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 97.2196
- net_realised_price_index_2026_100
- 96.8256
- revenue_usd_m
- 351.58848
- 売上高
- 2.63322706
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 99.4009
- net_realised_price_index_2026_100
- 99.2016
- revenue_usd_m
- 1142.16816
- 売上高
- 8.55428521
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 100.4004
- net_realised_price_index_2026_100
- 99.0025
- revenue_usd_m
- 607.06888
- 売上高
- 4.54665128
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 101.2036
- net_realised_price_index_2026_100
- 98.4064
- revenue_usd_m
- 335.58123
- 売上高
- 2.51334051
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 97.0225
- net_realised_price_index_2026_100
- 98.2081
- revenue_usd_m
- 778.23169
- 売上高
- 5.82857769
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 98.01
- net_realised_price_index_2026_100
- 98.01
- revenue_usd_m
- 575.34898
- 売上高
- 4.30908463
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 98.8036
- net_realised_price_index_2026_100
- 97.4169
- revenue_usd_m
- 384.33186
- 売上高
- 2.87845908
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 46.07627461
- revenue_usd_m
- 6152.10418564
- cogs
- 13.66622305
- sga_including_sbc
- 24.53710467
- rd
- 2.2485222
- operating_profit
- 5.62442469
- 営業利益率
- 12.21%
- finance_cost_net
- 1.24949165
- associates_profit
- 0.06740563
- pretax_profit
- 4.44233867
- tax_expense
- 1.02173789
- parent_profit_after_sbc
- 3.42060078
- sbc_expense_within_sga
- 0.51061595
- sbc_equity_credit
- 0.51061595
- depreciation_amortization
- 4.23901726
- capital_expenditure
- 4.23901726
- net_working_capital_investment
- -0.0082303
- cash_acquisitions
- 0.3686102
- lease_principal_paid
- 0.43772461
- fcfe_before_equity_distributions
- 3.13311222
- dividend_policy_adjusted_profit_proxy_usd_m
- 703.20377156
- dividend_policy_normalization_usd_m
- 246.4851559
- capital
内容を開く
- begin_parent_equity_oku
- 41.06779618
- period_parent_profit_after_sbc_oku
- 3.42060078
- noncash_sbc_equity_credit_oku
- 0.51061595
- new_issue_cash_proceeds_oku
- 0.03959074
- issuer_paid_dividends_oku
- 2.05294638
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 42.98565727
- begin_gross_financing_debt_oku
- 29.43136842
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 3.13311222
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 1.11975658
- ending_gross_financing_debt_oku
- 28.31161185
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 23.81161185
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 878.230024
- begin_treasury_m
- 44.6813665
- begin_employee_trust_m
- 0.1
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 878.630024
- ending_treasury_m
- 41.3813665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 837.2486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.99029575531
- old_holder_cash_oku
- dividends_received_oku
- 2.0376785584
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 2.0376785584
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 4
内容を開く
- fiscal_year
- 2029
- period_start_inclusive
2029-01-01
- 期間末
2029-12-31
- days_booked
- 365
- days_full_calendar_year
- 365
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2029
- segment_revenue_usd_m
- Orthopaedics
- 2253.00539
- Sports_Medicine_ENT
- 2074.32225
- Advanced_Wound_Management
- 1700.61826
- geography_revenue_usd_m
- US
- 3125.57884
- Other_Established
- 1849.29399
- Emerging
- 1053.07306
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 93.25748
- net_realised_price_index_2026_100
- 96.44303
- revenue_usd_m
- 1231.73296
- 売上高
- 9.22508206
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 94.69662
- net_realised_price_index_2026_100
- 96.15048
- revenue_usd_m
- 680.15285
- 売上高
- 5.09401477
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 95.85853
- net_realised_price_index_2026_100
- 95.27639
- revenue_usd_m
- 341.11958
- 売上高
- 2.55482009
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 99.1027
- net_realised_price_index_2026_100
- 98.80479
- revenue_usd_m
- 1134.18669
- 売上高
- 8.49450787
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 100.6012
- net_realised_price_index_2026_100
- 98.50749
- revenue_usd_m
- 605.2416
- 売上高
- 4.53296586
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 101.81082
- net_realised_price_index_2026_100
- 97.61915
- revenue_usd_m
- 334.89395
- 売上高
- 2.50819319
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 95.56716
- net_realised_price_index_2026_100
- 97.32423
- revenue_usd_m
- 759.65919
- 売上高
- 5.68947868
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 97.0299
- net_realised_price_index_2026_100
- 97.0299
- revenue_usd_m
- 563.89954
- 売上高
- 4.22333385
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 98.21078
- net_realised_price_index_2026_100
- 96.15048
- revenue_usd_m
- 377.05953
- 売上高
- 2.82399288
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 45.14638924
- revenue_usd_m
- 6027.94589105
- cogs
- 13.49425574
- sga_including_sbc
- 24.16870259
- rd
- 2.20991575
- operating_profit
- 5.27351515
- 営業利益率
- 11.68%
- finance_cost_net
- 1.20246187
- associates_profit
- 0.06740563
- pretax_profit
- 4.13845891
- tax_expense
- 0.95184555
- parent_profit_after_sbc
- 3.18661336
- sbc_expense_within_sga
- 0.50399659
- sbc_equity_credit
- 0.50399659
- depreciation_amortization
- 4.15346781
- capital_expenditure
- 4.15346781
- net_working_capital_investment
- -0.00734519
- cash_acquisitions
- 0.36117111
- lease_principal_paid
- 0.4288907
- fcfe_before_equity_distributions
- 2.90789333
- dividend_policy_adjusted_profit_proxy_usd_m
- 660.51911986
- dividend_policy_normalization_usd_m
- 235.04250404
- capital
内容を開く
- begin_parent_equity_oku
- 42.98565727
- period_parent_profit_after_sbc_oku
- 3.18661336
- noncash_sbc_equity_credit_oku
- 0.50399659
- new_issue_cash_proceeds_oku
- 0.03840382
- issuer_paid_dividends_oku
- 1.9400838
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 44.77458724
- begin_gross_financing_debt_oku
- 28.31161185
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 2.90789333
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 1.00621334
- ending_gross_financing_debt_oku
- 27.3053985
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 22.8053985
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 878.630024
- begin_treasury_m
- 41.3813665
- begin_employee_trust_m
- 0
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 879.030024
- ending_treasury_m
- 37.9813665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 841.0486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.9858214317
- old_holder_cash_oku
- dividends_received_oku
- 1.9169956824
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 1.9169956824
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 5
内容を開く
- fiscal_year
- 2030
- period_start_inclusive
2030-01-01
- 期間末
2030-12-31
- days_booked
- 365
- days_full_calendar_year
- 365
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2030
- segment_revenue_usd_m
- Orthopaedics
- 2179.15193
- Sports_Medicine_ENT
- 2063.88891
- Advanced_Wound_Management
- 1664.13267
- geography_revenue_usd_m
- US
- 3056.75318
- Other_Established
- 1815.32503
- Emerging
- 1035.0953
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 91.11256
- net_realised_price_index_2026_100
- 95.28571
- revenue_usd_m
- 1188.96226
- 売上高
- 8.90475031
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 92.99208
- net_realised_price_index_2026_100
- 94.90052
- revenue_usd_m
- 659.22727
- 売上高
- 4.93729231
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 94.51651
- net_realised_price_index_2026_100
- 93.75197
- revenue_usd_m
- 330.9624
- 売上高
- 2.47874777
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 98.80539
- net_realised_price_index_2026_100
- 98.40957
- revenue_usd_m
- 1126.26099
- 売上高
- 8.43514825
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 100.8024
- net_realised_price_index_2026_100
- 98.01495
- revenue_usd_m
- 603.41982
- 売上高
- 4.51932163
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 102.42169
- net_realised_price_index_2026_100
- 96.8382
- revenue_usd_m
- 334.20809
- 売上高
- 2.50305641
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 94.13366
- net_realised_price_index_2026_100
- 96.44831
- revenue_usd_m
- 741.52993
- 売上高
- 5.55369927
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 96.0596
- net_realised_price_index_2026_100
- 96.0596
- revenue_usd_m
- 552.67793
- 売上高
- 4.13928951
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 97.62151
- net_realised_price_index_2026_100
- 94.90052
- revenue_usd_m
- 369.92481
- 売上高
- 2.77055729
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 44.24186273
- revenue_usd_m
- 5907.17351222
- cogs
- 13.32564906
- sga_including_sbc
- 23.80872427
- rd
- 2.17227546
- operating_profit
- 4.93521395
- 営業利益率
- 11.16%
- finance_cost_net
- 1.16020091
- associates_profit
- 0.06740563
- pretax_profit
- 3.84241867
- tax_expense
- 0.88375629
- parent_profit_after_sbc
- 2.95866237
- sbc_expense_within_sga
- 0.49751049
- sbc_equity_credit
- 0.49751049
- depreciation_amortization
- 4.07025137
- capital_expenditure
- 4.07025137
- net_working_capital_investment
- -0.00649156
- cash_acquisitions
- 0.3539349
- lease_principal_paid
- 0.4202977
- fcfe_before_equity_distributions
- 2.68843183
- dividend_policy_adjusted_profit_proxy_usd_m
- 618.84390382
- dividend_policy_normalization_usd_m
- 223.80330376
- capital
内容を開く
- begin_parent_equity_oku
- 44.77458724
- period_parent_profit_after_sbc_oku
- 2.95866237
- noncash_sbc_equity_credit_oku
- 0.49751049
- new_issue_cash_proceeds_oku
- 0.03725559
- issuer_paid_dividends_oku
- 1.8399428
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 46.4280729
- begin_gross_financing_debt_oku
- 27.3053985
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 2.68843183
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 0.88574462
- ending_gross_financing_debt_oku
- 26.41965389
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 21.91965389
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 879.030024
- begin_treasury_m
- 37.9813665
- begin_employee_trust_m
- 0
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 879.430024
- ending_treasury_m
- 34.5813665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 844.8486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.98138735773
- old_holder_cash_oku
- dividends_received_oku
- 1.8098697834
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 1.8098697834
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 6
内容を開く
- fiscal_year
- 2031
- period_start_inclusive
2031-01-01
- 期間末
2031-12-31
- days_booked
- 365
- days_full_calendar_year
- 365
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2031
- segment_revenue_usd_m
- Orthopaedics
- 2107.72988
- Sports_Medicine_ENT
- 2053.51785
- Advanced_Wound_Management
- 1628.43805
- geography_revenue_usd_m
- US
- 2989.90073
- Other_Established
- 1782.22866
- Emerging
- 1017.55639
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 89.01697
- net_realised_price_index_2026_100
- 94.14228
- revenue_usd_m
- 1147.67674
- 売上高
- 8.59554176
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 91.31822
- net_realised_price_index_2026_100
- 93.66682
- revenue_usd_m
- 638.94548
- 売上高
- 4.78539157
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 93.19328
- net_realised_price_index_2026_100
- 92.25194
- revenue_usd_m
- 321.10767
- 売上高
- 2.40494057
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 98.50897
- net_realised_price_index_2026_100
- 98.01594
- revenue_usd_m
- 1118.39068
- 売上高
- 8.37620343
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 101.00401
- net_realised_price_index_2026_100
- 97.52488
- revenue_usd_m
- 601.60353
- 売上高
- 4.50571847
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 103.03622
- net_realised_price_index_2026_100
- 96.06349
- revenue_usd_m
- 333.52363
- 売上高
- 2.49793015
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 92.72165
- net_realised_price_index_2026_100
- 95.58027
- revenue_usd_m
- 723.83332
- 売上高
- 5.42116024
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 95.099
- net_realised_price_index_2026_100
- 95.099
- revenue_usd_m
- 541.67964
- 売上高
- 4.05691764
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 97.03578
- net_realised_price_index_2026_100
- 93.66682
- revenue_usd_m
- 362.92509
- 売上高
- 2.7181328
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 43.36193664
- revenue_usd_m
- 5789.68578053
- cogs
- 13.16034777
- sga_including_sbc
- 23.45697308
- rd
- 2.13557538
- operating_profit
- 4.60904042
- 営業利益率
- 10.63%
- finance_cost_net
- 1.12299964
- associates_profit
- 0.06740563
- pretax_profit
- 3.55344641
- tax_expense
- 0.81729267
- parent_profit_after_sbc
- 2.73615373
- sbc_expense_within_sga
- 0.49115483
- sbc_equity_credit
- 0.49115483
- depreciation_amortization
- 3.98929817
- capital_expenditure
- 3.98929817
- net_working_capital_investment
- -0.00566837
- cash_acquisitions
- 0.34689549
- lease_principal_paid
- 0.4119384
- fcfe_before_equity_distributions
- 2.47414304
- dividend_policy_adjusted_profit_proxy_usd_m
- 578.09412671
- dividend_policy_normalization_usd_m
- 212.76288006
- capital
内容を開く
- begin_parent_equity_oku
- 46.4280729
- period_parent_profit_after_sbc_oku
- 2.73615373
- noncash_sbc_equity_credit_oku
- 0.49115483
- new_issue_cash_proceeds_oku
- 0.03614169
- issuer_paid_dividends_oku
- 1.72187937
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 47.96964378
- begin_gross_financing_debt_oku
- 26.41965389
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 2.47414304
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 0.78840535
- ending_gross_financing_debt_oku
- 25.63124853
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 21.13124853
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 879.430024
- begin_treasury_m
- 34.5813665
- begin_employee_trust_m
- 0
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 879.830024
- ending_treasury_m
- 31.1813665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 848.6486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.97699299273
- old_holder_cash_oku
- dividends_received_oku
- 1.6861324717
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 1.6861324717
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 7
内容を開く
- fiscal_year
- 2032
- period_start_inclusive
2032-01-01
- 期間末
2032-12-31
- days_booked
- 366
- days_full_calendar_year
- 366
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2032
- segment_revenue_usd_m
- Orthopaedics
- 2038.65886
- Sports_Medicine_ENT
- 2043.20865
- Advanced_Wound_Management
- 1593.51708
- geography_revenue_usd_m
- US
- 2924.95921
- Other_Established
- 1749.98061
- Emerging
- 1000.44476
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 86.96958
- net_realised_price_index_2026_100
- 93.01257
- revenue_usd_m
- 1107.82481
- 売上高
- 8.29707016
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 89.67449
- net_realised_price_index_2026_100
- 92.44915
- revenue_usd_m
- 619.28769
- 売上高
- 4.63816422
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 91.88857
- net_realised_price_index_2026_100
- 90.77591
- revenue_usd_m
- 311.54636
- 売上高
- 2.33333106
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 98.21345
- net_realised_price_index_2026_100
- 97.62387
- revenue_usd_m
- 1110.57537
- 売上高
- 8.31767052
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 101.20602
- net_realised_price_index_2026_100
- 97.03725
- revenue_usd_m
- 599.7927
- 売上高
- 4.49215626
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 103.65443
- net_realised_price_index_2026_100
- 95.29498
- revenue_usd_m
- 332.84058
- 売上高
- 2.49281439
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 91.33083
- net_realised_price_index_2026_100
- 94.72005
- revenue_usd_m
- 706.55903
- 売上高
- 5.29178425
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 94.14801
- net_realised_price_index_2026_100
- 94.14801
- revenue_usd_m
- 530.90022
- 売上高
- 3.97618498
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 96.45357
- net_realised_price_index_2026_100
- 92.44915
- revenue_usd_m
- 356.05782
- 売上高
- 2.66670029
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 42.50587614
- revenue_usd_m
- 5675.38458232
- cogs
- 12.99829692
- sga_including_sbc
- 23.1132567
- rd
- 2.09979028
- operating_profit
- 4.29453223
- 営業利益率
- 10.10%
- finance_cost_net
- 1.08988661
- associates_profit
- 0.06740563
- pretax_profit
- 3.27205125
- tax_expense
- 0.75257179
- parent_profit_after_sbc
- 2.51947946
- sbc_expense_within_sga
- 0.48492682
- sbc_equity_credit
- 0.48492682
- depreciation_amortization
- 3.9105406
- capital_expenditure
- 3.9105406
- net_working_capital_investment
- -0.0048746
- cash_acquisitions
- 0.34004701
- lease_principal_paid
- 0.40380582
- fcfe_before_equity_distributions
- 2.26542805
- dividend_policy_adjusted_profit_proxy_usd_m
- 538.31755099
- dividend_policy_normalization_usd_m
- 201.91665318
- capital
内容を開く
- begin_parent_equity_oku
- 47.96964378
- period_parent_profit_after_sbc_oku
- 2.51947946
- noncash_sbc_equity_credit_oku
- 0.48492682
- new_issue_cash_proceeds_oku
- 0.0350494
- issuer_paid_dividends_oku
- 1.60637134
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 49.40272812
- begin_gross_financing_debt_oku
- 25.63124853
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 2.26542805
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 0.69410612
- ending_gross_financing_debt_oku
- 24.93714242
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 20.43714242
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 879.830024
- begin_treasury_m
- 31.1813665
- begin_employee_trust_m
- 0
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 880.230024
- ending_treasury_m
- 27.7813665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 852.4486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.97263780566
- old_holder_cash_oku
- dividends_received_oku
- 1.5659920137
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 1.5659920137
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 8
内容を開く
- fiscal_year
- 2033
- period_start_inclusive
2033-01-01
- 期間末
2033-12-31
- days_booked
- 365
- days_full_calendar_year
- 365
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2033
- segment_revenue_usd_m
- Orthopaedics
- 1971.86114
- Sports_Medicine_ENT
- 2032.96091
- Advanced_Wound_Management
- 1559.3528
- geography_revenue_usd_m
- US
- 2861.86837
- Other_Established
- 1718.55731
- Emerging
- 983.74918
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 84.96928
- net_realised_price_index_2026_100
- 91.89642
- revenue_usd_m
- 1069.3567
- 売上高
- 8.0089627
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 88.06035
- net_realised_price_index_2026_100
- 91.24731
- revenue_usd_m
- 600.23468
- 売上高
- 4.49546646
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 90.60213
- net_realised_price_index_2026_100
- 89.32349
- revenue_usd_m
- 302.26976
- 売上高
- 2.2638538
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 97.91881
- net_realised_price_index_2026_100
- 97.23338
- revenue_usd_m
- 1102.81467
- 売上高
- 8.25954664
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 101.40843
- net_realised_price_index_2026_100
- 96.55206
- revenue_usd_m
- 597.98733
- 売上高
- 4.47863487
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 104.27636
- net_realised_price_index_2026_100
- 94.53262
- revenue_usd_m
- 332.15892
- 売上高
- 2.48770911
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 89.96086
- net_realised_price_index_2026_100
- 93.86757
- revenue_usd_m
- 689.697
- 売上高
- 5.16549582
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 93.20653
- net_realised_price_index_2026_100
- 93.20653
- revenue_usd_m
- 520.3353
- 売上高
- 3.8970589
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 95.87485
- net_realised_price_index_2026_100
- 91.24731
- revenue_usd_m
- 349.3205
- 売上高
- 2.61624099
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 41.67296928
- revenue_usd_m
- 5564.17485818
- cogs
- 12.83944183
- sga_including_sbc
- 22.7773871
- rd
- 2.06489563
- operating_profit
- 3.99124472
- 営業利益率
- 9.58%
- finance_cost_net
- 1.06073416
- associates_profit
- 0.06740563
- pretax_profit
- 2.9979162
- tax_expense
- 0.68952072
- parent_profit_after_sbc
- 2.30839547
- sbc_expense_within_sga
- 0.47882378
- sbc_equity_credit
- 0.47882378
- depreciation_amortization
- 3.83391317
- capital_expenditure
- 3.83391317
- net_working_capital_investment
- -0.00410928
- cash_acquisitions
- 0.33338375
- lease_principal_paid
- 0.39589321
- fcfe_before_equity_distributions
- 2.06205157
- dividend_policy_adjusted_profit_proxy_usd_m
- 499.47710018
- dividend_policy_normalization_usd_m
- 191.26013698
- capital
内容を開く
- begin_parent_equity_oku
- 49.40272812
- period_parent_profit_after_sbc_oku
- 2.30839547
- noncash_sbc_equity_credit_oku
- 0.47882378
- new_issue_cash_proceeds_oku
- 0.03399863
- issuer_paid_dividends_oku
- 1.49370656
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 50.73023944
- begin_gross_financing_debt_oku
- 24.93714242
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 2.06205157
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 0.60234364
- ending_gross_financing_debt_oku
- 24.33479878
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 19.83479878
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 880.230024
- begin_treasury_m
- 27.7813665
- begin_employee_trust_m
- 0
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 880.630024
- ending_treasury_m
- 24.3813665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 856.2486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.9683212749
- old_holder_cash_oku
- dividends_received_oku
- 1.449679959
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 1.449679959
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 9
内容を開く
- fiscal_year
- 2034
- period_start_inclusive
2034-01-01
- 期間末
2034-12-31
- days_booked
- 365
- days_full_calendar_year
- 365
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2034
- segment_revenue_usd_m
- Orthopaedics
- 1907.26159
- Sports_Medicine_ENT
- 2022.77424
- Advanced_Wound_Management
- 1525.92867
- geography_revenue_usd_m
- US
- 2800.56994
- Other_Established
- 1687.93588
- Emerging
- 967.45869
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 83.01499
- net_realised_price_index_2026_100
- 90.79367
- revenue_usd_m
- 1032.22436
- 売上高
- 7.73085948
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 86.47527
- net_realised_price_index_2026_100
- 90.06109
- revenue_usd_m
- 581.76786
- 売上高
- 4.35715893
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 89.3337
- net_realised_price_index_2026_100
- 87.89432
- revenue_usd_m
- 293.26937
- 売上高
- 2.19644529
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 97.62505
- net_realised_price_index_2026_100
- 96.84444
- revenue_usd_m
- 1095.1082
- 売上高
- 8.20182893
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 101.61124
- net_realised_price_index_2026_100
- 96.0693
- revenue_usd_m
- 596.18739
- 売上高
- 4.46515418
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 104.90202
- net_realised_price_index_2026_100
- 93.77636
- revenue_usd_m
- 331.47866
- 売上高
- 2.48261428
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 88.61145
- net_realised_price_index_2026_100
- 93.02276
- revenue_usd_m
- 673.23738
- 売上高
- 5.04222126
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 92.27447
- net_realised_price_index_2026_100
- 92.27447
- revenue_usd_m
- 509.98063
- 売上高
- 3.81950743
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 95.2996
- net_realised_price_index_2026_100
- 90.06109
- revenue_usd_m
- 342.71065
- 売上高
- 2.56673648
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 40.86252625
- revenue_usd_m
- 5455.96450542
- cogs
- 12.68372815
- sga_including_sbc
- 22.44918036
- rd
- 2.03086755
- operating_profit
- 3.69875018
- 営業利益率
- 9.05%
- finance_cost_net
- 1.03543572
- associates_profit
- 0.06740563
- pretax_profit
- 2.73072009
- tax_expense
- 0.62806562
- parent_profit_after_sbc
- 2.10265447
- sbc_expense_within_sga
- 0.47284304
- sbc_equity_credit
- 0.47284304
- depreciation_amortization
- 3.75935242
- capital_expenditure
- 3.75935242
- net_working_capital_investment
- -0.00337147
- cash_acquisitions
- 0.32690021
- lease_principal_paid
- 0.388194
- fcfe_before_equity_distributions
- 1.86377477
- dividend_policy_adjusted_profit_proxy_usd_m
- 461.53536242
- dividend_policy_normalization_usd_m
- 180.78893746
- capital
内容を開く
- begin_parent_equity_oku
- 50.73023944
- period_parent_profit_after_sbc_oku
- 2.10265447
- noncash_sbc_equity_credit_oku
- 0.47284304
- new_issue_cash_proceeds_oku
- 0.03297936
- issuer_paid_dividends_oku
- 1.3836812
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 51.95503511
- begin_gross_financing_debt_oku
- 24.33479878
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 1.86377477
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 0.51307292
- ending_gross_financing_debt_oku
- 23.82172586
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 19.32172586
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 880.630024
- begin_treasury_m
- 24.3813665
- begin_employee_trust_m
- 0
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 881.030024
- ending_treasury_m
- 20.9813665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 860.0486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.96404288808
- old_holder_cash_oku
- dividends_received_oku
- 1.3369483902
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 1.3369483902
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 10
内容を開く
- fiscal_year
- 2035
- period_start_inclusive
2035-01-01
- 期間末
2035-12-31
- days_booked
- 365
- days_full_calendar_year
- 365
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2035
- segment_revenue_usd_m
- Orthopaedics
- 1844.78758
- Sports_Medicine_ENT
- 2012.64823
- Advanced_Wound_Management
- 1493.22847
- geography_revenue_usd_m
- US
- 2741.00755
- Other_Established
- 1658.09407
- Emerging
- 951.56266
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 81.10564
- net_realised_price_index_2026_100
- 89.70414
- revenue_usd_m
- 996.3814
- 売上高
- 7.46241312
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 84.91871
- net_realised_price_index_2026_100
- 88.8903
- revenue_usd_m
- 563.86919
- 売上高
- 4.22310658
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 88.08303
- net_realised_price_index_2026_100
- 86.48801
- revenue_usd_m
- 284.53699
- 売上高
- 2.13104393
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 97.33217
- net_realised_price_index_2026_100
- 96.45707
- revenue_usd_m
- 1087.45558
- 売上高
- 8.14451455
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 101.81447
- net_realised_price_index_2026_100
- 95.58896
- revenue_usd_m
- 594.39286
- 売上高
- 4.45171406
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 105.53143
- net_realised_price_index_2026_100
- 93.02615
- revenue_usd_m
- 330.79979
- 売上高
- 2.47752988
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 87.28228
- net_realised_price_index_2026_100
- 92.18556
- revenue_usd_m
- 657.17057
- 売上高
- 4.92188865
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 91.35172
- net_realised_price_index_2026_100
- 91.35172
- revenue_usd_m
- 499.83202
- 売上高
- 3.74349923
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 94.7278
- net_realised_price_index_2026_100
- 88.8903
- revenue_usd_m
- 336.22588
- 売上高
- 2.51816869
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 40.0738787
- revenue_usd_m
- 5350.66428377
- cogs
- 12.53110187
- sga_including_sbc
- 22.12845671
- rd
- 1.99768285
- operating_profit
- 3.41663726
- 営業利益率
- 8.53%
- finance_cost_net
- 1.01388666
- associates_profit
- 0.06740563
- pretax_profit
- 2.47015623
- tax_expense
- 0.56813593
- parent_profit_after_sbc
- 1.9020203
- sbc_expense_within_sga
- 0.46698201
- sbc_equity_credit
- 0.46698201
- depreciation_amortization
- 3.68679684
- capital_expenditure
- 3.68679684
- net_working_capital_investment
- -0.00266024
- cash_acquisitions
- 0.32059103
- lease_principal_paid
- 0.38070185
- fcfe_before_equity_distributions
- 1.67036967
- dividend_policy_adjusted_profit_proxy_usd_m
- 424.45650176
- dividend_policy_normalization_usd_m
- 170.49875119
- capital
内容を開く
- begin_parent_equity_oku
- 51.95503511
- period_parent_profit_after_sbc_oku
- 1.9020203
- noncash_sbc_equity_credit_oku
- 0.46698201
- new_issue_cash_proceeds_oku
- 0.03199064
- issuer_paid_dividends_oku
- 1.27618767
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 53.07984039
- begin_gross_financing_debt_oku
- 23.82172586
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 1.67036967
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 0.42617264
- ending_gross_financing_debt_oku
- 23.39555322
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 18.89555322
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 881.030024
- begin_treasury_m
- 20.9813665
- begin_employee_trust_m
- 0
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 881.430024
- ending_treasury_m
- 17.5813665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 863.8486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.95980214181
- old_holder_cash_oku
- dividends_received_oku
- 1.2276464379
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 1.2276464379
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 11
内容を開く
- fiscal_year
- 2036
- period_start_inclusive
2036-01-01
- 期間末
2036-11-06
- days_booked
- 311
- days_full_calendar_year
- 366
- accrual_fraction_of_calendar_year
- 0.849726775956
- is_partial_period
- はい
- period_status
暦年将来予測・最終期途中打切り
- financials_oku_gbp
内容を開く
- year
- 2036
- segment_revenue_usd_m
- Orthopaedics
- 1516.2259985246
- Sports_Medicine_ENT
- 1701.6479628142
- Advanced_Wound_Management
- 1241.6516695902
- geography_revenue_usd_m
- US
- 2279.924591776
- Other_Established
- 1384.2136617213
- Emerging
- 795.38737743169
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 79.24021
- net_realised_price_index_2026_100
- 88.62769
- revenue_usd_m
- 817.25281
- 売上高
- 6.12082693
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 83.39017
- net_realised_price_index_2026_100
- 87.73473
- revenue_usd_m
- 464.39369
- 売上高
- 3.47808336
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 86.84987
- net_realised_price_index_2026_100
- 85.1042
- revenue_usd_m
- 234.57949
- 売上高
- 1.75688656
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 97.04018
- net_realised_price_index_2026_100
- 96.07124
- revenue_usd_m
- 917.58293
- 売上高
- 6.87225085
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 102.0181
- net_realised_price_index_2026_100
- 95.11101
- revenue_usd_m
- 503.55127
- 売上高
- 3.77135459
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 106.16462
- net_realised_price_index_2026_100
- 92.28194
- revenue_usd_m
- 280.51377
- 売上高
- 2.10091198
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 85.97304
- net_realised_price_index_2026_100
- 91.35589
- revenue_usd_m
- 545.08885
- 売上高
- 4.08245093
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 90.43821
- net_realised_price_index_2026_100
- 90.43821
- revenue_usd_m
- 416.26871
- 売上高
- 3.1176506
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 94.15944
- net_realised_price_index_2026_100
- 87.73473
- revenue_usd_m
- 280.29412
- 売上高
- 2.09926691
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 33.3996827
- revenue_usd_m
- 4459.52563444
- cogs
- 10.52090005
- sga_including_sbc
- 18.5368239
- rd
- 1.66998414
- operating_profit
- 2.67197462
- 営業利益率
- 8.00%
- finance_cost_net
- 0.84631717
- associates_profit
- 0.05727637
- pretax_profit
- 1.88293381
- tax_expense
- 0.43307478
- parent_profit_after_sbc
- 1.44985904
- sbc_expense_within_sga
- 0.3919264
- sbc_equity_credit
- 0.3919264
- depreciation_amortization
- 3.07277081
- capital_expenditure
- 3.07277081
- net_working_capital_investment
- -0.00167796
- cash_acquisitions
- 0.26719746
- lease_principal_paid
- 0.31729699
- fcfe_before_equity_distributions
- 1.25896895
- dividend_policy_adjusted_profit_proxy_usd_m
- 388.2058635
- dividend_policy_normalization_usd_m
- 160.38536384
- capital
内容を開く
- begin_parent_equity_oku
- 53.07984039
- period_parent_profit_after_sbc_oku
- 1.44985904
- noncash_sbc_equity_credit_oku
- 0.3919264
- new_issue_cash_proceeds_oku
- 0.03103416
- issuer_paid_dividends_oku
- 1.17112507
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 53.78153491
- begin_gross_financing_debt_oku
- 23.39555322
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 1.25896895
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 0.11887803
- ending_gross_financing_debt_oku
- 23.27667518
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 18.77667518
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 881.430024
- begin_treasury_m
- 17.5813665
- begin_employee_trust_m
- 0
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 2.788
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 881.830024
- ending_treasury_m
- 14.7933665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 867.0366575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.95627305316
- old_holder_cash_oku
- dividends_received_oku
- 1.1216323173
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 1.1216323173
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- complete_calendar_year_projection_reference_not_fully_booked
内容を開く
- year
- 2036
- segment_revenue_usd_m
- Orthopaedics
- 1784.36886
- Sports_Medicine_ENT
- 2002.58249
- Advanced_Wound_Management
- 1461.23637
- geography_revenue_usd_m
- US
- 2683.12669
- Other_Established
- 1629.01029
- Emerging
- 936.05074
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 79.24021
- net_realised_price_index_2026_100
- 88.62769
- revenue_usd_m
- 961.78305
- 売上高
- 7.20328828
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 83.39017
- net_realised_price_index_2026_100
- 87.73473
- revenue_usd_m
- 546.52119
- 売上高
- 4.09317849
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 86.84987
- net_realised_price_index_2026_100
- 85.1042
- revenue_usd_m
- 276.06461
- 売上高
- 2.06758997
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 97.04018
- net_realised_price_index_2026_100
- 96.07124
- revenue_usd_m
- 1079.85644
- 売上高
- 8.08760068
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 102.0181
- net_realised_price_index_2026_100
- 95.11101
- revenue_usd_m
- 592.60374
- 売上高
- 4.4383144
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 106.16462
- net_realised_price_index_2026_100
- 92.28194
- revenue_usd_m
- 330.12231
- 売上高
- 2.4724559
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 85.97304
- net_realised_price_index_2026_100
- 91.35589
- revenue_usd_m
- 641.4872
- 売上高
- 4.80442778
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 90.43821
- net_realised_price_index_2026_100
- 90.43821
- revenue_usd_m
- 489.88536
- 売上高
- 3.6690036
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 94.15944
- net_realised_price_index_2026_100
- 87.73473
- revenue_usd_m
- 329.86382
- 売上高
- 2.4705199
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 39.306379
- revenue_usd_m
- 5248.18772413
- cogs
- 12.38150939
- sga_including_sbc
- 21.81504035
- rd
- 1.96531895
- operating_profit
- 3.14451032
- 営業利益率
- 8.00%
- finance_cost_net
- 0.99598741
- associates_profit
- 0.06740563
- pretax_profit
- 2.21592854
- tax_expense
- 0.50966356
- parent_profit_after_sbc
- 1.70626498
- sbc_expense_within_sga
- 0.46123814
- sbc_equity_credit
- 0.46123814
- depreciation_amortization
- 3.61618687
- capital_expenditure
- 3.61618687
- net_working_capital_investment
- -0.00197471
- cash_acquisitions
- 0.31445103
- lease_principal_paid
- 0.3734106
- fcfe_before_equity_distributions
- 1.48161619
- dividend_policy_adjusted_profit_proxy_usd_m
- 388.2058635
- dividend_policy_normalization_usd_m
- 160.38536384
- 注記
2036暦年全期の仮定値。11月7日以降の利益・資本・買戻し・配当を終点以前には計上しない。
- financials_2026_to_2036_including_partial_periods
内容を開く
- 1
内容を開く
- fiscal_year
- 2026
- period_start_inclusive
2026-11-07
- 期間末
2026-12-31
- days_booked
- 55
- days_full_calendar_year
- 365
- accrual_fraction_of_calendar_year
- 0.150684931507
- is_partial_period
- はい
- period_status
発行会社実績からの部分期間推計
- financials_oku_gbp
内容を開く
- year
- 2026
- revenue
- 7.42863351
- revenue_usd_m
- 991.87114583
- cogs
- 2.16916098
- sga_including_sbc
- 3.9636888
- rd
- 0.36028873
- operating_profit
- 0.93549499
- 営業利益率
- 12.59%
- finance_cost_net
- 0.06370211
- associates_profit
- 0.00858174
- pretax_profit
- 0.88037462
- tax_expense
- 0.20248616
- parent_profit_after_sbc
- 0.67788846
- sbc_expense_within_sga
- 0.07674188
- sbc_equity_credit
- 0.07674188
- depreciation_amortization
- 0.6771342
- capital_expenditure
- 0.49656508
- net_working_capital_investment
- -0.68684232
- cash_acquisitions
- 0
- lease_principal_paid
- 0.06997053
- fcfe_before_equity_distributions
- 1.55207124
- segment_revenue_usd_m
- Orthopaedics
- 386.5090625
- Sports_Medicine_ENT
- 327.435625
- Advanced_Wound_Management
- 277.92645833333
- geography_revenue_usd_m
- 未確認
- volume_price_region_matrix
- 未確認
- dividend_policy_normalization_usd_m
- 未確認
- dividend_policy_adjusted_profit_proxy_usd_m
- 未確認
- capital
内容を開く
- begin_parent_equity_oku
- 39.43229479
- period_parent_profit_after_sbc_oku
- 0.67788846
- noncash_sbc_equity_credit_oku
- 0.07674188
- new_issue_cash_proceeds_oku
- 0.00833067
- issuer_paid_dividends_oku
- 0
- issuer_gross_buybacks_oku
- 0.5617136
- ending_parent_equity_oku
- 39.63354219
- begin_gross_financing_debt_oku
- 28.34781306
- begin_cash_oku
- 6.05901738
- operating_fcfe_before_distributions_oku
- 1.55207124
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 2.55770568
- ending_gross_financing_debt_oku
- 25.79010738
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 21.29010738
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 877.750024
- begin_treasury_m
- 40.315859
- begin_employee_trust_m
- 0.2
- begin_old_cohort_m
- 837.234165
- new_issuance_m
- 0.08
- treasury_or_trust_shares_delivered_to_employees_m
- 0.45
- issuer_buyback_shares_m
- 4.8551632
- old_cohort_proportionally_tendered_shares_m
- 4.8520917
- ending_issued_m
- 877.830024
- ending_treasury_m
- 44.7210222
- ending_employee_trust_m
- 0.2
- ending_economic_shares_m
- 832.9090018
- ending_old_cohort_shares_m
- 832.3820733
- ending_old_cohort_economic_fraction
- 0.99936736373
- old_holder_cash_oku
- dividends_received_oku
- 0
- proportional_tender_proceeds_oku
- 0.5613582406
- total_received_oku
- 0.5613582406
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- complete_calendar_year_projection_reference_not_fully_booked
内容を開く
- fy_2026_reported_guidance_sales_usd_m_proxy
- 6411
- fy_2026_full_year_IFRS_operating_profit_usd_m_estimate
- 850
- fy_2026_full_year_parent_profit_usd_m_estimate
- 585
- fy_2026_full_year_capex_usd_m_estimate
- 440
- fy_2026_full_year_sbc_usd_m_estimate
- 68
- fy_2026_full_year_fcf_usd_m_company_guidance
- 750
- h1_actual_sales_usd_m
- 3097
- q3_actual_sales_usd_m
- 1551
- q4_full_estimated_sales_usd_m
- 1763
- q4_post_basis_day_fraction
- 0.57291666666667
- full_year_is_forecast
- はい
- 2
内容を開く
- fiscal_year
- 2027
- period_start_inclusive
2027-01-01
- 期間末
2027-12-31
- days_booked
- 365
- days_full_calendar_year
- 365
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2027
- segment_revenue_usd_m
- Orthopaedics
- 2408.34194
- Sports_Medicine_ENT
- 2095.37738
- Advanced_Wound_Management
- 1776.0336
- geography_revenue_usd_m
- US
- 3269.40954
- Other_Established
- 1919.95037
- Emerging
- 1090.39302
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 97.7
- net_realised_price_index_2026_100
- 98.8
- revenue_usd_m
- 1321.94548
- 売上高
- 9.90073009
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 98.2
- net_realised_price_index_2026_100
- 98.7
- revenue_usd_m
- 724.0178
- 売上高
- 5.42254193
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 98.6
- net_realised_price_index_2026_100
- 98.4
- revenue_usd_m
- 362.37866
- 売上高
- 2.71404032
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 99.7
- net_realised_price_index_2026_100
- 99.6
- revenue_usd_m
- 1150.2058
- 売上高
- 8.61448322
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 100.2
- net_realised_price_index_2026_100
- 99.5
- revenue_usd_m
- 608.90167
- 売上高
- 4.56037802
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 100.6
- net_realised_price_index_2026_100
- 99.2
- revenue_usd_m
- 336.26991
- 売上高
- 2.5184984
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 98.5
- net_realised_price_index_2026_100
- 99.1
- revenue_usd_m
- 797.25826
- 売上高
- 5.97107745
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 99
- net_realised_price_index_2026_100
- 99
- revenue_usd_m
- 587.03089
- 売上高
- 4.39657651
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 99.4
- net_realised_price_index_2026_100
- 98.7
- revenue_usd_m
- 391.74445
- 売上高
- 2.93397577
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 47.03230171
- revenue_usd_m
- 6279.75292377
- cogs
- 13.84160639
- sga_including_sbc
- 24.91413155
- rd
- 2.28812148
- operating_profit
- 5.98844229
- 営業利益率
- 12.73%
- finance_cost_net
- 1.09655869
- associates_profit
- 0.06740563
- pretax_profit
- 4.95928923
- tax_expense
- 1.14063652
- parent_profit_after_sbc
- 3.81865271
- sbc_expense_within_sga
- 0.51737145
- sbc_equity_credit
- 0.51737145
- depreciation_amortization
- 4.32697176
- capital_expenditure
- 4.32697176
- net_working_capital_investment
- 4.25244976
- cash_acquisitions
- 0.37625841
- lease_principal_paid
- 0.44680687
- fcfe_before_equity_distributions
- -0.73949089
- dividend_policy_adjusted_profit_proxy_usd_m
- 768.0025408
- dividend_policy_normalization_usd_m
- 258.13603114
- capital
内容を開く
- begin_parent_equity_oku
- 39.63354219
- period_parent_profit_after_sbc_oku
- 3.81865271
- noncash_sbc_equity_credit_oku
- 0.51737145
- new_issue_cash_proceeds_oku
- 0.04081775
- issuer_paid_dividends_oku
- 2.56811217
- issuer_gross_buybacks_oku
- 0.37447573
- ending_parent_equity_oku
- 41.06779618
- begin_gross_financing_debt_oku
- 25.79010738
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- -0.73949089
- additional_new_debt_borrowings_oku
- 3.64126105
- debt_principal_repayment_oku
- 0
- ending_gross_financing_debt_oku
- 29.43136842
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 24.93136842
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 877.830024
- begin_treasury_m
- 44.7210222
- begin_employee_trust_m
- 0.2
- begin_old_cohort_m
- 832.3820733
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 3.2603442
- old_cohort_proportionally_tendered_shares_m
- 3.2582816
- ending_issued_m
- 878.230024
- ending_treasury_m
- 44.6813665
- ending_employee_trust_m
- 0.1
- ending_economic_shares_m
- 833.4486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.99481087911
- old_holder_cash_oku
- dividends_received_oku
- 2.5608946353
- proportional_tender_proceeds_oku
- 0.374238827
- total_received_oku
- 2.9351334623
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 3
内容を開く
- fiscal_year
- 2028
- period_start_inclusive
2028-01-01
- 期間末
2028-12-31
- days_booked
- 366
- days_full_calendar_year
- 366
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2028
- segment_revenue_usd_m
- Orthopaedics
- 2329.37339
- Sports_Medicine_ENT
- 2084.81827
- Advanced_Wound_Management
- 1737.91253
- geography_revenue_usd_m
- US
- 3196.4421
- Other_Established
- 1884.16053
- Emerging
- 1071.50156
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 95.4529
- net_realised_price_index_2026_100
- 97.6144
- revenue_usd_m
- 1276.04225
- 売上高
- 9.55693714
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 96.4324
- net_realised_price_index_2026_100
- 97.4169
- revenue_usd_m
- 701.74267
- 売上高
- 5.255712
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 97.2196
- net_realised_price_index_2026_100
- 96.8256
- revenue_usd_m
- 351.58848
- 売上高
- 2.63322706
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 99.4009
- net_realised_price_index_2026_100
- 99.2016
- revenue_usd_m
- 1142.16816
- 売上高
- 8.55428521
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 100.4004
- net_realised_price_index_2026_100
- 99.0025
- revenue_usd_m
- 607.06888
- 売上高
- 4.54665128
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 101.2036
- net_realised_price_index_2026_100
- 98.4064
- revenue_usd_m
- 335.58123
- 売上高
- 2.51334051
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 97.0225
- net_realised_price_index_2026_100
- 98.2081
- revenue_usd_m
- 778.23169
- 売上高
- 5.82857769
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 98.01
- net_realised_price_index_2026_100
- 98.01
- revenue_usd_m
- 575.34898
- 売上高
- 4.30908463
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 98.8036
- net_realised_price_index_2026_100
- 97.4169
- revenue_usd_m
- 384.33186
- 売上高
- 2.87845908
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 46.07627461
- revenue_usd_m
- 6152.10418564
- cogs
- 13.66622305
- sga_including_sbc
- 24.53710467
- rd
- 2.2485222
- operating_profit
- 5.62442469
- 営業利益率
- 12.21%
- finance_cost_net
- 1.24949165
- associates_profit
- 0.06740563
- pretax_profit
- 4.44233867
- tax_expense
- 1.02173789
- parent_profit_after_sbc
- 3.42060078
- sbc_expense_within_sga
- 0.51061595
- sbc_equity_credit
- 0.51061595
- depreciation_amortization
- 4.23901726
- capital_expenditure
- 4.23901726
- net_working_capital_investment
- -0.0082303
- cash_acquisitions
- 0.3686102
- lease_principal_paid
- 0.43772461
- fcfe_before_equity_distributions
- 3.13311222
- dividend_policy_adjusted_profit_proxy_usd_m
- 703.20377156
- dividend_policy_normalization_usd_m
- 246.4851559
- capital
内容を開く
- begin_parent_equity_oku
- 41.06779618
- period_parent_profit_after_sbc_oku
- 3.42060078
- noncash_sbc_equity_credit_oku
- 0.51061595
- new_issue_cash_proceeds_oku
- 0.03959074
- issuer_paid_dividends_oku
- 2.05294638
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 42.98565727
- begin_gross_financing_debt_oku
- 29.43136842
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 3.13311222
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 1.11975658
- ending_gross_financing_debt_oku
- 28.31161185
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 23.81161185
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 878.230024
- begin_treasury_m
- 44.6813665
- begin_employee_trust_m
- 0.1
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 878.630024
- ending_treasury_m
- 41.3813665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 837.2486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.99029575531
- old_holder_cash_oku
- dividends_received_oku
- 2.0376785584
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 2.0376785584
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 4
内容を開く
- fiscal_year
- 2029
- period_start_inclusive
2029-01-01
- 期間末
2029-12-31
- days_booked
- 365
- days_full_calendar_year
- 365
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2029
- segment_revenue_usd_m
- Orthopaedics
- 2253.00539
- Sports_Medicine_ENT
- 2074.32225
- Advanced_Wound_Management
- 1700.61826
- geography_revenue_usd_m
- US
- 3125.57884
- Other_Established
- 1849.29399
- Emerging
- 1053.07306
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 93.25748
- net_realised_price_index_2026_100
- 96.44303
- revenue_usd_m
- 1231.73296
- 売上高
- 9.22508206
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 94.69662
- net_realised_price_index_2026_100
- 96.15048
- revenue_usd_m
- 680.15285
- 売上高
- 5.09401477
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 95.85853
- net_realised_price_index_2026_100
- 95.27639
- revenue_usd_m
- 341.11958
- 売上高
- 2.55482009
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 99.1027
- net_realised_price_index_2026_100
- 98.80479
- revenue_usd_m
- 1134.18669
- 売上高
- 8.49450787
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 100.6012
- net_realised_price_index_2026_100
- 98.50749
- revenue_usd_m
- 605.2416
- 売上高
- 4.53296586
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 101.81082
- net_realised_price_index_2026_100
- 97.61915
- revenue_usd_m
- 334.89395
- 売上高
- 2.50819319
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 95.56716
- net_realised_price_index_2026_100
- 97.32423
- revenue_usd_m
- 759.65919
- 売上高
- 5.68947868
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 97.0299
- net_realised_price_index_2026_100
- 97.0299
- revenue_usd_m
- 563.89954
- 売上高
- 4.22333385
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 98.21078
- net_realised_price_index_2026_100
- 96.15048
- revenue_usd_m
- 377.05953
- 売上高
- 2.82399288
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 45.14638924
- revenue_usd_m
- 6027.94589105
- cogs
- 13.49425574
- sga_including_sbc
- 24.16870259
- rd
- 2.20991575
- operating_profit
- 5.27351515
- 営業利益率
- 11.68%
- finance_cost_net
- 1.20246187
- associates_profit
- 0.06740563
- pretax_profit
- 4.13845891
- tax_expense
- 0.95184555
- parent_profit_after_sbc
- 3.18661336
- sbc_expense_within_sga
- 0.50399659
- sbc_equity_credit
- 0.50399659
- depreciation_amortization
- 4.15346781
- capital_expenditure
- 4.15346781
- net_working_capital_investment
- -0.00734519
- cash_acquisitions
- 0.36117111
- lease_principal_paid
- 0.4288907
- fcfe_before_equity_distributions
- 2.90789333
- dividend_policy_adjusted_profit_proxy_usd_m
- 660.51911986
- dividend_policy_normalization_usd_m
- 235.04250404
- capital
内容を開く
- begin_parent_equity_oku
- 42.98565727
- period_parent_profit_after_sbc_oku
- 3.18661336
- noncash_sbc_equity_credit_oku
- 0.50399659
- new_issue_cash_proceeds_oku
- 0.03840382
- issuer_paid_dividends_oku
- 1.9400838
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 44.77458724
- begin_gross_financing_debt_oku
- 28.31161185
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 2.90789333
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 1.00621334
- ending_gross_financing_debt_oku
- 27.3053985
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 22.8053985
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 878.630024
- begin_treasury_m
- 41.3813665
- begin_employee_trust_m
- 0
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 879.030024
- ending_treasury_m
- 37.9813665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 841.0486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.9858214317
- old_holder_cash_oku
- dividends_received_oku
- 1.9169956824
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 1.9169956824
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 5
内容を開く
- fiscal_year
- 2030
- period_start_inclusive
2030-01-01
- 期間末
2030-12-31
- days_booked
- 365
- days_full_calendar_year
- 365
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2030
- segment_revenue_usd_m
- Orthopaedics
- 2179.15193
- Sports_Medicine_ENT
- 2063.88891
- Advanced_Wound_Management
- 1664.13267
- geography_revenue_usd_m
- US
- 3056.75318
- Other_Established
- 1815.32503
- Emerging
- 1035.0953
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 91.11256
- net_realised_price_index_2026_100
- 95.28571
- revenue_usd_m
- 1188.96226
- 売上高
- 8.90475031
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 92.99208
- net_realised_price_index_2026_100
- 94.90052
- revenue_usd_m
- 659.22727
- 売上高
- 4.93729231
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 94.51651
- net_realised_price_index_2026_100
- 93.75197
- revenue_usd_m
- 330.9624
- 売上高
- 2.47874777
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 98.80539
- net_realised_price_index_2026_100
- 98.40957
- revenue_usd_m
- 1126.26099
- 売上高
- 8.43514825
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 100.8024
- net_realised_price_index_2026_100
- 98.01495
- revenue_usd_m
- 603.41982
- 売上高
- 4.51932163
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 102.42169
- net_realised_price_index_2026_100
- 96.8382
- revenue_usd_m
- 334.20809
- 売上高
- 2.50305641
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 94.13366
- net_realised_price_index_2026_100
- 96.44831
- revenue_usd_m
- 741.52993
- 売上高
- 5.55369927
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 96.0596
- net_realised_price_index_2026_100
- 96.0596
- revenue_usd_m
- 552.67793
- 売上高
- 4.13928951
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 97.62151
- net_realised_price_index_2026_100
- 94.90052
- revenue_usd_m
- 369.92481
- 売上高
- 2.77055729
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 44.24186273
- revenue_usd_m
- 5907.17351222
- cogs
- 13.32564906
- sga_including_sbc
- 23.80872427
- rd
- 2.17227546
- operating_profit
- 4.93521395
- 営業利益率
- 11.16%
- finance_cost_net
- 1.16020091
- associates_profit
- 0.06740563
- pretax_profit
- 3.84241867
- tax_expense
- 0.88375629
- parent_profit_after_sbc
- 2.95866237
- sbc_expense_within_sga
- 0.49751049
- sbc_equity_credit
- 0.49751049
- depreciation_amortization
- 4.07025137
- capital_expenditure
- 4.07025137
- net_working_capital_investment
- -0.00649156
- cash_acquisitions
- 0.3539349
- lease_principal_paid
- 0.4202977
- fcfe_before_equity_distributions
- 2.68843183
- dividend_policy_adjusted_profit_proxy_usd_m
- 618.84390382
- dividend_policy_normalization_usd_m
- 223.80330376
- capital
内容を開く
- begin_parent_equity_oku
- 44.77458724
- period_parent_profit_after_sbc_oku
- 2.95866237
- noncash_sbc_equity_credit_oku
- 0.49751049
- new_issue_cash_proceeds_oku
- 0.03725559
- issuer_paid_dividends_oku
- 1.8399428
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 46.4280729
- begin_gross_financing_debt_oku
- 27.3053985
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 2.68843183
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 0.88574462
- ending_gross_financing_debt_oku
- 26.41965389
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 21.91965389
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 879.030024
- begin_treasury_m
- 37.9813665
- begin_employee_trust_m
- 0
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 879.430024
- ending_treasury_m
- 34.5813665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 844.8486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.98138735773
- old_holder_cash_oku
- dividends_received_oku
- 1.8098697834
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 1.8098697834
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 6
内容を開く
- fiscal_year
- 2031
- period_start_inclusive
2031-01-01
- 期間末
2031-12-31
- days_booked
- 365
- days_full_calendar_year
- 365
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2031
- segment_revenue_usd_m
- Orthopaedics
- 2107.72988
- Sports_Medicine_ENT
- 2053.51785
- Advanced_Wound_Management
- 1628.43805
- geography_revenue_usd_m
- US
- 2989.90073
- Other_Established
- 1782.22866
- Emerging
- 1017.55639
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 89.01697
- net_realised_price_index_2026_100
- 94.14228
- revenue_usd_m
- 1147.67674
- 売上高
- 8.59554176
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 91.31822
- net_realised_price_index_2026_100
- 93.66682
- revenue_usd_m
- 638.94548
- 売上高
- 4.78539157
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 93.19328
- net_realised_price_index_2026_100
- 92.25194
- revenue_usd_m
- 321.10767
- 売上高
- 2.40494057
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 98.50897
- net_realised_price_index_2026_100
- 98.01594
- revenue_usd_m
- 1118.39068
- 売上高
- 8.37620343
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 101.00401
- net_realised_price_index_2026_100
- 97.52488
- revenue_usd_m
- 601.60353
- 売上高
- 4.50571847
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 103.03622
- net_realised_price_index_2026_100
- 96.06349
- revenue_usd_m
- 333.52363
- 売上高
- 2.49793015
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 92.72165
- net_realised_price_index_2026_100
- 95.58027
- revenue_usd_m
- 723.83332
- 売上高
- 5.42116024
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 95.099
- net_realised_price_index_2026_100
- 95.099
- revenue_usd_m
- 541.67964
- 売上高
- 4.05691764
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 97.03578
- net_realised_price_index_2026_100
- 93.66682
- revenue_usd_m
- 362.92509
- 売上高
- 2.7181328
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 43.36193664
- revenue_usd_m
- 5789.68578053
- cogs
- 13.16034777
- sga_including_sbc
- 23.45697308
- rd
- 2.13557538
- operating_profit
- 4.60904042
- 営業利益率
- 10.63%
- finance_cost_net
- 1.12299964
- associates_profit
- 0.06740563
- pretax_profit
- 3.55344641
- tax_expense
- 0.81729267
- parent_profit_after_sbc
- 2.73615373
- sbc_expense_within_sga
- 0.49115483
- sbc_equity_credit
- 0.49115483
- depreciation_amortization
- 3.98929817
- capital_expenditure
- 3.98929817
- net_working_capital_investment
- -0.00566837
- cash_acquisitions
- 0.34689549
- lease_principal_paid
- 0.4119384
- fcfe_before_equity_distributions
- 2.47414304
- dividend_policy_adjusted_profit_proxy_usd_m
- 578.09412671
- dividend_policy_normalization_usd_m
- 212.76288006
- capital
内容を開く
- begin_parent_equity_oku
- 46.4280729
- period_parent_profit_after_sbc_oku
- 2.73615373
- noncash_sbc_equity_credit_oku
- 0.49115483
- new_issue_cash_proceeds_oku
- 0.03614169
- issuer_paid_dividends_oku
- 1.72187937
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 47.96964378
- begin_gross_financing_debt_oku
- 26.41965389
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 2.47414304
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 0.78840535
- ending_gross_financing_debt_oku
- 25.63124853
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 21.13124853
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 879.430024
- begin_treasury_m
- 34.5813665
- begin_employee_trust_m
- 0
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 879.830024
- ending_treasury_m
- 31.1813665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 848.6486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.97699299273
- old_holder_cash_oku
- dividends_received_oku
- 1.6861324717
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 1.6861324717
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 7
内容を開く
- fiscal_year
- 2032
- period_start_inclusive
2032-01-01
- 期間末
2032-12-31
- days_booked
- 366
- days_full_calendar_year
- 366
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2032
- segment_revenue_usd_m
- Orthopaedics
- 2038.65886
- Sports_Medicine_ENT
- 2043.20865
- Advanced_Wound_Management
- 1593.51708
- geography_revenue_usd_m
- US
- 2924.95921
- Other_Established
- 1749.98061
- Emerging
- 1000.44476
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 86.96958
- net_realised_price_index_2026_100
- 93.01257
- revenue_usd_m
- 1107.82481
- 売上高
- 8.29707016
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 89.67449
- net_realised_price_index_2026_100
- 92.44915
- revenue_usd_m
- 619.28769
- 売上高
- 4.63816422
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 91.88857
- net_realised_price_index_2026_100
- 90.77591
- revenue_usd_m
- 311.54636
- 売上高
- 2.33333106
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 98.21345
- net_realised_price_index_2026_100
- 97.62387
- revenue_usd_m
- 1110.57537
- 売上高
- 8.31767052
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 101.20602
- net_realised_price_index_2026_100
- 97.03725
- revenue_usd_m
- 599.7927
- 売上高
- 4.49215626
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 103.65443
- net_realised_price_index_2026_100
- 95.29498
- revenue_usd_m
- 332.84058
- 売上高
- 2.49281439
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 91.33083
- net_realised_price_index_2026_100
- 94.72005
- revenue_usd_m
- 706.55903
- 売上高
- 5.29178425
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 94.14801
- net_realised_price_index_2026_100
- 94.14801
- revenue_usd_m
- 530.90022
- 売上高
- 3.97618498
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 96.45357
- net_realised_price_index_2026_100
- 92.44915
- revenue_usd_m
- 356.05782
- 売上高
- 2.66670029
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 42.50587614
- revenue_usd_m
- 5675.38458232
- cogs
- 12.99829692
- sga_including_sbc
- 23.1132567
- rd
- 2.09979028
- operating_profit
- 4.29453223
- 営業利益率
- 10.10%
- finance_cost_net
- 1.08988661
- associates_profit
- 0.06740563
- pretax_profit
- 3.27205125
- tax_expense
- 0.75257179
- parent_profit_after_sbc
- 2.51947946
- sbc_expense_within_sga
- 0.48492682
- sbc_equity_credit
- 0.48492682
- depreciation_amortization
- 3.9105406
- capital_expenditure
- 3.9105406
- net_working_capital_investment
- -0.0048746
- cash_acquisitions
- 0.34004701
- lease_principal_paid
- 0.40380582
- fcfe_before_equity_distributions
- 2.26542805
- dividend_policy_adjusted_profit_proxy_usd_m
- 538.31755099
- dividend_policy_normalization_usd_m
- 201.91665318
- capital
内容を開く
- begin_parent_equity_oku
- 47.96964378
- period_parent_profit_after_sbc_oku
- 2.51947946
- noncash_sbc_equity_credit_oku
- 0.48492682
- new_issue_cash_proceeds_oku
- 0.0350494
- issuer_paid_dividends_oku
- 1.60637134
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 49.40272812
- begin_gross_financing_debt_oku
- 25.63124853
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 2.26542805
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 0.69410612
- ending_gross_financing_debt_oku
- 24.93714242
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 20.43714242
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 879.830024
- begin_treasury_m
- 31.1813665
- begin_employee_trust_m
- 0
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 880.230024
- ending_treasury_m
- 27.7813665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 852.4486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.97263780566
- old_holder_cash_oku
- dividends_received_oku
- 1.5659920137
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 1.5659920137
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 8
内容を開く
- fiscal_year
- 2033
- period_start_inclusive
2033-01-01
- 期間末
2033-12-31
- days_booked
- 365
- days_full_calendar_year
- 365
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2033
- segment_revenue_usd_m
- Orthopaedics
- 1971.86114
- Sports_Medicine_ENT
- 2032.96091
- Advanced_Wound_Management
- 1559.3528
- geography_revenue_usd_m
- US
- 2861.86837
- Other_Established
- 1718.55731
- Emerging
- 983.74918
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 84.96928
- net_realised_price_index_2026_100
- 91.89642
- revenue_usd_m
- 1069.3567
- 売上高
- 8.0089627
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 88.06035
- net_realised_price_index_2026_100
- 91.24731
- revenue_usd_m
- 600.23468
- 売上高
- 4.49546646
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 90.60213
- net_realised_price_index_2026_100
- 89.32349
- revenue_usd_m
- 302.26976
- 売上高
- 2.2638538
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 97.91881
- net_realised_price_index_2026_100
- 97.23338
- revenue_usd_m
- 1102.81467
- 売上高
- 8.25954664
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 101.40843
- net_realised_price_index_2026_100
- 96.55206
- revenue_usd_m
- 597.98733
- 売上高
- 4.47863487
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 104.27636
- net_realised_price_index_2026_100
- 94.53262
- revenue_usd_m
- 332.15892
- 売上高
- 2.48770911
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 89.96086
- net_realised_price_index_2026_100
- 93.86757
- revenue_usd_m
- 689.697
- 売上高
- 5.16549582
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 93.20653
- net_realised_price_index_2026_100
- 93.20653
- revenue_usd_m
- 520.3353
- 売上高
- 3.8970589
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 95.87485
- net_realised_price_index_2026_100
- 91.24731
- revenue_usd_m
- 349.3205
- 売上高
- 2.61624099
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 41.67296928
- revenue_usd_m
- 5564.17485818
- cogs
- 12.83944183
- sga_including_sbc
- 22.7773871
- rd
- 2.06489563
- operating_profit
- 3.99124472
- 営業利益率
- 9.58%
- finance_cost_net
- 1.06073416
- associates_profit
- 0.06740563
- pretax_profit
- 2.9979162
- tax_expense
- 0.68952072
- parent_profit_after_sbc
- 2.30839547
- sbc_expense_within_sga
- 0.47882378
- sbc_equity_credit
- 0.47882378
- depreciation_amortization
- 3.83391317
- capital_expenditure
- 3.83391317
- net_working_capital_investment
- -0.00410928
- cash_acquisitions
- 0.33338375
- lease_principal_paid
- 0.39589321
- fcfe_before_equity_distributions
- 2.06205157
- dividend_policy_adjusted_profit_proxy_usd_m
- 499.47710018
- dividend_policy_normalization_usd_m
- 191.26013698
- capital
内容を開く
- begin_parent_equity_oku
- 49.40272812
- period_parent_profit_after_sbc_oku
- 2.30839547
- noncash_sbc_equity_credit_oku
- 0.47882378
- new_issue_cash_proceeds_oku
- 0.03399863
- issuer_paid_dividends_oku
- 1.49370656
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 50.73023944
- begin_gross_financing_debt_oku
- 24.93714242
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 2.06205157
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 0.60234364
- ending_gross_financing_debt_oku
- 24.33479878
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 19.83479878
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 880.230024
- begin_treasury_m
- 27.7813665
- begin_employee_trust_m
- 0
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 880.630024
- ending_treasury_m
- 24.3813665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 856.2486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.9683212749
- old_holder_cash_oku
- dividends_received_oku
- 1.449679959
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 1.449679959
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 9
内容を開く
- fiscal_year
- 2034
- period_start_inclusive
2034-01-01
- 期間末
2034-12-31
- days_booked
- 365
- days_full_calendar_year
- 365
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2034
- segment_revenue_usd_m
- Orthopaedics
- 1907.26159
- Sports_Medicine_ENT
- 2022.77424
- Advanced_Wound_Management
- 1525.92867
- geography_revenue_usd_m
- US
- 2800.56994
- Other_Established
- 1687.93588
- Emerging
- 967.45869
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 83.01499
- net_realised_price_index_2026_100
- 90.79367
- revenue_usd_m
- 1032.22436
- 売上高
- 7.73085948
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 86.47527
- net_realised_price_index_2026_100
- 90.06109
- revenue_usd_m
- 581.76786
- 売上高
- 4.35715893
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 89.3337
- net_realised_price_index_2026_100
- 87.89432
- revenue_usd_m
- 293.26937
- 売上高
- 2.19644529
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 97.62505
- net_realised_price_index_2026_100
- 96.84444
- revenue_usd_m
- 1095.1082
- 売上高
- 8.20182893
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 101.61124
- net_realised_price_index_2026_100
- 96.0693
- revenue_usd_m
- 596.18739
- 売上高
- 4.46515418
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 104.90202
- net_realised_price_index_2026_100
- 93.77636
- revenue_usd_m
- 331.47866
- 売上高
- 2.48261428
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 88.61145
- net_realised_price_index_2026_100
- 93.02276
- revenue_usd_m
- 673.23738
- 売上高
- 5.04222126
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 92.27447
- net_realised_price_index_2026_100
- 92.27447
- revenue_usd_m
- 509.98063
- 売上高
- 3.81950743
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 95.2996
- net_realised_price_index_2026_100
- 90.06109
- revenue_usd_m
- 342.71065
- 売上高
- 2.56673648
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 40.86252625
- revenue_usd_m
- 5455.96450542
- cogs
- 12.68372815
- sga_including_sbc
- 22.44918036
- rd
- 2.03086755
- operating_profit
- 3.69875018
- 営業利益率
- 9.05%
- finance_cost_net
- 1.03543572
- associates_profit
- 0.06740563
- pretax_profit
- 2.73072009
- tax_expense
- 0.62806562
- parent_profit_after_sbc
- 2.10265447
- sbc_expense_within_sga
- 0.47284304
- sbc_equity_credit
- 0.47284304
- depreciation_amortization
- 3.75935242
- capital_expenditure
- 3.75935242
- net_working_capital_investment
- -0.00337147
- cash_acquisitions
- 0.32690021
- lease_principal_paid
- 0.388194
- fcfe_before_equity_distributions
- 1.86377477
- dividend_policy_adjusted_profit_proxy_usd_m
- 461.53536242
- dividend_policy_normalization_usd_m
- 180.78893746
- capital
内容を開く
- begin_parent_equity_oku
- 50.73023944
- period_parent_profit_after_sbc_oku
- 2.10265447
- noncash_sbc_equity_credit_oku
- 0.47284304
- new_issue_cash_proceeds_oku
- 0.03297936
- issuer_paid_dividends_oku
- 1.3836812
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 51.95503511
- begin_gross_financing_debt_oku
- 24.33479878
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 1.86377477
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 0.51307292
- ending_gross_financing_debt_oku
- 23.82172586
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 19.32172586
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 880.630024
- begin_treasury_m
- 24.3813665
- begin_employee_trust_m
- 0
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 881.030024
- ending_treasury_m
- 20.9813665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 860.0486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.96404288808
- old_holder_cash_oku
- dividends_received_oku
- 1.3369483902
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 1.3369483902
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 10
内容を開く
- fiscal_year
- 2035
- period_start_inclusive
2035-01-01
- 期間末
2035-12-31
- days_booked
- 365
- days_full_calendar_year
- 365
- accrual_fraction_of_calendar_year
- 1
- is_partial_period
- いいえ
- period_status
将来予測
- financials_oku_gbp
内容を開く
- year
- 2035
- segment_revenue_usd_m
- Orthopaedics
- 1844.78758
- Sports_Medicine_ENT
- 2012.64823
- Advanced_Wound_Management
- 1493.22847
- geography_revenue_usd_m
- US
- 2741.00755
- Other_Established
- 1658.09407
- Emerging
- 951.56266
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 81.10564
- net_realised_price_index_2026_100
- 89.70414
- revenue_usd_m
- 996.3814
- 売上高
- 7.46241312
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 84.91871
- net_realised_price_index_2026_100
- 88.8903
- revenue_usd_m
- 563.86919
- 売上高
- 4.22310658
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 88.08303
- net_realised_price_index_2026_100
- 86.48801
- revenue_usd_m
- 284.53699
- 売上高
- 2.13104393
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 97.33217
- net_realised_price_index_2026_100
- 96.45707
- revenue_usd_m
- 1087.45558
- 売上高
- 8.14451455
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 101.81447
- net_realised_price_index_2026_100
- 95.58896
- revenue_usd_m
- 594.39286
- 売上高
- 4.45171406
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 105.53143
- net_realised_price_index_2026_100
- 93.02615
- revenue_usd_m
- 330.79979
- 売上高
- 2.47752988
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 87.28228
- net_realised_price_index_2026_100
- 92.18556
- revenue_usd_m
- 657.17057
- 売上高
- 4.92188865
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 91.35172
- net_realised_price_index_2026_100
- 91.35172
- revenue_usd_m
- 499.83202
- 売上高
- 3.74349923
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 94.7278
- net_realised_price_index_2026_100
- 88.8903
- revenue_usd_m
- 336.22588
- 売上高
- 2.51816869
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 40.0738787
- revenue_usd_m
- 5350.66428377
- cogs
- 12.53110187
- sga_including_sbc
- 22.12845671
- rd
- 1.99768285
- operating_profit
- 3.41663726
- 営業利益率
- 8.53%
- finance_cost_net
- 1.01388666
- associates_profit
- 0.06740563
- pretax_profit
- 2.47015623
- tax_expense
- 0.56813593
- parent_profit_after_sbc
- 1.9020203
- sbc_expense_within_sga
- 0.46698201
- sbc_equity_credit
- 0.46698201
- depreciation_amortization
- 3.68679684
- capital_expenditure
- 3.68679684
- net_working_capital_investment
- -0.00266024
- cash_acquisitions
- 0.32059103
- lease_principal_paid
- 0.38070185
- fcfe_before_equity_distributions
- 1.67036967
- dividend_policy_adjusted_profit_proxy_usd_m
- 424.45650176
- dividend_policy_normalization_usd_m
- 170.49875119
- capital
内容を開く
- begin_parent_equity_oku
- 51.95503511
- period_parent_profit_after_sbc_oku
- 1.9020203
- noncash_sbc_equity_credit_oku
- 0.46698201
- new_issue_cash_proceeds_oku
- 0.03199064
- issuer_paid_dividends_oku
- 1.27618767
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 53.07984039
- begin_gross_financing_debt_oku
- 23.82172586
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 1.67036967
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 0.42617264
- ending_gross_financing_debt_oku
- 23.39555322
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 18.89555322
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 881.030024
- begin_treasury_m
- 20.9813665
- begin_employee_trust_m
- 0
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 3.4
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 881.430024
- ending_treasury_m
- 17.5813665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 863.8486575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.95980214181
- old_holder_cash_oku
- dividends_received_oku
- 1.2276464379
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 1.2276464379
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- 11
内容を開く
- fiscal_year
- 2036
- period_start_inclusive
2036-01-01
- 期間末
2036-11-06
- days_booked
- 311
- days_full_calendar_year
- 366
- accrual_fraction_of_calendar_year
- 0.849726775956
- is_partial_period
- はい
- period_status
暦年将来予測・最終期途中打切り
- financials_oku_gbp
内容を開く
- year
- 2036
- segment_revenue_usd_m
- Orthopaedics
- 1516.2259985246
- Sports_Medicine_ENT
- 1701.6479628142
- Advanced_Wound_Management
- 1241.6516695902
- geography_revenue_usd_m
- US
- 2279.924591776
- Other_Established
- 1384.2136617213
- Emerging
- 795.38737743169
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 79.24021
- net_realised_price_index_2026_100
- 88.62769
- revenue_usd_m
- 817.25281
- 売上高
- 6.12082693
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 83.39017
- net_realised_price_index_2026_100
- 87.73473
- revenue_usd_m
- 464.39369
- 売上高
- 3.47808336
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 86.84987
- net_realised_price_index_2026_100
- 85.1042
- revenue_usd_m
- 234.57949
- 売上高
- 1.75688656
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 97.04018
- net_realised_price_index_2026_100
- 96.07124
- revenue_usd_m
- 917.58293
- 売上高
- 6.87225085
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 102.0181
- net_realised_price_index_2026_100
- 95.11101
- revenue_usd_m
- 503.55127
- 売上高
- 3.77135459
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 106.16462
- net_realised_price_index_2026_100
- 92.28194
- revenue_usd_m
- 280.51377
- 売上高
- 2.10091198
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 85.97304
- net_realised_price_index_2026_100
- 91.35589
- revenue_usd_m
- 545.08885
- 売上高
- 4.08245093
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 90.43821
- net_realised_price_index_2026_100
- 90.43821
- revenue_usd_m
- 416.26871
- 売上高
- 3.1176506
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 94.15944
- net_realised_price_index_2026_100
- 87.73473
- revenue_usd_m
- 280.29412
- 売上高
- 2.09926691
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 33.3996827
- revenue_usd_m
- 4459.52563444
- cogs
- 10.52090005
- sga_including_sbc
- 18.5368239
- rd
- 1.66998414
- operating_profit
- 2.67197462
- 営業利益率
- 8.00%
- finance_cost_net
- 0.84631717
- associates_profit
- 0.05727637
- pretax_profit
- 1.88293381
- tax_expense
- 0.43307478
- parent_profit_after_sbc
- 1.44985904
- sbc_expense_within_sga
- 0.3919264
- sbc_equity_credit
- 0.3919264
- depreciation_amortization
- 3.07277081
- capital_expenditure
- 3.07277081
- net_working_capital_investment
- -0.00167796
- cash_acquisitions
- 0.26719746
- lease_principal_paid
- 0.31729699
- fcfe_before_equity_distributions
- 1.25896895
- dividend_policy_adjusted_profit_proxy_usd_m
- 388.2058635
- dividend_policy_normalization_usd_m
- 160.38536384
- capital
内容を開く
- begin_parent_equity_oku
- 53.07984039
- period_parent_profit_after_sbc_oku
- 1.44985904
- noncash_sbc_equity_credit_oku
- 0.3919264
- new_issue_cash_proceeds_oku
- 0.03103416
- issuer_paid_dividends_oku
- 1.17112507
- issuer_gross_buybacks_oku
- 0
- ending_parent_equity_oku
- 53.78153491
- begin_gross_financing_debt_oku
- 23.39555322
- begin_cash_oku
- 4.5
- operating_fcfe_before_distributions_oku
- 1.25896895
- additional_new_debt_borrowings_oku
- 0
- debt_principal_repayment_oku
- 0.11887803
- ending_gross_financing_debt_oku
- 23.27667518
- ending_cash_oku
- 4.5
- ending_simple_net_debt_oku
- 18.77667518
- ending_required_operating_cash_oku
- 4.5
- other_comprehensive_income_assumed_oku
- 0
- sbc_transfer_book_value_equity_effect_assumed_oku
- 0
- lease_liability_replenishment_assumption
リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映
- 株数
内容を開く
- begin_issued_m
- 881.430024
- begin_treasury_m
- 17.5813665
- begin_employee_trust_m
- 0
- begin_old_cohort_m
- 829.1237917
- new_issuance_m
- 0.4
- treasury_or_trust_shares_delivered_to_employees_m
- 2.788
- issuer_buyback_shares_m
- 0
- old_cohort_proportionally_tendered_shares_m
- 0
- ending_issued_m
- 881.830024
- ending_treasury_m
- 14.7933665
- ending_employee_trust_m
- 0
- ending_economic_shares_m
- 867.0366575
- ending_old_cohort_shares_m
- 829.1237917
- ending_old_cohort_economic_fraction
- 0.95627305316
- old_holder_cash_oku
- dividends_received_oku
- 1.1216323173
- proportional_tender_proceeds_oku
- 0
- total_received_oku
- 1.1216323173
- income_statement_technical
内容を開く
- rd_already_expensed_in_operating_profit
- はい
- sbc_expense_included_in_IFRS_operating_costs_and_profit
- はい
- consolidation_NCI_profit_assumed
- 0
- equity_settled_sbc_credit_is_not_cash_proceeds
- はい
- period_reconciliation_absolute_errors
内容を開く
- equity_bridge_abs_error
- 0
- cash_bridge_abs_error
- 0
- shares_bridge_abs_error_m
- 0
- old_holder_shares_bridge_abs_error_m
- 0
- income_statement_abs_error_oku
- 0
- attributable_profit_abs_error_oku
- 0
- fcfe_cash_identity_abs_error_oku
- 0
- complete_calendar_year_projection_reference_not_fully_booked
内容を開く
- year
- 2036
- segment_revenue_usd_m
- Orthopaedics
- 1784.36886
- Sports_Medicine_ENT
- 2002.58249
- Advanced_Wound_Management
- 1461.23637
- geography_revenue_usd_m
- US
- 2683.12669
- Other_Established
- 1629.01029
- Emerging
- 936.05074
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 79.24021
- net_realised_price_index_2026_100
- 88.62769
- revenue_usd_m
- 961.78305
- 売上高
- 7.20328828
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 83.39017
- net_realised_price_index_2026_100
- 87.73473
- revenue_usd_m
- 546.52119
- 売上高
- 4.09317849
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 86.84987
- net_realised_price_index_2026_100
- 85.1042
- revenue_usd_m
- 276.06461
- 売上高
- 2.06758997
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 97.04018
- net_realised_price_index_2026_100
- 96.07124
- revenue_usd_m
- 1079.85644
- 売上高
- 8.08760068
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 102.0181
- net_realised_price_index_2026_100
- 95.11101
- revenue_usd_m
- 592.60374
- 売上高
- 4.4383144
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 106.16462
- net_realised_price_index_2026_100
- 92.28194
- revenue_usd_m
- 330.12231
- 売上高
- 2.4724559
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 85.97304
- net_realised_price_index_2026_100
- 91.35589
- revenue_usd_m
- 641.4872
- 売上高
- 4.80442778
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 90.43821
- net_realised_price_index_2026_100
- 90.43821
- revenue_usd_m
- 489.88536
- 売上高
- 3.6690036
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 94.15944
- net_realised_price_index_2026_100
- 87.73473
- revenue_usd_m
- 329.86382
- 売上高
- 2.4705199
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 39.306379
- revenue_usd_m
- 5248.18772413
- cogs
- 12.38150939
- sga_including_sbc
- 21.81504035
- rd
- 1.96531895
- operating_profit
- 3.14451032
- 営業利益率
- 8.00%
- finance_cost_net
- 0.99598741
- associates_profit
- 0.06740563
- pretax_profit
- 2.21592854
- tax_expense
- 0.50966356
- parent_profit_after_sbc
- 1.70626498
- sbc_expense_within_sga
- 0.46123814
- sbc_equity_credit
- 0.46123814
- depreciation_amortization
- 3.61618687
- capital_expenditure
- 3.61618687
- net_working_capital_investment
- -0.00197471
- cash_acquisitions
- 0.31445103
- lease_principal_paid
- 0.3734106
- fcfe_before_equity_distributions
- 1.48161619
- dividend_policy_adjusted_profit_proxy_usd_m
- 388.2058635
- dividend_policy_normalization_usd_m
- 160.38536384
- 注記
2036暦年全期の仮定値。11月7日以降の利益・資本・買戻し・配当を終点以前には計上しない。
- dividend_timetable_ex_dates
内容を開く
- 1
内容を開く
- fiscal_year
- 2026
- kind
final
- declaration_date_assumed
2027-02-26
- ex_date
2027-03-25
- record_date
2027-03-26
- payment_date
2027-05-26
- 状態
all_future_dates_assumed
- usd_per_share
- 0.25
- gbp_per_share_fixed_fx
- 0.1872379
- recheck_date_assumed
2027-03-04
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 2
内容を開く
- fiscal_year
- 2027
- kind
interim
- declaration_date_assumed
2027-08-04
- ex_date
2027-10-07
- record_date
2027-10-08
- payment_date
2027-11-05
- 状態
all_future_dates_assumed
- usd_per_share
- 0.1624
- gbp_per_share_fixed_fx
- 0.1216297
- recheck_date_assumed
2027-09-16
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 3
内容を開く
- fiscal_year
- 2027
- kind
final
- declaration_date_assumed
2028-02-25
- ex_date
2028-03-30
- record_date
2028-03-31
- payment_date
2028-05-24
- 状態
all_future_dates_assumed
- usd_per_share
- 0.1879876
- gbp_per_share_fixed_fx
- 0.1407936
- recheck_date_assumed
2028-03-09
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 4
内容を開く
- fiscal_year
- 2028
- kind
interim
- declaration_date_assumed
2028-08-04
- ex_date
2028-10-05
- record_date
2028-10-06
- payment_date
2028-11-03
- 状態
all_future_dates_assumed
- usd_per_share
- 0.140155
- gbp_per_share_fixed_fx
- 0.1049693
- recheck_date_assumed
2028-09-14
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 5
内容を開く
- fiscal_year
- 2028
- kind
final
- declaration_date_assumed
2029-02-26
- ex_date
2029-03-29
- record_date
2029-03-30
- payment_date
2029-05-23
- 状態
all_future_dates_assumed
- usd_per_share
- 0.1804615
- gbp_per_share_fixed_fx
- 0.1351569
- recheck_date_assumed
2029-03-08
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 6
内容を開く
- fiscal_year
- 2029
- kind
interim
- declaration_date_assumed
2029-08-03
- ex_date
2029-10-04
- record_date
2029-10-05
- payment_date
2029-11-05
- 状態
all_future_dates_assumed
- usd_per_share
- 0.1282466
- gbp_per_share_fixed_fx
- 0.0960505
- recheck_date_assumed
2029-09-13
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 7
内容を開く
- fiscal_year
- 2029
- kind
final
- declaration_date_assumed
2030-02-26
- ex_date
2030-03-28
- record_date
2030-03-29
- payment_date
2030-05-22
- 状態
all_future_dates_assumed
- usd_per_share
- 0.1715416
- gbp_per_share_fixed_fx
- 0.1284763
- recheck_date_assumed
2030-03-07
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 8
内容を開く
- fiscal_year
- 2030
- kind
interim
- declaration_date_assumed
2030-08-02
- ex_date
2030-10-03
- record_date
2030-10-04
- payment_date
2030-11-05
- 状態
all_future_dates_assumed
- usd_per_share
- 0.1199153
- gbp_per_share_fixed_fx
- 0.0898107
- recheck_date_assumed
2030-09-12
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 9
内容を開く
- fiscal_year
- 2030
- kind
final
- declaration_date_assumed
2031-02-26
- ex_date
2031-03-27
- record_date
2031-03-28
- payment_date
2031-05-28
- 状態
all_future_dates_assumed
- usd_per_share
- 0.1596889
- gbp_per_share_fixed_fx
- 0.1195992
- recheck_date_assumed
2031-03-06
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 10
内容を開く
- fiscal_year
- 2031
- kind
interim
- declaration_date_assumed
2031-08-04
- ex_date
2031-10-02
- record_date
2031-10-03
- payment_date
2031-11-05
- 状態
all_future_dates_assumed
- usd_per_share
- 0.1118417
- gbp_per_share_fixed_fx
- 0.083764
- recheck_date_assumed
2031-09-11
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 11
内容を開く
- fiscal_year
- 2031
- kind
final
- declaration_date_assumed
2032-02-26
- ex_date
2032-03-25
- record_date
2032-03-26
- payment_date
2032-05-26
- 状態
all_future_dates_assumed
- usd_per_share
- 0.1481762
- gbp_per_share_fixed_fx
- 0.1109768
- recheck_date_assumed
2032-03-04
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 12
内容を開く
- fiscal_year
- 2032
- kind
interim
- declaration_date_assumed
2032-08-04
- ex_date
2032-10-07
- record_date
2032-10-08
- payment_date
2032-11-05
- 状態
all_future_dates_assumed
- usd_per_share
- 0.1040072
- gbp_per_share_fixed_fx
- 0.0778963
- recheck_date_assumed
2032-09-16
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 13
内容を開く
- fiscal_year
- 2032
- kind
final
- declaration_date_assumed
2033-02-25
- ex_date
2033-03-31
- record_date
2033-04-01
- payment_date
2033-05-25
- 状態
all_future_dates_assumed
- usd_per_share
- 0.1370357
- gbp_per_share_fixed_fx
- 0.1026331
- recheck_date_assumed
2033-03-10
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 14
内容を開く
- fiscal_year
- 2033
- kind
interim
- declaration_date_assumed
2033-08-04
- ex_date
2033-10-06
- record_date
2033-10-07
- payment_date
2033-11-04
- 状態
all_future_dates_assumed
- usd_per_share
- 0.0964171
- gbp_per_share_fixed_fx
- 0.0722118
- recheck_date_assumed
2033-09-15
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 15
内容を開く
- fiscal_year
- 2033
- kind
final
- declaration_date_assumed
2034-02-24
- ex_date
2034-03-30
- record_date
2034-03-31
- payment_date
2034-05-24
- 状態
all_future_dates_assumed
- usd_per_share
- 0.1262371
- gbp_per_share_fixed_fx
- 0.0945455
- recheck_date_assumed
2034-03-09
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 16
内容を開く
- fiscal_year
- 2034
- kind
interim
- declaration_date_assumed
2034-08-04
- ex_date
2034-10-05
- record_date
2034-10-06
- payment_date
2034-11-03
- 状態
all_future_dates_assumed
- usd_per_share
- 0.0890617
- gbp_per_share_fixed_fx
- 0.0667029
- recheck_date_assumed
2034-09-14
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 17
内容を開く
- fiscal_year
- 2034
- kind
final
- declaration_date_assumed
2035-02-26
- ex_date
2035-03-29
- record_date
2035-03-30
- payment_date
2035-05-23
- 状態
all_future_dates_assumed
- usd_per_share
- 0.115766
- gbp_per_share_fixed_fx
- 0.0867031
- recheck_date_assumed
2035-03-08
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 18
内容を開く
- fiscal_year
- 2035
- kind
interim
- declaration_date_assumed
2035-08-03
- ex_date
2035-10-04
- record_date
2035-10-05
- payment_date
2035-11-05
- 状態
all_future_dates_assumed
- usd_per_share
- 0.0819311
- gbp_per_share_fixed_fx
- 0.0613624
- recheck_date_assumed
2035-09-13
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 19
内容を開く
- fiscal_year
- 2035
- kind
final
- declaration_date_assumed
2036-02-26
- ex_date
2036-03-27
- record_date
2036-03-28
- payment_date
2036-05-28
- 状態
all_future_dates_assumed
- usd_per_share
- 0.1056089
- gbp_per_share_fixed_fx
- 0.0790959
- recheck_date_assumed
2036-03-06
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 20
内容を開く
- fiscal_year
- 2036
- kind
interim
- declaration_date_assumed
2036-08-04
- ex_date
2036-10-02
- record_date
2036-10-03
- payment_date
2036-11-05
- 状態
all_future_dates_assumed
- usd_per_share
- 0.075016
- gbp_per_share_fixed_fx
- 0.0561833
- recheck_date_assumed
2036-09-11
- ex_date_is_issuer_confirmed
- いいえ
- ex_date_status
future_assumed_reconfirm_before_ex_date
- 終価
- 10.770428062
- 期間内株主受取
- 17.649067317
- terminal_2036_11_06
内容を開く
- 終了日
2036-11-06
- date_status
forecast_not_announced
- terminal_year_actual_days_over_365_25
- 10.001368925394
- company_issued_shares_m
- 881.830024
- treasury_shares_m
- 14.7933665
- employee_trust_shares_m
- 0
- company_economic_shares_m
- 867.0366575
- old_cohort_remaining_shares_m
- 829.1237917
- old_cohort_fraction
- 0.9562730532
- company_parent_equity_book_oku
- 53.78153491
- company_gross_debt_oku
- 23.27667518
- company_cash_oku
- 4.5
- company_simple_net_debt_oku
- 18.77667518
- forward_12_months_2036_11_07_to_2037_11_06_company_fcfe_oku
- 1.45095136
- forward_fcfe_blend
- 2036_year_end_55_days_over_leap_366
- 0.150273224
- 2037_to_Nov06_310_days_over_365
- 0.8493150685
- long_run_total_company_fcfe_growth
- 0
- next_12m_vested_and_new_shares_m
- 3.8
- post_horizon_annual_share_dilution_fraction
- 0.004382744336
- post_horizon_cohort_fcfe_growth_after_dilution
- 未確認
- cashflow_to_old_cohort_forward_year_after_dilution_oku
- 1.39195869
- terminal_k
- 0.125
- terminal_denominator_k_minus_effective_old_growth
- 未確認
- terminal_company_equivalent_value_without_extra_cash_oku
- 11.26292122
- old_cohort_operating_terminal_oku
- 10.77042806
- nonoperating_excess_cash_company_oku
- 0
- nonoperating_excess_cash_old_cohort_oku
- 0
- terminal_old_cohort_total_oku
- 10.77042806
- terminal_remaining_cohort_implied_price_per_share_gbp
- 1.29901327
- IFRS_2036_full_calendar_year_reference_not_booked_in_full
内容を開く
- year
- 2036
- segment_revenue_usd_m
- Orthopaedics
- 1784.36886
- Sports_Medicine_ENT
- 2002.58249
- Advanced_Wound_Management
- 1461.23637
- geography_revenue_usd_m
- US
- 2683.12669
- Other_Established
- 1629.01029
- Emerging
- 936.05074
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 79.24021
- net_realised_price_index_2026_100
- 88.62769
- revenue_usd_m
- 961.78305
- 売上高
- 7.20328828
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 83.39017
- net_realised_price_index_2026_100
- 87.73473
- revenue_usd_m
- 546.52119
- 売上高
- 4.09317849
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 86.84987
- net_realised_price_index_2026_100
- 85.1042
- revenue_usd_m
- 276.06461
- 売上高
- 2.06758997
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 97.04018
- net_realised_price_index_2026_100
- 96.07124
- revenue_usd_m
- 1079.85644
- 売上高
- 8.08760068
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 102.0181
- net_realised_price_index_2026_100
- 95.11101
- revenue_usd_m
- 592.60374
- 売上高
- 4.4383144
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 106.16462
- net_realised_price_index_2026_100
- 92.28194
- revenue_usd_m
- 330.12231
- 売上高
- 2.4724559
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 85.97304
- net_realised_price_index_2026_100
- 91.35589
- revenue_usd_m
- 641.4872
- 売上高
- 4.80442778
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 90.43821
- net_realised_price_index_2026_100
- 90.43821
- revenue_usd_m
- 489.88536
- 売上高
- 3.6690036
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 94.15944
- net_realised_price_index_2026_100
- 87.73473
- revenue_usd_m
- 329.86382
- 売上高
- 2.4705199
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 39.306379
- revenue_usd_m
- 5248.18772413
- cogs
- 12.38150939
- sga_including_sbc
- 21.81504035
- rd
- 1.96531895
- operating_profit
- 3.14451032
- 営業利益率
- 8.00%
- finance_cost_net
- 0.99598741
- associates_profit
- 0.06740563
- pretax_profit
- 2.21592854
- tax_expense
- 0.50966356
- parent_profit_after_sbc
- 1.70626498
- sbc_expense_within_sga
- 0.46123814
- sbc_equity_credit
- 0.46123814
- depreciation_amortization
- 3.61618687
- capital_expenditure
- 3.61618687
- net_working_capital_investment
- -0.00197471
- cash_acquisitions
- 0.31445103
- lease_principal_paid
- 0.3734106
- fcfe_before_equity_distributions
- 1.48161619
- dividend_policy_adjusted_profit_proxy_usd_m
- 388.2058635
- dividend_policy_normalization_usd_m
- 160.38536384
- 注記
2036暦年全期の仮定値。11月7日以降の利益・資本・買戻し・配当を終点以前には計上しない。
- IFRS_2037_full_calendar_year_forward_reference
内容を開く
- year
- 2037
- segment_revenue_usd_m
- Orthopaedics
- 1725.93753
- Sports_Medicine_ENT
- 1992.57663
- Advanced_Wound_Management
- 1429.93688
- geography_revenue_usd_m
- US
- 2626.87461
- Other_Established
- 1600.66356
- Emerging
- 920.91287
- volume_price_region_matrix
内容を開く
- 1
内容を開く
- segment
Orthopaedics
- region
US
- volume_index_2026_100
- 77.41769
- net_realised_price_index_2026_100
- 87.56416
- revenue_usd_m
- 928.3861
- 売上高
- 6.9531613
- volume_growth_assumed
- -0.023
- net_price_growth_assumed
- -0.012
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 2
内容を開く
- segment
Orthopaedics
- region
Other_Established
- volume_index_2026_100
- 81.88915
- net_realised_price_index_2026_100
- 86.59418
- revenue_usd_m
- 529.70692
- 売上高
- 3.96724776
- volume_growth_assumed
- -0.018
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 3
内容を開く
- segment
Orthopaedics
- region
Emerging
- volume_index_2026_100
- 85.63397
- net_realised_price_index_2026_100
- 83.74253
- revenue_usd_m
- 267.84451
- 売上高
- 2.00602541
- volume_growth_assumed
- -0.014
- net_price_growth_assumed
- -0.016
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 4
内容を開く
- segment
Sports_Medicine_ENT
- region
US
- volume_index_2026_100
- 96.74906
- net_realised_price_index_2026_100
- 95.68695
- revenue_usd_m
- 1072.31041
- 売上高
- 8.03108452
- volume_growth_assumed
- -0.003
- net_price_growth_assumed
- -0.004
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 5
内容を開く
- segment
Sports_Medicine_ENT
- region
Other_Established
- volume_index_2026_100
- 102.22213
- net_realised_price_index_2026_100
- 94.63546
- revenue_usd_m
- 590.82
- 売上高
- 4.42495508
- volume_growth_assumed
- 0.002
- net_price_growth_assumed
- -0.005
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 6
内容を開く
- segment
Sports_Medicine_ENT
- region
Emerging
- volume_index_2026_100
- 106.80161
- net_realised_price_index_2026_100
- 91.54369
- revenue_usd_m
- 329.44622
- 売上高
- 2.46739231
- volume_growth_assumed
- 0.006
- net_price_growth_assumed
- -0.008
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 7
内容を開く
- segment
Advanced_Wound_Management
- region
US
- volume_index_2026_100
- 84.68345
- net_realised_price_index_2026_100
- 90.53369
- revenue_usd_m
- 626.1781
- 売上高
- 4.68977011
- volume_growth_assumed
- -0.015
- net_price_growth_assumed
- -0.009
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 8
内容を開く
- segment
Advanced_Wound_Management
- region
Other_Established
- volume_index_2026_100
- 89.53383
- net_realised_price_index_2026_100
- 89.53383
- revenue_usd_m
- 480.13664
- 売上高
- 3.59599043
- volume_growth_assumed
- -0.01
- net_price_growth_assumed
- -0.01
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- 9
内容を開く
- segment
Advanced_Wound_Management
- region
Emerging
- volume_index_2026_100
- 93.59448
- net_realised_price_index_2026_100
- 86.59418
- revenue_usd_m
- 323.62213
- 売上高
- 2.42377273
- volume_growth_assumed
- -0.006
- net_price_growth_assumed
- -0.013
- actual_procedure_counts
- 未確認
- actual_net_asp
- 未確認
- unknown_reason
会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値
- revenue
- 38.55939964
- revenue_usd_m
- 5148.45104022
- cogs
- 12.14621089
- sga_including_sbc
- 21.4004668
- rd
- 1.92796998
- operating_profit
- 3.08475197
- 営業利益率
- 8.00%
- finance_cost_net
- 0.99099453
- associates_profit
- 0.06740563
- pretax_profit
- 2.16116307
- tax_expense
- 0.49706751
- parent_profit_after_sbc
- 1.66409556
- sbc_expense_within_sga
- 0.45560894
- sbc_equity_credit
- 0.45560894
- depreciation_amortization
- 3.54746477
- capital_expenditure
- 3.54746477
- net_working_capital_investment
- -0.00131403
- cash_acquisitions
- 0.3084752
- lease_principal_paid
- 0.3663143
- fcfe_before_equity_distributions
- 1.44622904
- dividend_policy_adjusted_profit_proxy_usd_m
- 372.63468836
- dividend_policy_normalization_usd_m
- 150.4446487
- perpetuity_continuation_mode
zero_further_discretionary_buybacks;constant_absolute_annual_free_SBC_and_paid_employee_shares;paid_issue_subscriptions_immediately_pass_through_to_preissue_equity_holders;post_issue_share_count_increases;no_double_debt_deduction
- neutral_repurchase_cost_sensitivity
内容を開く
- 方法
at_year_end_repurchase_exactly_free_awards_plus_paid_issued_shares_at_endogenous_policy_fair_price;paid_subscription_funds_offset_gross_repurchase_spending
- policy
alternative_only_do_not_combine_with_dilution_terminal
- old_cohort_tender_rule
For comparison assume shares repurchased from each year's newly delivered employee cohort, so old cohort has no repurchase proceeds and maintains same original share count; not a forecast of actual corporate repurchase allocation.
- new_shares_per_year_m
- 3.8
- free_award_shares_per_year_m
- 3.4
- paid_employee_shares_per_year_m
- 0.4
- price_for_replacement_gbp_per_share_endogenous
- 1.29758253
- replacement_policy_2036_terminal_equilibrium_price_GBP
- 1.29758253
- replacement_policy_2037_year_end_price_GBP
- 1.29758253
- employee_paid_subscription_price_GBP
- 1.16782427
- required_cash_oku_per_year
- 0.049308136
- gross_market_repurchase_oku_2037
- 0.049308136
- employee_subscription_proceeds_oku_2037
- 0.004671297
- incremental_net_cash_needed_oku_2037
- 0.044636839
- market_neutral_share_equivalent_dilution_m
- 3.44
- SBC_expense_recognised_in_IFRS_profit_next_year_oku
- 0.45626728
- SBC_expense_reference_period
2036-11-07 to 2037-11-06 blend: 55/366 FY2036 SBC plus 310/365 FY2037 SBC, matching FCFE forward year
- SBC_non_cash_addback_to_company_FCFE_next_year_oku
- 0.45626728
- additional_cash_required_minus_SBC_accounting_expense_oku
- -0.411630442
- company_forward_FCFE_after_cash_replacement_oku
- 1.406314521
- neutral_company_terminal_oku_excess_cash_excluded
- 11.25051617
- neutral_old_cohort_terminal_value_oku_including_separate_excess_cash
- 10.758565447
- cashflow_and_shares_reconcile
- はい
- 計算式
P0 = 100*FCFE1 / [S0*(k-g)+(1+g)*(q_free+(1-h)*q_paid)]; P1=P0*(1+g); gross buyback=(q_free+q_paid)*P1/100; employee cash=q_paid*h*P1/100; net cash=(q_free+(1-h)*q_paid)*P1/100.
- 注記
会社は全付与・発行株を時価買戻し、申込金は支払額から一度だけ控除する。SBC会計費用は既にIFRS費用に計上されFCFEで非現金戻入済みなので、追加費用として重複控除しない。
- post_horizon_model_revision
v2_constant_absolute_shares_paid_issuance_cash_included
- next_12m_free_SBC_deliveries_m
- 3.4
- next_12m_employee_paid_issuance_m
- 0.4
- post_horizon_annual_share_dilution_fraction_description
FIRST YEAR ONLY: q/S0; every future year uses q/(S0+(t-1)q).
- post_horizon_cohort_fcfe_growth_after_dilution_reason
S_t=S_0+t*q, constant absolute q implies year-varying percentage dilution; single Gordon-growth rate is mathematically invalid.
- cashflow_to_old_cohort_forward_year_after_dilution_note
先に旧株主へ配分されるFCFE及び有償申込金。交付後希薄化は次年度以降の分母に反映。
- terminal_denominator_k_minus_effective_old_growth_reason
旧式の一定d永久成長分母を廃止。未来1100期間を年次株数で逆算。
- post_horizon_year2_share_increase_fraction
- 0.004363619707
- continuation_financing_dilution_audit
内容を開く
- 方法
constant_number_annual_issue_dynamic_share_denominator_1100_step_backward_recursion
- future_issuer_cash_policy
All annual paid employee share plan capital proceeds assumed distributed to shareholders who held shares just before that year's new deliveries, as a separate capital distribution. No capital proceeds kept in cash or reinvested; this prevents double recognition. Future gross FCFE remains operating FCFE only.
- first_continuation_year_2036_11_07_to_2037_11_06
- はい
- timing_convention
All employee deliveries/subscriptions and their pass-through are aggregated at the END of each 12-month continuation year. This is a valuation modeling convention, not an exercise or ex-date prediction.
- from_company_2025_20f
内容を開く
- 2025_12_31_share_options_outstanding_m
- 3.259
- 2025_share_option_range_gbp_per_share
- 1
- 8.43
- 2
- 12.35
- 2025_maximum_long_term_awards_m
- 7.542
- 2037_options_terms_known
- いいえ
- source_key
company_fy2025_20f
- pre2036_calendar_year_subscription_proceeds_recorded_in_equity_cash_ledger
- はい
- post2036_start_economic_shares_m
- 867.0366575
- post2036_start_old_remaining_shares_m
- 829.1237917
- annual_free_SBC_shares_m
- 3.4
- annual_paid_employee_new_shares_m
- 0.4
- annual_total_new_economic_shares_m
- 3.8
- annual_paid_issuance_discount_factor_of_endogenous_market_price
- 0.9
- discount_and_issue_volume_are_analyst_assumptions_not_issuer_confirmations
- はい
- 2037_post_issue_fair_GBP_per_share_endogenous
- 1.29350683
- 2037_employee_subscription_price_GBP
- 1.164156147
- 2037_company_subscription_cash_oku
- 0.0046566246
- 2037_forward_12m_SBC_expense_oku_55days_2036_plus_310days_2037
- 0.45626728
- FY2036_full_SBC_oku_reference
- 0.46123814
- FY2037_full_SBC_oku_reference
- 0.45560894
- 2037_company_operating_FCFE_excluding_paid_subscription_oku
- 1.45095136
- 2037_company_cash_to_equity_preissue_oku
- 1.455607985
- 2037_old_operating_cash_oku
- 1.387505687
- 2037_old_subscription_cash_oku
- 0.004453005
- 2037_old_total_cash_oku
- 1.391958692
- 2037_end_economic_shares_m
- 870.8366575
- 2037_end_old_fraction
- 0.952100241256
- 2038_year2_dilution_fraction
- 0.004363619707
- annual_issue_cash_not_recorded_as_IFRS_profit_or_operating_FCFE
- はい
- SBC_non_cash_addback_in_FCFE_and_dilution_recognized_once_each
- はい
- if_subscription_funds_were_reinvested_or_retained_policy_would_need_new_explicit_cash_asset_valuation
- はい
- first_20_continuation_years_annual_ledger
内容を開く
- 1
内容を開く
- continuation_year
- 1
- period_start
2036-11-07
- 期間末
2037-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 867.0366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 870.8366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.956273053196
- old_fraction_close
- 0.952100241256
- share_count_increase_fraction_of_opening
- 0.004382744336
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.29350683
- paid_issue_price_GBP_per_share_assumed
- 1.16415615
- issuer_paid_subscription_cash_oku
- 0.004656625
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.004656625
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.455607985
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.387505687
- old_cohort_subscription_proceeds_cash_oku
- 0.004453005
- old_cohort_total_cash_oku
- 1.391958692
- old_cohort_cash_PV_at_terminal_oku
- 1.237296615
- old_cohort_residual_shares_value_oku
- 10.724772878
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 2
内容を開く
- continuation_year
- 2
- period_start
2037-11-07
- 期間末
2038-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 870.8366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 874.6366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.952100241256
- old_fraction_close
- 0.947963688224
- share_count_increase_fraction_of_opening
- 0.004363619707
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.28804692
- paid_issue_price_GBP_per_share_assumed
- 1.15924223
- issuer_paid_subscription_cash_oku
- 0.004636969
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.004636969
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.455588329
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.38145114
- old_cohort_subscription_proceeds_cash_oku
- 0.004414859
- old_cohort_total_cash_oku
- 1.385865999
- old_cohort_cash_PV_at_terminal_oku
- 1.095005234
- old_cohort_residual_shares_value_oku
- 10.679503489
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 3
内容を開く
- continuation_year
- 3
- period_start
2038-11-07
- 期間末
2039-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 874.6366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 878.4366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.947963688224
- old_fraction_close
- 0.943862923548
- share_count_increase_fraction_of_opening
- 0.004344661257
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.28263296
- paid_issue_price_GBP_per_share_assumed
- 1.15436966
- issuer_paid_subscription_cash_oku
- 0.004617479
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.004617479
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.455568839
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.375449203
- old_cohort_subscription_proceeds_cash_oku
- 0.004377202
- old_cohort_total_cash_oku
- 1.379826405
- old_cohort_cash_PV_at_terminal_oku
- 0.969096186
- old_cohort_residual_shares_value_oku
- 10.63461502
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 4
内容を開く
- continuation_year
- 4
- period_start
2039-11-07
- 期間末
2040-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 878.4366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 882.2366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.943862923548
- old_fraction_close
- 0.939797484781
- share_count_increase_fraction_of_opening
- 0.004325866831
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.27726436
- paid_issue_price_GBP_per_share_assumed
- 1.14953792
- issuer_paid_subscription_cash_oku
- 0.004598152
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.004598152
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.455549512
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.369499193
- old_cohort_subscription_proceeds_cash_oku
- 0.004340025
- old_cohort_total_cash_oku
- 1.373839217
- old_cohort_cash_PV_at_terminal_oku
- 0.85768106
- old_cohort_residual_shares_value_oku
- 10.590102681
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 5
内容を開く
- continuation_year
- 5
- period_start
2040-11-07
- 期間末
2041-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 882.2366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 886.0366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.939797484781
- old_fraction_close
- 0.935766917409
- share_count_increase_fraction_of_opening
- 0.004307234309
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.27194055
- paid_issue_price_GBP_per_share_assumed
- 1.1447465
- issuer_paid_subscription_cash_oku
- 0.004578986
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.004578986
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.455530346
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.363600439
- old_cohort_subscription_proceeds_cash_oku
- 0.00430332
- old_cohort_total_cash_oku
- 1.367903758
- old_cohort_cash_PV_at_terminal_oku
- 0.759089406
- old_cohort_residual_shares_value_oku
- 10.545961757
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 6
内容を開く
- continuation_year
- 6
- period_start
2041-11-07
- 期間末
2042-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 886.0366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 889.8366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.935766917409
- old_fraction_close
- 0.931770774683
- share_count_increase_fraction_of_opening
- 0.004288761608
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.26666099
- paid_issue_price_GBP_per_share_assumed
- 1.13999489
- issuer_paid_subscription_cash_oku
- 0.00455998
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.00455998
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.45551134
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.357752281
- old_cohort_subscription_proceeds_cash_oku
- 0.004267078
- old_cohort_total_cash_oku
- 1.362019359
- old_cohort_cash_PV_at_terminal_oku
- 0.67184354
- old_cohort_residual_shares_value_oku
- 10.502187618
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 7
内容を開く
- continuation_year
- 7
- period_start
2042-11-07
- 期間末
2043-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 889.8366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 893.6366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.931770774683
- old_fraction_close
- 0.927808617453
- share_count_increase_fraction_of_opening
- 0.00427044668
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.26142511
- paid_issue_price_GBP_per_share_assumed
- 1.1352826
- issuer_paid_subscription_cash_oku
- 0.00454113
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.00454113
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.45549249
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.351954073
- old_cohort_subscription_proceeds_cash_oku
- 0.004231293
- old_cohort_total_cash_oku
- 1.356185365
- old_cohort_cash_PV_at_terminal_oku
- 0.594636271
- old_cohort_residual_shares_value_oku
- 10.458775705
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 8
内容を開く
- continuation_year
- 8
- period_start
2043-11-07
- 期間末
2044-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 893.6366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 897.4366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.927808617453
- old_fraction_close
- 0.923880014005
- share_count_increase_fraction_of_opening
- 0.004252287513
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.25623238
- paid_issue_price_GBP_per_share_assumed
- 1.13060914
- issuer_paid_subscription_cash_oku
- 0.004522437
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.004522437
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.455473797
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.346205175
- old_cohort_subscription_proceeds_cash_oku
- 0.004195956
- old_cohort_total_cash_oku
- 1.350401131
- old_cohort_cash_PV_at_terminal_oku
- 0.526311202
- old_cohort_residual_shares_value_oku
- 10.415721537
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 9
内容を開く
- continuation_year
- 9
- period_start
2044-11-07
- 期間末
2045-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 897.4366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 901.2366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.923880014005
- old_fraction_close
- 0.91998453991
- share_count_increase_fraction_of_opening
- 0.004234282128
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.25108226
- paid_issue_price_GBP_per_share_assumed
- 1.12597404
- issuer_paid_subscription_cash_oku
- 0.004503896
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.004503896
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.455455256
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.340504963
- old_cohort_subscription_proceeds_cash_oku
- 0.00416106
- old_cohort_total_cash_oku
- 1.344666022
- old_cohort_cash_PV_at_terminal_oku
- 0.465845312
- old_cohort_residual_shares_value_oku
- 10.373020706
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 10
内容を開く
- continuation_year
- 10
- period_start
2045-11-07
- 期間末
2046-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 901.2366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 905.0366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.91998453991
- old_fraction_close
- 0.916121777863
- share_count_increase_fraction_of_opening
- 0.00421642858
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.24597424
- paid_issue_price_GBP_per_share_assumed
- 1.12137682
- issuer_paid_subscription_cash_oku
- 0.004485507
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.004485507
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.455436867
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.334852819
- old_cohort_subscription_proceeds_cash_oku
- 0.004126597
- old_cohort_total_cash_oku
- 1.338979417
- old_cohort_cash_PV_at_terminal_oku
- 0.412333553
- old_cohort_residual_shares_value_oku
- 10.330668878
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 11
内容を開く
- continuation_year
- 11
- period_start
2046-11-07
- 期間末
2047-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 905.0366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 908.8366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.916121777863
- old_fraction_close
- 0.912291317541
- share_count_increase_fraction_of_opening
- 0.004198724956
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.2409078
- paid_issue_price_GBP_per_share_assumed
- 1.11681702
- issuer_paid_subscription_cash_oku
- 0.004467268
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.004467268
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.455418628
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.32924814
- old_cohort_subscription_proceeds_cash_oku
- 0.004092562
- old_cohort_total_cash_oku
- 1.333340701
- old_cohort_cash_PV_at_terminal_oku
- 0.364975229
- old_cohort_residual_shares_value_oku
- 10.288661787
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 12
内容を開く
- continuation_year
- 12
- period_start
2047-11-07
- 期間末
2048-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 908.8366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 912.6366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.912291317541
- old_fraction_close
- 0.908492755453
- share_count_increase_fraction_of_opening
- 0.004181169376
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.23588243
- paid_issue_price_GBP_per_share_assumed
- 1.11229418
- issuer_paid_subscription_cash_oku
- 0.004449177
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.004449177
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.455400537
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.323690328
- old_cohort_subscription_proceeds_cash_oku
- 0.004058945
- old_cohort_total_cash_oku
- 1.327749273
- old_cohort_cash_PV_at_terminal_oku
- 0.323061945
- old_cohort_residual_shares_value_oku
- 10.246995237
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 13
内容を開く
- continuation_year
- 13
- period_start
2048-11-07
- 期間末
2049-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 912.6366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 916.4366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.908492755453
- old_fraction_close
- 0.904725694803
- share_count_increase_fraction_of_opening
- 0.00416375999
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.23089763
- paid_issue_price_GBP_per_share_assumed
- 1.10780787
- issuer_paid_subscription_cash_oku
- 0.004431231
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.004431231
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.455382591
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.318178799
- old_cohort_subscription_proceeds_cash_oku
- 0.004025742
- old_cohort_total_cash_oku
- 1.322204541
- old_cohort_cash_PV_at_terminal_oku
- 0.285966956
- old_cohort_residual_shares_value_oku
- 10.205665101
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 14
内容を開く
- continuation_year
- 14
- period_start
2049-11-07
- 期間末
2050-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 916.4366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 920.2366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.904725694803
- old_fraction_close
- 0.900989745347
- share_count_increase_fraction_of_opening
- 0.00414649498
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.22595292
- paid_issue_price_GBP_per_share_assumed
- 1.10335763
- issuer_paid_subscription_cash_oku
- 0.004413431
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.004413431
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.455364791
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.312712977
- old_cohort_subscription_proceeds_cash_oku
- 0.003992944
- old_cohort_total_cash_oku
- 1.316705921
- old_cohort_cash_PV_at_terminal_oku
- 0.253135744
- old_cohort_residual_shares_value_oku
- 10.164667317
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 15
内容を開く
- continuation_year
- 15
- period_start
2050-11-07
- 期間末
2051-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 920.2366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 924.0366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.900989745347
- old_fraction_close
- 0.89728452326
- share_count_increase_fraction_of_opening
- 0.004129372558
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.22104781
- paid_issue_price_GBP_per_share_assumed
- 1.09894303
- issuer_paid_subscription_cash_oku
- 0.004395772
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.004395772
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.455347132
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.307292296
- old_cohort_subscription_proceeds_cash_oku
- 0.003960546
- old_cohort_total_cash_oku
- 1.311252842
- old_cohort_cash_PV_at_terminal_oku
- 0.224077683
- old_cohort_residual_shares_value_oku
- 10.123997889
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 16
内容を開く
- continuation_year
- 16
- period_start
2051-11-07
- 期間末
2052-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 924.0366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 927.8366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.89728452326
- old_fraction_close
- 0.893609651007
- share_count_increase_fraction_of_opening
- 0.004112390963
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.21618183
- paid_issue_price_GBP_per_share_assumed
- 1.09456365
- issuer_paid_subscription_cash_oku
- 0.004378255
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.004378255
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.455329615
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.301916199
- old_cohort_subscription_proceeds_cash_oku
- 0.00392854
- old_cohort_total_cash_oku
- 1.305844739
- old_cohort_cash_PV_at_terminal_oku
- 0.198358669
- old_cohort_residual_shares_value_oku
- 10.083652886
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 17
内容を開く
- continuation_year
- 17
- period_start
2052-11-07
- 期間末
2053-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 927.8366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 931.6366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.893609651007
- old_fraction_close
- 0.88996475721
- share_count_increase_fraction_of_opening
- 0.004095548467
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.21135451
- paid_issue_price_GBP_per_share_assumed
- 1.09021906
- issuer_paid_subscription_cash_oku
- 0.004360876
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.004360876
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.455312236
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.296584138
- old_cohort_subscription_proceeds_cash_oku
- 0.003896921
- old_cohort_total_cash_oku
- 1.30048106
- old_cohort_cash_PV_at_terminal_oku
- 0.175594597
- old_cohort_residual_shares_value_oku
- 10.043628437
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 18
内容を開く
- continuation_year
- 18
- period_start
2053-11-07
- 期間末
2054-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 931.6366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 935.4366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.88996475721
- old_fraction_close
- 0.886349476528
- share_count_increase_fraction_of_opening
- 0.004078843366
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.20656539
- paid_issue_price_GBP_per_share_assumed
- 1.08590885
- issuer_paid_subscription_cash_oku
- 0.004343635
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.004343635
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.455294995
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.291295575
- old_cohort_subscription_proceeds_cash_oku
- 0.003865682
- old_cohort_total_cash_oku
- 1.295161257
- old_cohort_cash_PV_at_terminal_oku
- 0.155445603
- old_cohort_residual_shares_value_oku
- 10.003920735
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 19
内容を開く
- continuation_year
- 19
- period_start
2054-11-07
- 期間末
2055-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 935.4366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 939.2366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.886349476528
- old_fraction_close
- 0.88276344953
- share_count_increase_fraction_of_opening
- 0.004062273987
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.20181403
- paid_issue_price_GBP_per_share_assumed
- 1.08163262
- issuer_paid_subscription_cash_oku
- 0.00432653
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.00432653
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.45527789
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.286049978
- old_cohort_subscription_proceeds_cash_oku
- 0.003834818
- old_cohort_total_cash_oku
- 1.289884796
- old_cohort_cash_PV_at_terminal_oku
- 0.137610951
- old_cohort_residual_shares_value_oku
- 9.96452603
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- 20
内容を開く
- continuation_year
- 20
- period_start
2055-11-07
- 期間末
2056-11-06
- classification
long_run_model_assumption_not_issuer_event_guidance
- shares_open_economic_m
- 939.2366575
- free_SBC_shares_delivered_m
- 3.4
- paid_employee_subscribed_shares_m
- 0.4
- issued_total_m
- 3.8
- shares_close_economic_m
- 943.0366575
- old_cohort_m
- 829.1237917
- old_fraction_open
- 0.88276344953
- old_fraction_close
- 0.879206322581
- share_count_increase_fraction_of_opening
- 0.004045838682
- future_operating_FCFE_before_subscriptions_oku
- 1.45095136
- market_price_post_annual_issue_GBP_endogenous
- 1.19709997
- paid_issue_price_GBP_per_share_assumed
- 1.07738997
- issuer_paid_subscription_cash_oku
- 0.00430956
- issuer_subscription_cash_classification
equity_financing_not_operating_profit_not_FCFE
- issuer_cash_passed_through_to_preissue_shareholders_oku
- 0.00430956
- issuer_payout_from_operations_oku
- 1.45095136
- issuer_total_cash_to_preissue_shares_oku
- 1.45526092
- issuer_paid_proceeds_ending_cash_retained_oku
- 0
- old_cohort_operating_cash_oku
- 1.280846828
- old_cohort_subscription_proceeds_cash_oku
- 0.003804322
- old_cohort_total_cash_oku
- 1.28465115
- old_cohort_cash_PV_at_terminal_oku
- 0.121824535
- old_cohort_residual_shares_value_oku
- 9.925440635
- discount_rate
- 0.125
- ex_date_or_transaction_date_observed
- いいえ
- 注記
定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。
- first_20_years_PV_old_cash_oku
- 9.82919029
- end_20yr_residual_PV_old_oku
- 0.941237772
- reconstructed_old_operating_terminal_PV_oku
- 10.770428062
- reconstruction_abs_error_oku
- 5.66E-10
- tail_years_used
- 1100
- approximation_years_900_vs_1100_price_difference_GBP
- 0
- per_share_recursive_equation
P[t-1] = (100 * FCFE[t] / S[t-1] + (1 + paid_discount * paid_shares / S[t-1]) * P[t]) / (1 + k); S[t] = S[t-1] + free_shares + paid_shares; F[t]=F[1]*(1+g)^(t-1).
- per_share_gbp_price_at_terminal_ex_excess_cash
- 1.299013268
- discounting_coc_is_scenario_specific
- 0.125
- counterfactual_paid_issue_cash_ignored_but_same_share_dilution_terminal_old_oku
- 10.737024537
- value_added_by_paid_subscriptions_vs_omission_oku
- 0.033403525
- counterfactual_paid_issue_at_full_fair_market_terminal_old_oku
- 10.774151978
- counterfactual_no_2037plus_share_issuance_terminal_old_oku
- 11.100045497
- counterfactual_no_paid_employee_shares_but_free_awards_remain_old_oku
- 10.772984455
- verified_fully_paid_fair_market_invariance_vs_no_issuance_GBP_price_abs_error
- 0
- comparison_original_v1_terminal_old_oku
- 10.678822546
- terminal_old_value_change_vs_v1_oku
- 0.091605516
- y10
内容を開く
- キャッシュフローの算出方法
timed_holder_cashflows_v1
- 開始日
2026-11-06
- 終了日
2036-11-06
- 期間内株主受取
- 17.649067317
- 終価
- 10.770428062
- 日付別キャッシュフロー
内容を開く
- 1
内容を開く
- year
- 0.106776180698
- 想定日
2026-12-15
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.45
- source_treasury_shares_m
- 0.45
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9994628047
- 2
内容を開く
- year
- 0.112251882272
- 想定日
2026-12-17
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.08
- discounted_issuer_subscription_gbp
- 10.413335
- issuer_cash_proceeds_oku
- 0.0083306678
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9993673637
- 3
内容を開く
- year
- 0.11498973306
- 想定日
2026-12-18
- 金額
- 0.5613582406
- 種類
proportional_old_holder_buyback_tender
- date_status
仮定
- 金額の単位
億GBP
- issuer_buyback_cash_oku
- 0.561713601
- assumed_execution_price_gbp
- 11.569407
- bought_total_shares_m
- 4.85516322
- tendered_old_cohort_shares_m
- 4.85209167
- old_holder_fraction_before
- 0.9993673637
- old_holder_fraction_after
- 0.9993673637
- program_classification
announced_remaining_assumed
- price_is_scenario_assumption_not_a_terminal_multiple
- はい
- 4
内容を開く
- year
- 0.323066392882
- 想定日
2027-03-04
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2027-03-25
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2026
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 5
内容を開く
- year
- 0.35318275154
- 想定日
2027-03-15
- 金額
- 0.374238827
- 種類
proportional_old_holder_buyback_tender
- date_status
仮定
- 金額の単位
億GBP
- issuer_buyback_cash_oku
- 0.374475734
- assumed_execution_price_gbp
- 11.485773
- bought_total_shares_m
- 3.26034423
- tendered_old_cohort_shares_m
- 3.25828162
- old_holder_fraction_before
- 0.9993673637
- old_holder_fraction_after
- 0.9993673637
- program_classification
announced_remaining_assumed
- price_is_scenario_assumption_not_a_terminal_multiple
- はい
- 6
内容を開く
- year
- 0.355920602327
- 想定日
2027-03-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.891
- source_employee_trust_shares_m
- 0.027
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9982627935
- 7
内容を開く
- year
- 0.380561259411
- 想定日
2027-03-25
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2026
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
2027-03-25
- record_date
2027-03-26
- payment_date
2027-05-26
- board_declaration_date_assumed
2027-02-26
- usd_per_share
- 0.25
- gbp_per_share
- 0.18723787
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 830.5666575
- old_holder_entitlement_oku
- 1.5524337023
- issuer_dividend_liability_oku
- 1.5551352935
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2027-03-04
- needs_issuer_confirmation_before_date
- はい
- 8
内容を開く
- year
- 0.550308008214
- 想定日
2027-05-26
- 金額
- 1.5524337023
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 1.5551352935
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2026
- dividend_kind
final
- 9
内容を開く
- year
- 0.607802874743
- 想定日
2027-06-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.924
- source_employee_trust_shares_m
- 0.028
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9971198892
- 10
内容を開く
- year
- 0.777549623546
- 想定日
2027-08-17
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 10.204438
- issuer_cash_proceeds_oku
- 0.0408177525
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9966404578
- 11
内容を開く
- year
- 0.859685147159
- 想定日
2027-09-16
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2027-10-07
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2027
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 12
内容を開く
- year
- 0.859685147159
- 想定日
2027-09-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.891
- source_employee_trust_shares_m
- 0.027
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9955419039
- 13
内容を開く
- year
- 0.917180013689
- 想定日
2027-10-07
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2027
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
2027-10-07
- record_date
2027-10-08
- payment_date
2027-11-05
- board_declaration_date_assumed
2027-08-04
- usd_per_share
- 0.1624
- gbp_per_share
- 0.12162972
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 832.8366575
- old_holder_entitlement_oku
- 1.008460933
- issuer_dividend_liability_oku
- 1.0129768813
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2027-09-16
- needs_issuer_confirmation_before_date
- はい
- 14
内容を開く
- year
- 0.996577686516
- 想定日
2027-11-05
- 金額
- 1.008460933
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 1.0129768813
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2027
- dividend_kind
interim
- 15
内容を開く
- year
- 1.108829568789
- 想定日
2027-12-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.594
- source_employee_trust_shares_m
- 0.018
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9948108791
- 16
内容を開く
- year
- 1.338809034908
- 想定日
2028-03-09
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2028-03-30
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2027
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 17
内容を開く
- year
- 1.357973990418
- 想定日
2028-03-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.891
- source_employee_trust_shares_m
- 0.027
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9937163527
- 18
内容を開く
- year
- 1.396303901437
- 想定日
2028-03-30
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2027
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
2028-03-30
- record_date
2028-03-31
- payment_date
2028-05-24
- board_declaration_date_assumed
2028-02-25
- usd_per_share
- 0.1879876
- gbp_per_share
- 0.14079357
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 834.3666575
- old_holder_entitlement_oku
- 1.1673529895
- issuer_dividend_liability_oku
- 1.1747346075
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2028-03-09
- needs_issuer_confirmation_before_date
- はい
- 19
内容を開く
- year
- 1.54688569473
- 想定日
2028-05-24
- 金額
- 1.1673529895
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 1.1747346075
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2027
- dividend_kind
final
- 20
内容を開く
- year
- 1.609856262834
- 想定日
2028-06-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.924
- source_employee_trust_shares_m
- 0.028
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9925838292
- 21
内容を開く
- year
- 1.779603011636
- 想定日
2028-08-17
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 9.897686
- issuer_cash_proceeds_oku
- 0.0395907436
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9921087488
- 22
内容を開く
- year
- 1.856262833676
- 想定日
2028-09-14
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2028-10-05
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2028
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 23
内容を開く
- year
- 1.859000684463
- 想定日
2028-09-15
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.891
- source_employee_trust_shares_m
- 0.027
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.991020157
- 24
内容を開く
- year
- 1.913757700205
- 想定日
2028-10-05
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2028
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
2028-10-05
- record_date
2028-10-06
- payment_date
2028-11-03
- board_declaration_date_assumed
2028-08-04
- usd_per_share
- 0.140155
- gbp_per_share
- 0.10496932
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 836.6366575
- old_holder_entitlement_oku
- 0.870325569
- issuer_dividend_liability_oku
- 0.8782117728
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2028-09-14
- needs_issuer_confirmation_before_date
- はい
- 25
内容を開く
- year
- 1.993155373032
- 想定日
2028-11-03
- 金額
- 0.870325569
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.8782117728
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2028
- dividend_kind
interim
- 26
内容を開く
- year
- 2.108145106092
- 想定日
2028-12-15
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.594
- source_employee_trust_shares_m
- 0.018
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9902957553
- 27
内容を開く
- year
- 2.335386721424
- 想定日
2029-03-08
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2029-03-29
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2028
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 28
内容を開く
- year
- 2.357289527721
- 想定日
2029-03-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9892111363
- 29
内容を開く
- year
- 2.392881587953
- 想定日
2029-03-29
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2028
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
2029-03-29
- record_date
2029-03-30
- payment_date
2029-05-23
- board_declaration_date_assumed
2029-02-26
- usd_per_share
- 0.1804615
- gbp_per_share
- 0.13515692
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 838.1666575
- old_holder_entitlement_oku
- 1.120618182
- issuer_dividend_liability_oku
- 1.1328402409
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2029-03-08
- needs_issuer_confirmation_before_date
- はい
- 30
内容を開く
- year
- 2.543463381246
- 想定日
2029-05-23
- 金額
- 1.120618182
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 1.1328402409
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2028
- dividend_kind
final
- 31
内容を開く
- year
- 2.60643394935
- 想定日
2029-06-15
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.952
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9880888528
- 32
内容を開く
- year
- 2.778918548939
- 想定日
2029-08-17
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 9.600955
- issuer_cash_proceeds_oku
- 0.0384038219
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9876180645
- 33
内容を開く
- year
- 2.852840520192
- 想定日
2029-09-13
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2029-10-04
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2029
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 34
内容を開く
- year
- 2.855578370979
- 想定日
2029-09-14
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9865392999
- 35
内容を開く
- year
- 2.910335386721
- 想定日
2029-10-04
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2029
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
2029-10-04
- record_date
2029-10-05
- payment_date
2029-11-05
- board_declaration_date_assumed
2029-08-03
- usd_per_share
- 0.1282466
- gbp_per_share
- 0.09605049
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 840.4366575
- old_holder_entitlement_oku
- 0.7963775004
- issuer_dividend_liability_oku
- 0.8072435639
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2029-09-13
- needs_issuer_confirmation_before_date
- はい
- 36
内容を開く
- year
- 2.99794661191
- 想定日
2029-11-05
- 金額
- 0.7963775004
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.8072435639
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2029
- dividend_kind
interim
- 37
内容を開く
- year
- 3.104722792608
- 想定日
2029-12-14
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.612
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9858214317
- 38
内容を開く
- year
- 3.33196440794
- 想定日
2030-03-07
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2030-03-28
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2029
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 39
内容を開く
- year
- 3.353867214237
- 想定日
2030-03-15
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9847465862
- 40
内容を開く
- year
- 3.38945927447
- 想定日
2030-03-28
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2029
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
2030-03-28
- record_date
2030-03-29
- payment_date
2030-05-22
- board_declaration_date_assumed
2030-02-26
- usd_per_share
- 0.1715416
- gbp_per_share
- 0.12847632
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 841.9666575
- old_holder_entitlement_oku
- 1.0652277023
- issuer_dividend_liability_oku
- 1.0817277432
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2030-03-07
- needs_issuer_confirmation_before_date
- はい
- 41
内容を開く
- year
- 3.540041067762
- 想定日
2030-05-22
- 金額
- 1.0652277023
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 1.0817277432
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2029
- dividend_kind
final
- 42
内容を開く
- year
- 3.603011635866
- 想定日
2030-06-14
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.952
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9836344044
- 43
内容を開く
- year
- 3.775496235455
- 想定日
2030-08-16
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 9.313898
- issuer_cash_proceeds_oku
- 0.0372555906
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9831678504
- 44
内容を開く
- year
- 3.849418206708
- 想定日
2030-09-12
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2030-10-03
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2030
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 45
内容を開く
- year
- 3.860369609856
- 想定日
2030-09-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9820987804
- 46
内容を開く
- year
- 3.906913073238
- 想定日
2030-10-03
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2030
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
2030-10-03
- record_date
2030-10-04
- payment_date
2030-11-05
- board_declaration_date_assumed
2030-08-02
- usd_per_share
- 0.1199153
- gbp_per_share
- 0.08981072
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 844.2366575
- old_holder_entitlement_oku
- 0.7446420811
- issuer_dividend_liability_oku
- 0.7582150553
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2030-09-12
- needs_issuer_confirmation_before_date
- はい
- 47
内容を開く
- year
- 3.997262149213
- 想定日
2030-11-05
- 金額
- 0.7446420811
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.7582150553
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2030
- dividend_kind
interim
- 48
内容を開く
- year
- 4.109514031485
- 想定日
2030-12-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.612
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9813873577
- 49
内容を開く
- year
- 4.328542094456
- 想定日
2031-03-06
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2031-03-27
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2030
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 50
内容を開く
- year
- 4.350444900753
- 想定日
2031-03-14
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9803221542
- 51
内容を開く
- year
- 4.386036960986
- 想定日
2031-03-27
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2030
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
2031-03-27
- record_date
2031-03-28
- payment_date
2031-05-28
- board_declaration_date_assumed
2031-02-26
- usd_per_share
- 0.1596889
- gbp_per_share
- 0.1195992
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 845.7666575
- old_holder_entitlement_oku
- 0.9916254567
- issuer_dividend_liability_oku
- 1.0115301917
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2031-03-06
- needs_issuer_confirmation_before_date
- はい
- 52
内容を開く
- year
- 4.555783709788
- 想定日
2031-05-28
- 金額
- 0.9916254567
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 1.0115301917
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2030
- dividend_kind
final
- 53
内容を開く
- year
- 4.607802874743
- 想定日
2031-06-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.952
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9792199384
- 54
内容を開く
- year
- 4.772073921971
- 想定日
2031-08-15
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 9.035423
- issuer_cash_proceeds_oku
- 0.0361416902
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9787575617
- 55
内容を開く
- year
- 4.845995893224
- 想定日
2031-09-11
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2031-10-02
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2031
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 56
内容を開く
- year
- 4.859685147159
- 想定日
2031-09-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9776980562
- 57
内容を開く
- year
- 4.903490759754
- 想定日
2031-10-02
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2031
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
2031-10-02
- record_date
2031-10-03
- payment_date
2031-11-05
- board_declaration_date_assumed
2031-08-04
- usd_per_share
- 0.1118417
- gbp_per_share
- 0.08376397
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 848.0366575
- old_holder_entitlement_oku
- 0.6945070151
- issuer_dividend_liability_oku
- 0.7103491826
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2031-09-11
- needs_issuer_confirmation_before_date
- はい
- 58
内容を開く
- year
- 4.996577686516
- 想定日
2031-11-05
- 金額
- 0.6945070151
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.7103491826
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2031
- dividend_kind
interim
- 59
内容を開く
- year
- 5.108829568789
- 想定日
2031-12-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.612
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9769929927
- 60
内容を開く
- year
- 5.325119780972
- 想定日
2032-03-04
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2032-03-25
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2031
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 61
内容を開く
- year
- 5.357973990418
- 想定日
2032-03-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9759373021
- 62
内容を開く
- year
- 5.382614647502
- 想定日
2032-03-25
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2031
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
2032-03-25
- record_date
2032-03-26
- payment_date
2032-05-26
- board_declaration_date_assumed
2032-02-26
- usd_per_share
- 0.1481762
- gbp_per_share
- 0.11097681
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 849.5666575
- old_holder_entitlement_oku
- 0.9201351483
- issuer_dividend_liability_oku
- 0.942821989
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2032-03-04
- needs_issuer_confirmation_before_date
- はい
- 63
内容を開く
- year
- 5.552361396304
- 想定日
2032-05-26
- 金額
- 0.9201351483
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.942821989
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2031
- dividend_kind
final
- 64
内容を開く
- year
- 5.609856262834
- 想定日
2032-06-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.952
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9748449189
- 65
内容を開く
- year
- 5.779603011636
- 想定日
2032-08-17
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 8.76235
- issuer_cash_proceeds_oku
- 0.0350494007
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9743866636
- 66
内容を開く
- year
- 5.86173853525
- 想定日
2032-09-16
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2032-10-07
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2032
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 67
内容を開く
- year
- 5.86173853525
- 想定日
2032-09-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.973336595
- 68
内容を開く
- year
- 5.91923340178
- 想定日
2032-10-07
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2032
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
2032-10-07
- record_date
2032-10-08
- payment_date
2032-11-05
- board_declaration_date_assumed
2032-08-04
- usd_per_share
- 0.1040072
- gbp_per_share
- 0.07789631
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 851.8366575
- old_holder_entitlement_oku
- 0.6458568654
- issuer_dividend_liability_oku
- 0.6635493505
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2032-09-16
- needs_issuer_confirmation_before_date
- はい
- 69
内容を開く
- year
- 5.998631074606
- 想定日
2032-11-05
- 金額
- 0.6458568654
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.6635493505
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2032
- dividend_kind
interim
- 70
内容を開く
- year
- 6.110882956879
- 想定日
2032-12-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.612
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9726378057
- 71
内容を開く
- year
- 6.340862422998
- 想定日
2033-03-10
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2033-03-31
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2032
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 72
内容を開く
- year
- 6.357289527721
- 想定日
2033-03-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.971591501
- 73
内容を開く
- year
- 6.398357289528
- 想定日
2033-03-31
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2032
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
2033-03-31
- record_date
2033-04-01
- payment_date
2033-05-25
- board_declaration_date_assumed
2033-02-25
- usd_per_share
- 0.1370357
- gbp_per_share
- 0.10263306
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 853.3666575
- old_holder_entitlement_oku
- 0.8509551521
- issuer_dividend_liability_oku
- 0.8758363481
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2033-03-10
- needs_issuer_confirmation_before_date
- はい
- 74
内容を開く
- year
- 6.54893908282
- 想定日
2033-05-25
- 金額
- 0.8509551521
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.8758363481
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2032
- dividend_kind
final
- 75
内容を開く
- year
- 6.609171800137
- 想定日
2033-06-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.952
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9705088194
- 76
内容を開く
- year
- 6.778918548939
- 想定日
2033-08-17
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 8.499657
- issuer_cash_proceeds_oku
- 0.0339986274
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9700546307
- 77
内容を開く
- year
- 6.858316221766
- 想定日
2033-09-15
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2033-10-06
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2033
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 78
内容を開く
- year
- 6.861054072553
- 想定日
2033-09-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9690138734
- 79
内容を開く
- year
- 6.915811088296
- 想定日
2033-10-06
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2033
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
2033-10-06
- record_date
2033-10-07
- payment_date
2033-11-04
- board_declaration_date_assumed
2033-08-04
- usd_per_share
- 0.0964171
- gbp_per_share
- 0.07221175
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 855.6366575
- old_holder_entitlement_oku
- 0.598724807
- issuer_dividend_liability_oku
- 0.6178702116
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2033-09-15
- needs_issuer_confirmation_before_date
- はい
- 80
内容を開く
- year
- 6.995208761123
- 想定日
2033-11-04
- 金額
- 0.598724807
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.6178702116
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2033
- dividend_kind
interim
- 81
内容を開く
- year
- 7.110198494182
- 想定日
2033-12-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.612
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9683212749
- 82
内容を開く
- year
- 7.337440109514
- 想定日
2034-03-09
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2034-03-30
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2033
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 83
内容を開く
- year
- 7.356605065024
- 想定日
2034-03-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9672842316
- 84
内容を開く
- year
- 7.394934976044
- 想定日
2034-03-30
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2033
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
2034-03-30
- record_date
2034-03-31
- payment_date
2034-05-24
- board_declaration_date_assumed
2034-02-24
- usd_per_share
- 0.1262371
- gbp_per_share
- 0.09454546
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 857.1666575
- old_holder_entitlement_oku
- 0.7838989053
- issuer_dividend_liability_oku
- 0.8104121619
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2034-03-09
- needs_issuer_confirmation_before_date
- はい
- 85
内容を開く
- year
- 7.545516769336
- 想定日
2034-05-24
- 金額
- 0.7838989053
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.8104121619
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2033
- dividend_kind
final
- 86
内容を開く
- year
- 7.60848733744
- 想定日
2034-06-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.952
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9662111229
- 87
内容を開く
- year
- 7.778234086242
- 想定日
2034-08-17
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 8.244839
- issuer_cash_proceeds_oku
- 0.0329793562
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.965760947
- 88
内容を開く
- year
- 7.854893908282
- 想定日
2034-09-14
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2034-10-05
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2034
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 89
内容を開く
- year
- 7.857631759069
- 想定日
2034-09-15
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9647293776
- 90
内容を開く
- year
- 7.912388774812
- 想定日
2034-10-05
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2034
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
2034-10-05
- record_date
2034-10-06
- payment_date
2034-11-03
- board_declaration_date_assumed
2034-08-04
- usd_per_share
- 0.0890617
- gbp_per_share
- 0.06670288
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 859.4366575
- old_holder_entitlement_oku
- 0.5530494849
- issuer_dividend_liability_oku
- 0.5732690408
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2034-09-14
- needs_issuer_confirmation_before_date
- はい
- 91
内容を開く
- year
- 7.991786447639
- 想定日
2034-11-03
- 金額
- 0.5530494849
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.5732690408
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2034
- dividend_kind
interim
- 92
内容を開く
- year
- 8.106776180698
- 想定日
2034-12-15
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.612
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9640428881
- 93
内容を開く
- year
- 8.33401779603
- 想定日
2035-03-08
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2035-03-29
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2034
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 94
内容を開く
- year
- 8.355920602327
- 想定日
2035-03-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9630149837
- 95
内容を開く
- year
- 8.39151266256
- 想定日
2035-03-29
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2034
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
2035-03-29
- record_date
2035-03-30
- payment_date
2035-05-23
- board_declaration_date_assumed
2035-02-26
- usd_per_share
- 0.115766
- gbp_per_share
- 0.08670312
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 860.9666575
- old_holder_entitlement_oku
- 0.7188761742
- issuer_dividend_liability_oku
- 0.7464849316
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2035-03-08
- needs_issuer_confirmation_before_date
- はい
- 96
内容を開く
- year
- 8.542094455852
- 想定日
2035-05-23
- 金額
- 0.7188761742
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.7464849316
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2034
- dividend_kind
final
- 97
内容を開く
- year
- 8.605065023956
- 想定日
2035-06-15
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.952
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9619513216
- 98
内容を開く
- year
- 8.777549623546
- 想定日
2035-08-17
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 7.997661
- issuer_cash_proceeds_oku
- 0.0319906424
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9615051054
- 99
内容を開く
- year
- 8.851471594798
- 想定日
2035-09-13
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2035-10-04
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2035
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 100
内容を開く
- year
- 8.854209445585
- 想定日
2035-09-14
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9604826028
- 101
内容を開く
- year
- 8.908966461328
- 想定日
2035-10-04
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2035
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
2035-10-04
- record_date
2035-10-05
- payment_date
2035-11-05
- board_declaration_date_assumed
2035-08-03
- usd_per_share
- 0.0819311
- gbp_per_share
- 0.0613624
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 863.2366575
- old_holder_entitlement_oku
- 0.5087702637
- issuer_dividend_liability_oku
- 0.5297027371
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2035-09-13
- needs_issuer_confirmation_before_date
- はい
- 102
内容を開く
- year
- 8.996577686516
- 想定日
2035-11-05
- 金額
- 0.5087702637
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.5297027371
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2035
- dividend_kind
interim
- 103
内容を開く
- year
- 9.103353867214
- 想定日
2035-12-14
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.612
- source_treasury_shares_m
- 0.612
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9598021418
- 104
内容を開く
- year
- 9.330595482546
- 想定日
2036-03-06
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2036-03-27
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2035
- dividend_kind
final
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 105
内容を開く
- year
- 9.352498288843
- 想定日
2036-03-14
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9587832561
- 106
内容を開く
- year
- 9.388090349076
- 想定日
2036-03-27
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2035
- dividend_kind
final
- date_confirmed
- いいえ
- ex_date
2036-03-27
- record_date
2036-03-28
- payment_date
2036-05-28
- board_declaration_date_assumed
2036-02-26
- usd_per_share
- 0.1056089
- gbp_per_share
- 0.07909591
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 864.7666575
- old_holder_entitlement_oku
- 0.6558030084
- issuer_dividend_liability_oku
- 0.6839950575
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2036-03-06
- needs_issuer_confirmation_before_date
- はい
- 107
内容を開く
- year
- 9.557837097878
- 想定日
2036-05-28
- 金額
- 0.6558030084
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.6839950575
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2035
- dividend_kind
final
- 108
内容を開く
- year
- 9.609856262834
- 想定日
2036-06-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.952
- source_treasury_shares_m
- 0.952
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9577289163
- 109
内容を開く
- year
- 9.774127310062
- 想定日
2036-08-15
- 金額
- 0
- 種類
employee_share_plan_issuance_no_holder_cashflow
- date_status
仮定
- 金額の単位
億GBP
- issued_shares_m
- 0.4
- discounted_issuer_subscription_gbp
- 7.75854
- issuer_cash_proceeds_oku
- 0.031034158
- old_holder_shares_change_m
- 0
- old_holder_fraction_after
- 0.9572866079
- 110
内容を開く
- year
- 9.848049281314
- 想定日
2036-09-11
- 金額
- 0
- 種類
dividend_ex_date_preannouncement_recheck_no_cashflow
- date_status
future_assumed_review_date_not_performed
- 金額の単位
億GBP
- ex_date
2036-10-02
- ex_date_status
future_unconfirmed_assumption
- assumed_ex_date_published_by_issuer
- いいえ
- fiscal_year
- 2036
- dividend_kind
interim
- required_action
当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
- old_holder_cash_receipt_oku
- 0
- 111
内容を開く
- year
- 9.86173853525
- 想定日
2036-09-16
- 金額
- 0
- 種類
sbc_share_delivery_no_cashflow
- date_status
仮定
- 金額の単位
億GBP
- delivered_shares_m
- 0.918
- source_treasury_shares_m
- 0.918
- source_employee_trust_shares_m
- 0
- old_holder_shares_change_m
- 0
- issuer_cash_paid_oku
- 0
- equity_book_value_transfer_net_total_oku
- 0
- old_holder_fraction_after
- 0.9562730532
- 112
内容を開く
- year
- 9.905544147844
- 想定日
2036-10-02
- 金額
- 0
- 種類
dividend_ex_date
- date_status
future_assumed_not_confirmed
- 金額の単位
億GBP
- fiscal_year
- 2036
- dividend_kind
interim
- date_confirmed
- いいえ
- ex_date
2036-10-02
- record_date
2036-10-03
- payment_date
2036-11-05
- board_declaration_date_assumed
2036-08-04
- usd_per_share
- 0.075016
- gbp_per_share
- 0.05618332
- entitled_old_cohort_shares_m
- 829.1237917
- issuer_economic_shares_m
- 867.0366575
- old_holder_entitlement_oku
- 0.4658293088
- issuer_dividend_liability_oku
- 0.4871300172
- ex_date_status
future_unconfirmed_assumption
- recheck_date_assumed
2036-09-11
- needs_issuer_confirmation_before_date
- はい
- 113
内容を開く
- year
- 9.998631074606
- 想定日
2036-11-05
- 金額
- 0.4658293088
- 種類
dividend_payment
- date_status
仮定
- 金額の単位
億GBP
- issuer_total_distribution_oku
- 0.4871300172
- old_cohort_entitlement_locked_at_ex_date
- はい
- fiscal_year
- 2036
- dividend_kind
interim
- valuation
内容を開く
- initial_old_cohort_market_cap_oku
- 97.20288656
- pv_old_holder_cashflows_oku_at_coc_k
- 12.34092294
- pv_old_cohort_terminal_oku_at_coc_k
- 4.34548062
- total_present_value_oku_at_coc_k
- 16.68640356
- NPV_oku
- -80.516483
- value_to_market_ratio
- 0.17166572
- IRR_timed_old_holder
- -0.1526010931
- comparison_v1_IRR_timed_old_holder
- -0.1531105824
- comparison_no_future_paid_subscription_proceeds_IRR_timed
- -0.1527865282
- comparison_full_market_paid_subscription_IRR_timed
- -0.1525804449
- comparison_market_repurchase_neutral_IRR_timed
- -0.1526669012
- audits
内容を開く
- number_of_full_forecast_fiscal_years_2027_to_2036
- 10
- number_of_partial_period_ledger_rows
- 2
- end_excluded_future_period_days_in_2036
- 55
- total_unique_cashflow_events
- 113
- cashflow_events_with_zero_amount
- 91
- max_row_identity_error
- 0
- sum_timed_cashflow_oku
- 17.649067317
- sum_yearly_legacy_cashflow_oku
- 17.649067317
- initial_old_cohort_equals_current_economic_float
- はい
- all_event_dates_after_basis_and_not_after_endpoint
- はい
- event_year_computed_by_exact_days_div_365_25
- はい
- terminal_value_not_deducting_book_debt_twice
- はい
- year_2036_after_11_06_flows_not_included
- はい
- stock_compensation_cashflow_zero
- はい
- pre_ex_date_rechecks_included_count
- 20
- post_horizon_constant_absolute_share_delivery_mode_verified
- はい
- post_horizon_paid_issue_cash_included_once_and_separate_from_FCFE
- はい
- future_paid_issue_reinvestment_or_retention_assumed
- いいえ
- original_2026_2036_ledger_SHA256_unchanged
c1a3b546cd8847dce8be9cfad727549c050a3f2e81a70832280f68783a48a4f3
- 売上高
- 39.306379
- 営業利益
- 3.14451032
- 純利益
- 1.70626498
- equity_oku
- 53.78153491
- 期間内の親会社利益合計（億）
- 27.08098015
- multiple
- kind
dcf
- why
2037年以降の発行株数、有償引受と旧株主持分を毎年更新した継続価値。
- detail
内容を開く
- version
v2_2026_11_08
- 理由
- 1
Paid new issue capital proceeds missing from v1 terminal
- 2
Fixed annual shares incorrectly treated with perpetually fixed issuance ratio
- 3
Future ex-dates need separate pre-ex reconfirmation events
- source_file
smith_nephew_aiv2_eu_20261106_full.json
- all_years_2026_to_2036_ledgers_preserved_verbatim
- はい
- company_issuer_future_paid_cash_not_operating_FCFE
- はい
- issuer_cash_assumed_passed_through_to_preissue_holders_not_retained
- はい
- mathematical_cash_treatment
Paid cash enters one time; no separate addition to company terminal equity and no double subtraction of buyback expenses.
- future_review_events_are_not_automated_reminders
- はい
- scenario_corrections
内容を開く
- 1
内容を開く
- id
very_bear
- label
最悪
- 確率
- 10.00%
- free_SBC_m
- 3.4
- paid_issued_m
- 0.4
- total_issued_m
- 3.8
- old_2036_terminal_oku
- 10.678822546
- corrected_2036_terminal_oku
- 10.770428062326
- old_2036_IRR
- -0.1531105824
- corrected_2036_IRR
- -0.1526010931
- old_PV_oku
- 16.64944402
- corrected_PV_oku
- 16.68640356
- start_2036_economic_shares_m
- 867.0366575
- 2037_post_economic_shares_m
- 870.8366575
- 2037_issuer_paid_subscriptions_oku
- 0.0046566245895818
- 2037_paid_issue_per_share_GBP
- 1.1641561473954
- 2037_fair_price_after_issue_GBP
- 1.2935068304394
- 2037_fair_price_market_buyback_policy_GBP
- 1.2975825267948
- 2037_gross_repurchase_market_oku
- 0.049308136018204
- 2037_paid_issue_cash_market_neutral_policy_oku
- 0.0046712970964614
- 2037_net_cash_required_market_neutral_policy_oku
- 0.044636838921743
- 2037_future_SBC_expense_oku
- 0.45626728043192
- no_future_paid_issuance_terminal_old_oku
- 10.772984454596
- ignored_paid_proceeds_2036_terminal_oku
- 10.737024536969
- full_fair_market_paid_proceeds_2036_terminal_oku
- 10.774151977858
- market_neutral_repurchase_2036_terminal_oku
- 10.758565446598
- ex_date_rechecks_count
- 20
- FY_ledger_2026_to_2036_SHA256
c1a3b546cd8847dce8be9cfad727549c050a3f2e81a70832280f68783a48a4f3
- 2
内容を開く
- id
bear
- label
弱気
- 確率
- 20.00%
- free_SBC_m
- 3.15
- paid_issued_m
- 0.28
- total_issued_m
- 3.43
- old_2036_terminal_oku
- 41.949231702
- corrected_2036_terminal_oku
- 42.301083592521
- old_2036_IRR
- -0.0424760546
- corrected_2036_IRR
- -0.0418433201
- old_PV_oku
- 34.2419803
- corrected_PV_oku
- 34.38393989
- start_2036_economic_shares_m
- 836.1709874
- 2037_post_economic_shares_m
- 839.6009874
- 2037_issuer_paid_subscriptions_oku
- 0.013337295340245
- 2037_paid_issue_per_share_GBP
- 4.7633197643733
- 2037_fair_price_after_issue_GBP
- 5.2925775159703
- 2037_fair_price_market_buyback_policy_GBP
- 5.3055846700607
- 2037_gross_repurchase_market_oku
- 0.18198155418308
- 2037_paid_issue_cash_market_neutral_policy_oku
- 0.013370073368553
- 2037_net_cash_required_market_neutral_policy_oku
- 0.16861148081453
- 2037_future_SBC_expense_oku
- 0.56106876163074
- no_future_paid_issuance_terminal_old_oku
- 42.30951074455
- ignored_paid_proceeds_2036_terminal_oku
- 42.182331118377
- full_fair_market_paid_proceeds_2036_terminal_oku
- 42.314318079806
- market_neutral_repurchase_2036_terminal_oku
- 42.237692980634
- ex_date_rechecks_count
- 20
- FY_ledger_2026_to_2036_SHA256
a2e5b5ea6f11ae27f99b0e9ef7fb45ccfb193bd7e58dd3d6ecefffce2ba154f2
- 3
内容を開く
- id
base
- label
中立
- 確率
- 40.00%
- free_SBC_m
- 2.9
- paid_issued_m
- 0.2
- total_issued_m
- 3.1
- old_2036_terminal_oku
- 114.63489927
- corrected_2036_terminal_oku
- 115.75462821196
- old_2036_IRR
- 0.0635234669
- corrected_2036_IRR
- 0.0643258394
- old_PV_oku
- 76.78471106
- corrected_PV_oku
- 77.23648145
- start_2036_economic_shares_m
- 730.2724252
- 2037_post_economic_shares_m
- 733.3724252
- 2037_issuer_paid_subscriptions_oku
- 0.03008847851086
- 2037_paid_issue_per_share_GBP
- 15.04423925543
- 2037_fair_price_after_issue_GBP
- 16.715821394922
- 2037_fair_price_market_buyback_policy_GBP
- 16.739661132638
- 2037_gross_repurchase_market_oku
- 0.51892949511179
- 2037_paid_issue_cash_market_neutral_policy_oku
- 0.030131390038749
- 2037_net_cash_required_market_neutral_policy_oku
- 0.48879810507304
- 2037_future_SBC_expense_oku
- 0.70783231206378
- no_future_paid_issuance_terminal_old_oku
- 115.77471799239
- ignored_paid_proceeds_2036_terminal_oku
- 115.41430820689
- full_fair_market_paid_proceeds_2036_terminal_oku
- 115.79255978604
- market_neutral_repurchase_2036_terminal_oku
- 115.45189520245
- ex_date_rechecks_count
- 20
- FY_ledger_2026_to_2036_SHA256
86bf5243f42d553f0bdf9d6126c77ba8638d36579d68bbc75616192591e11fe5
- 4
内容を開く
- id
bull
- label
強気
- 確率
- 22.00%
- free_SBC_m
- 2.9
- paid_issued_m
- 0.2
- total_issued_m
- 3.1
- old_2036_terminal_oku
- 203.684307187
- corrected_2036_terminal_oku
- 206.18132779122
- old_2036_IRR
- 0.1254535399
- corrected_2036_IRR
- 0.1265285363
- old_PV_oku
- 122.1404103
- corrected_PV_oku
- 123.14786837
- start_2036_economic_shares_m
- 687.4005414
- 2037_post_economic_shares_m
- 690.5005414
- 2037_issuer_paid_subscriptions_oku
- 0.057310035570423
- 2037_paid_issue_per_share_GBP
- 28.655017785211
- 2037_fair_price_after_issue_GBP
- 31.838908650235
- 2037_fair_price_market_buyback_policy_GBP
- 31.844463999628
- 2037_gross_repurchase_market_oku
- 0.98717838398848
- 2037_paid_issue_cash_market_neutral_policy_oku
- 0.057320035199331
- 2037_net_cash_required_market_neutral_policy_oku
- 0.92985834878915
- 2037_future_SBC_expense_oku
- 0.86055882766899
- no_future_paid_issuance_terminal_old_oku
- 206.21758591791
- ignored_paid_proceeds_2036_terminal_oku
- 205.42105562617
- full_fair_market_paid_proceeds_2036_terminal_oku
- 206.26613094086
- market_neutral_repurchase_2036_terminal_oku
- 205.34347903854
- ex_date_rechecks_count
- 20
- FY_ledger_2026_to_2036_SHA256
f1f361d13021796ed8f9b406e365682ab4eaf0d6db69b4cfc986b8a2f1dce40a
- 5
内容を開く
- id
very_bull
- label
最良
- 確率
- 8.00%
- free_SBC_m
- 3.05
- paid_issued_m
- 0.24
- total_issued_m
- 3.29
- old_2036_terminal_oku
- 300.349987929
- corrected_2036_terminal_oku
- 305.34655505458
- old_2036_IRR
- 0.1685798416
- corrected_2036_IRR
- 0.1701055776
- old_PV_oku
- 168.88656248
- corrected_PV_oku
- 170.90249774
- start_2036_economic_shares_m
- 668.745312
- 2037_post_economic_shares_m
- 672.035312
- 2037_issuer_paid_subscriptions_oku
- 0.10556409673347
- 2037_paid_issue_per_share_GBP
- 43.985040305614
- 2037_fair_price_after_issue_GBP
- 48.872267006237
- 2037_fair_price_market_buyback_policy_GBP
- 48.784554666435
- 2037_gross_repurchase_market_oku
- 1.6050118485257
- 2037_paid_issue_cash_market_neutral_policy_oku
- 0.1053746380795
- 2037_net_cash_required_market_neutral_policy_oku
- 1.4996372104462
- 2037_future_SBC_expense_oku
- 1.0172246276761
- no_future_paid_issuance_terminal_old_oku
- 305.40141089449
- ignored_paid_proceeds_2036_terminal_oku
- 303.74247715319
- full_fair_market_paid_proceeds_2036_terminal_oku
- 305.52576372641
- market_neutral_repurchase_2036_terminal_oku
- 303.40973167543
- ex_date_rechecks_count
- 20
- FY_ledger_2026_to_2036_SHA256
a67ab6a8b4b7e5b01bccdf926c4036ea419ebf17cb0749a98dd17593a8ba4420
- v1_expected_IRR
- 0.0687102009
- v2_expected_IRR
- 0.0697092425
- v1_expected_PV_oku
- 79.60904015
- v2_expected_PV_oku
- 80.204751772
- old_10y_cash_receipts_sum_expected_unchanged
- はい
- scenario_annual_rows
- 55
- first_20year_future_sensitivity_ledger_rows
- 100
- future_pre_ex_date_review_zero_cash_events_added
- 100
単位の説明
- money
億GBP
- one_oku_gbp
100,000,000 GBP
- reported_actuals
USD million
- 株数
million shares (m) except where stated
- rates
decimal
- events
amount=億GBP、date_assumed=YYYY-MM-DD、year=daycount/365.25
分析基準とデータ
- 価格・単価
- 11.61
- 株価基準日
2026-11-06
- 株数
- 837234165
- 株価の出所
https://shareprices.com/lse/sn./
- 株数の出所
https://www.smith-nephew.com/en/investors
- detail
内容を開く
- 価格・単価
内容を開く
- 日付
2026-11-06
- exchange
London Stock Exchange
- gbp_pence
- 1161
- gbp_per_share
- 11.61
- source_key
ft_price_20261106
- 状態
現地主上場市場の二次情報で確認済み終値
- 株数
内容を開く
- reference_date
2026-10-31
- date_published
2026-11-02
- 発行済株式数
- 877750024
- 自己株式数
- 40315859
- voting_rights_shares
- 837434165
- employee_trust_held_shares_2025_12_31_approx
- 400000
- employee_trust_shares_at_basis_proxy
- 200000
- employee_trust_at_basis_strictly_verified
- いいえ
- economic_shares_m_at_basis_proxy
- 837.234165
- market_cap_oku_GBP_using_voting_rights
- 97.22610656
- market_cap_oku_GBP_using_economic_denominator_proxy
- 97.20288656
- ordinary_issued_changes_Nov1_to_Nov6_verified
- いいえ
- denominator_basis
発行済−自己株−2026年11月6日時点未確認の従業員信託0.2百万株代理。自己株と信託を重複控除しない。
- source_key
lse_total_voting_rights_20261031
- sensitivity_no_trust_mcap_oku
- 97.22610656
- sensitivity_trust_0_4_mcap_oku
- 97.17966656
- fx
内容を開く
- GBPUSD
- 1.3352
- 日付
2026-11-06
- historical_market_spot_source
gbpusd_20261106
- forecast_conversion_rule
全予測2026-2037年でGBPUSD=1.3352固定。現実には変動し、感応度で見直す。
- financial_actual_2025_IFRS_usdm
内容を開く
- sales
- 6164
- costs_including_sbc
- 5370
- operating_profit
- 794
- profit_before_tax
- 779
- parent_attributable_profit_after_sbc
- 625
- parent_equity
- 5289
- cash
- 557
- gross_debt_incl_lease
- 3327
- simple_net_debt
- 2770
- company_reported_net_debt
- 2759
- cash_capex
- 433
- SBC_expense
- 43
- dividends_paid
- 330
- purchase_own_shares_paid
- 502
- FY2025_trading_profit_nonIFRS
- 1211
- US_sales
- 3306
- Other_Established_sales
- 1855
- Emerging_sales
- 1003
- source_key
company_fy2025_20f
- financial_actual_H1_2026_IFRS_usdm
内容を開く
- 期間末
2026-06-27
- sales
- 3097
- COGS
- 901
- SGA_including_SBC
- 1598
- RD
- 150
- operating_profit
- 448
- net_interest_income
- 10
- interest_expense
- 65
- other_finance_cost
- 18
- associate_income
- 5
- profit_before_tax
- 380
- income_tax
- 77
- parent_attributable_profit_after_sbc
- 303
- noncontrolling_interest
- 0
- parent_equity
- 5180
- cash
- 754
- gross_borrowings_including_lease
- 3785
- company_reported_net_debt
- 3019
- simple_net_debt
- 3031
- company_net_debt_vs_simple_gap_explained_by_definition_usdm
- -12
- cash_capex
- 190
- SBC_expense_equity_settled
- 34
- dividends_paid
- 205
- cash_paid_for_own_shares_H1
- 116
- H1_equity_reduction_for_buyback_including_obligations
- 250
- H1_buyback_purchased_shares
- 9076588
- H1_buyback_purchased_cost_usdm
- 137
- H1_buyback_forward_contract_commitment_usdm
- 113
- H1_contingent_acquisition_consideration_liability
- 286
- source_key
company_h1_2026_6k
- Q3_2026_actual_revenue_usdm
内容を開く
- quarter_end
2026-09-26
- consolidated
- 1551
- sports_medicine_ENT
- 507
- advanced_wound
- 454
- orthopaedics
- 590
- US
- 812
- Other_Established
- 456
- Emerging
- 283
- source_key
company_q3_2026
- 2026_Q4_full_projection_from_guidance_usdm
内容を開く
- consolidated
- 1763
- by_segment
- Orthopaedics
- 687
- Sports_Medicine_ENT
- 582
- Advanced_Wound_Management
- 494
- reported_2026_full_sales
- 6411
- company_guidance_trading_profit_usdm_around
- 1250
- company_guidance_free_cash_flow_usdm_around
- 750
- company_guidance_underlying_revenue_growth
- 0.03
- comment
2026Q4=6411−3097−1551; 6411は2025年6164に会社示唆約4.0%報告成長を適用した予測、確定実績ではない
- at_asof_2026_11_06_financial_proxy_usdm
内容を開く
- H1_2026_reported_parent_equity
- 5180
- post_H1_to_Nov06_parent_profit_forecast
- 190
- post_H1_to_Nov06_SBC_non_cash_equity_credit_forecast
- 26
- interim_dividend_declared_and_paid_post_H1_estimate
- 131
- extra_H2_buyback_equity_debit_before_Nov06_assumed
- 0
- post_H1_OCI_assumed
- 0
- calculated_proxy_parent_equity
- 5265
- cash_at_H1
- 754
- post_H1_pre_basis_fcf_proxy
- 320
- post_H1_pre_basis_prior_buyback_obligation_cash_settlement_proxy
- 134
- interim_dividend_payment_proxy
- 131
- estimated_cash_at_Nov06
- 809
- estimated_gross_borrowings_at_Nov06
- 3785
- unreconciled_exact_post_H1_event_data
- 未確認
- uncertainty
2026-06-27から2026-11-06の実際の損益・現金・SBC交付・取得決済は未公表。2.50億USDの買戻しはH1資本に既に計上済みで、当該決済を再び資本控除しない。
- prior_ex_div_payment_excluded_from_future_holder_flows
内容を開く
- fiscal_year
- 2026
- kind
interim
- usd_per_share
- 0.156
- confirmed_ex_date
2026-10-01
- confirmed_record_date
2026-10-02
- confirmed_payment_date
2026-11-06
- date_status
confirmed_by_issuer
- cashflow_in_y10
- いいえ
- 理由
基準日11月6日終値から買う/同日終値で評価する旧株主群に新しい権利は付かず、基準日前に権利が分離済み。
追加データ・検証記録
分析ごとに収録された追加の前提、年度別データ、検証上の注意を確認できます。